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Abstract  
Extracellular matrix (ECM) molecules play important structural and mechanical 
roles in muscle tissue. They are also critical for normal muscle homeostasis, but it 
is poorly understood how individual matrix proteins like collagen type I or 
fibronectin, or a mixture of ECM proteins affects myoblast behaviour. Aspects of 
this question have been examined in this thesis using both acellular matrices from 
skeletal muscle and artificial scaffolds prepared from silk proteins. The ability of 
these surfaces to support myoblast proliferation and differentiation was examined 
using a murine myoblast cell line and primary human skeletal muscle myoblasts.  
This study describes a new method for decellularisation of skeletal muscle that 
uses an enzyme called phospholipase A2 and a mild detergent, sodium 
deoxycholate. This decellularisation method effectively removed all intact muscle 
cells, and the majority of the nuclear material and cytoplasmic proteins. The 
remaining acellular ECM contained most of the structural matrix proteins for 
example: collagens type I, III, IV and VI; major glycoprotein components like 
fibronectin and laminin-α2; and proteoglycans like perlecan, decorin, plus the 
retention of a heparan sulphate epitope. Scanning electron microscopy and atomic 
force microscopy revealed ultrastructural and nanotopographical differences in the 
control muscle and decellularised muscle matrices.  
The mouse myoblast cell line, C2C12, was used to assess the functionality of the 
acellular matrix.  Proliferation and differentiation of C2C12 cells on solubilized 
and three-dimensional skeletal muscle matrices in a serum free culture system 
were examined. Use of a serum free culture system removed any possibility that 
soluble ECM molecules in the culture medium have affected cell behaviour, or 
have modulated the contribution of the matrix protein substrates to myoblast 
differentiation. C2C12 mouse myoblasts proliferated on a muscle matrix substrate 
prepared from solubilized acellular muscle, but seemed to progress towards 
differentiation at a lower confluency when compared to C2C12 cells cultured on 
collagen type I and fibronectin coated surfaces. Gene expression data of a 
selection of genes responsible for myotube formation suggested a similar 
differentiation pattern on muscle matrix and fibronectin. Furthermore, three-
dimensional acellular muscle matrix supported cell growth and provided physical 
xii 
 
and chemical signals for cell alignment/orientation, suggesting that in vivo it is the 
muscle ECM that directs cell positioning.  
The artificial scaffolds were prepared from silk fibroin of four insect species: the 
mulberry variety Bombyx mori and non-mulberry varieties Antheraea mylitta, 
Antheraea assamensis/assama and Samia ricini. These scaffolds were tested in 
vitro to determine if it may be possible to utilize scaffolds from a particular 
species as a biomaterial for future skeletal muscle tissue engineering in vivo. All 
the silk proteins, when solubilised and used as substrates, promoted the growth, 
proliferation and differentiation of C2C12 myoblasts in serum free cultures. Silk 
fibroin substrates also supported the differentiation of primary human skeletal 
muscle myoblasts (HSMMs) as was shown by immunostaining against 
antibodies to skeletal muscle slow myosin heavy chain and the glucose 
transporter 4. Scanning electron microscopy of the three-dimensional silk 
scaffolds revealed that the HSMMs spread across the scaffold pores and 
deposited matrix proteins onto the scaffold material. Differentiation of HSMMs 
on the three-dimensional scaffolds was triggered more readily on some scaffolds 
than on others. For example, on B. mori scaffolds HSMMs formed extremely 
long, well aligned myotubes that stained for myosin, whereas the myotubes 
formed on A. mylitta scaffolds appeared thicker and much shorter. The other two 
scaffolds from A. assamensis and S. ricini silk fibroin poorly supported 
differentiation of HSMMs. As a result, it is proposed that B. mori and A. mylitta 
scaffolds are most likely to be useful as three dimensional frameworks for 
skeletal muscle repair in in vivo muscle injury models.   
 
Overall, the goal of this project was to use natural skeletal muscle matrices and 
silk bio-scaffolds to obtain information about ECM components that promote 
growth and differentiation of muscle precursor cells. This information will assist 
the development of a muscle specific scaffold that stimulates and enhances the 
repair and regeneration of aged or damaged skeletal muscle.  
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Chapter 1: 
Introduction and Literature Review 
Chapter 1 
2 
 
1.0 History of Tissue Engineering: 
The concept of tissue engineering (TE) evolved from a mythical Greek story where 
Prometheus is punished by Zeus for stealing fire from the Gods and giving it to 
mankind. Every day an eagle would eat his liver but it is said that Prometheus liver grew 
as much as it was eaten (Hesiod theogony, 1987). In the modern world context, the idea 
of using one tissue as a replacement for another was first attempted by Prof Alexis 
Carrel and Charles Lindbergh at the Rockefeller Institute for Medical Research when 
they transplanted blood vessels from dogs to the abdominal aorta of cats. In 1912 Alexis 
Carrel received the Nobel Prize for physiology or medicine for his work on “vascular 
suture and the transplantation of organs” [1]. It is against this background that the idea 
of TE emerged, where functional tissue is fabricated using living cells and scaffolds 
(natural and synthetic) that guide tissue development. The term TE was coined by Prof. 
Y C Fung (University of California, San Diego) in 1987 at a National Science 
Foundation meeting. The fields of TE and regenerative medicine were described as 
“emerging multidisciplinary fields involving biology, medicine, and engineering that are 
likely to revolutionize the ways we improve the health and quality of life for millions of 
people worldwide by restoring, maintaining, or enhancing tissue and organ function” 
(National Institute for Health, USA). The goals are to regenerate new biological tissue to 
replace diseased or aged tissue by using cells and extracellular matrix or scaffolds [2].   
End-stage organ failure is a major cause of death worldwide. Organ transplantation is 
presently the only solution to this problem. However, even with the recent technological 
advancements in the field of reconstructive surgery, thousands of people die every year 
due to shortage of organs. In addition, after successful transplantation of an organ there 
are risks associated with chronic immune rejection, lifelong immunosuppression and 
destruction of the transplanted tissue over time. Although Australia is a world leader for 
successful transplant outcomes, it has one of the lowest donation rates in the developed 
world. Around 1600 people are on Australian organ transplant waiting lists (Donate Life 
report, 2011). A more recent Donate life report (2013) revealed the percentage of 
musculoskeletal transplants is a staggering 84% of all the tissue transplants performed, 
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thus, highlighting the need for alternative avenues for musculoskeletal repair and 
regeneration (Donate Life report, 2013) (http://www.donatelife.gov.au). 
1.1 Muscle mass loss due to injury, disease or ageing 
Skeletal muscle mass gradually decreases as people age, with 20-30% of the skeletal 
muscle mass lost between the ages of 40 and 80 years [3]. This is likely to be due to an 
age-related gradual decline in the regenerative response of the skeletal muscle to 
damage. Compared to young muscle, aged muscle responds with a delayed and 
sometimes only partly effective regeneration response to injury or overuse [4]. Data 
suggests that these age related changes in regeneration may be due to changes in the 
external environment rather than changes intrinsic to muscle satellite cells or to a 
decrease in the number of satellite cells [5-8]. A number of other factors may also 
contribute to muscle loss. Various muscle related disorders like Duchenne muscular 
dystrophy (DMD), dermatomyositis or polymyositis lead to a progressive reduction in 
muscle mass. Muscle fibre necrosis is the most common form of damage to muscle 
fibres, the other being muscle fibre atrophy. Muscle injuries are very common in sports, 
accounting for 10%-55% of sports injuries [9]. These statistics suggests that muscle 
repair and regeneration is an important issue which needs more focus and attention. 
1.2 Skeletal muscle:  
1.2.1 Structure of a skeletal muscle        
Skeletal muscle performs diverse functions like walking, running, holding an object or 
maintaining the posture. If a skeletal muscle is damaged due to a disease or trauma, it 
can account for changes in lifestyle, restricting movement or sometimes causing muscle 
impairment and disability. Skeletal muscle consists of individual muscle cells called 
muscle fibres or myofibres. They are among the largest cells in the human body ranging 
from 10µm to 100µm in diameter. Each one contains many nuclei surrounded by a 
common cytoplasm and is formed by the fusion of myoblasts as these myoblasts 
terminally differentiate and cease dividing. Each muscle fibre runs along the entire 
length of the muscle, which can be as long as 35 cm in a human thigh. It contains many 
individual contractile subunits called myofibrils extending from one end of the fibre to 
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the other. Each cylindrical myofibril is surrounded by sarcoplasmic reticulum, a 
complex of membranes forming a network of hollow tubes [10]. The sarcoplasmic 
reticulum surrounds the myofibrils and holds a reserve of calcium ions needed for 
muscle contraction.  
The principal cytoplasmic proteins of the myofibres are myosin and actin (also known as 
"thick" and "thin" filaments, respectively), which are arranged in a repeating unit called 
a sarcomere. This arrangement of actin and myosin gives skeletal muscle its 
characteristic striated appearance when a stained longitudinal section of a muscle is 
viewed under a light microscope [11]. The interaction of myosin with actin is 
responsible for muscle contraction. Skeletal muscle can produce contractions ranging 
from quick twitches to powerful sustained tensions [12]. Figure 1.1 shows the structure 
of a skeletal muscle [13].  
1.2.2 Muscle repair and regeneration: 
1.2.2.1 Satellite cells      
Skeletal muscles have the ability to repair themselves after damage or loss due to injury, 
disease or ageing. This is due to the presence of a small population of cells called 
satellite cells or muscle stem cells. Satellite cells (SC) are mononuclear progenitor cells 
that are located on the outside of the muscle fibres between the basement membrane and 
the plasma membrane (sarcolemma) of muscle fibres and are responsible for the 
regenerative potential of skeletal muscle. Satellite cells were first observed in the 
Tibialis anticus muscle of a frog [14]. They are present in all mammalian voluntary 
muscles including the muscle spindles [15]. However, other involuntary muscles like 
cardiac striated muscle and smooth muscle do not contain satellite cells [16]. Although 
they are generally evenly distributed along a muscle fibre some studies suggest an 
increased number of satellite cells over at the myoneural junctions in association with 
soluble acetyl-cholinesterase (AChE) at the end of the fibres [17]. Satellite cell numbers 
vary according to the type of muscle. Lagord et al (1998) did an in vitro study to 
compare the proliferation and differentiation potential of satellite cells isolated from two 
different muscles from rats, extensor digitorum longus (EDL) and soleus. They found  
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Figure 1.1 Structure of a skeletal muscle. Skeletal muscle consists of 
individual muscle cells called muscle fibres or myofibres. Each one contains 
many nuclei surrounded by a common cytoplasm and is formed by the fusion of 
myoblasts as they terminally differentiate and cease dividing. Each muscle fibre 
runs along the entire length of the muscle, which can be as long as 35 cm in a 
human thigh. It contains many individual contractile subunits called myofibrils 
extending from one end of the fibre to the other. Each cylindrical myofibril is 
surrounded by sarcoplasmic reticulum, a complex of membranes forming a 
network of hollow tubes. The sarcoplasmic reticulum surrounds the myofibrils 
and holds a reserve of calcium ions needed for muscle contraction. The principal 
cytoplasmic proteins of the myofibres are myosin and actin (also known as 
"thick" and "thin" filaments, respectively), which are arranged in a repeating unit 
called a sarcomere. This arrangement of actin and myosin gives skeletal muscle 
its characteristic striated appearance when a stained longitudinal section of a 
muscle is viewed under a light microscope. (Image adapted from [13]) 
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that the satellite cell yield from soleus was 50% higher than EDL. After culturing these 
satellite cells on gelatin-coated culture dishes using normal growth media, they found 
that satellite cells from soleus muscles were more proliferative than the EDL derived 
satellite cells. However, the differentiation potential of EDL derived satellite cells was 
significantly higher than soleus derived satellite cells. Their study suggested that satellite 
cells have intrinsic differences which can affect the repair process of a muscle [18].  
Once activated, satellite cells proliferate, migrate to the damaged area of the muscle, 
differentiate and fuse to form new muscle fibres which leads to an increase in the cross 
sectional area of the muscle [19]. Satellite cells are considered functionally 
heterogeneous in terms of their proliferative and myogenic potential. This is believed to 
be due to the effects of the different niches, or the microenvironment surrounding the 
cells [20, 21]. Although satellite cells play an indispensable role in skeletal muscle repair 
and regeneration, they are not the only cells capable of skeletal muscle repair. In recent 
years, several research groups have shown that other muscle derived stem-cells and 
circulating progenitor cells such as bone-marrow-derived cells have a potential for 
skeletal muscle repair [21-24]. Merritt and colleagues (2010) demonstrated the 
regenerative potential of bone-marrow derived mesenchymal stem cells (MSCs) in vivo 
[25]. They developed an injury model by creating a full thickness defect in the lateral 
gastrocnemius (LGAS) of Lewis rats. They implanted decellularized extracellular matrix 
(ECM) at the injury site and after 7 days seeded MSCs onto the ECM. They showed 
enhanced functional recovery of the muscle and 94% tension (maximum tetanic force 
per unit of muscle cross-sectional area) restoration when compared to the contralateral 
muscle after 42 days of implantation [25]. 
1.2.2.2 Skeletal muscle repair 
Skeletal muscle repair is a highly synchronized process which follows a universal 
pattern independent of the type or severity of the injury [9] [26]. It can be divided into 
three phases:         
1. Inflammatory phase: This is when rupture and necrosis of myofibres occurs and an 
inflammatory cell reaction is elicited. When a muscle is injured, myofibres rupture and 
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release their intracellular contents into the extracellular environment. This is triggered 
by an increased influx of Ca
2+
 through either, voltage gated Na
2+
 channels or through 
transient receptor potential channels. Increased Ca
2+
 levels activate Ca
2+
 dependent 
caspases like calpain, which leads to disintegration of the plasma membrane and other 
cell constituents. Increased cytosolic Ca
2+
 levels can also trigger membrane lipid 
peroxidation which is caused by an increase in the reactive oxygen species (ROS) levels 
[27]. What follows is the entry of plasma proteins into the damaged myofibres which 
leads to the activation of the complement cascade, resulting in the release of chemotactic 
factors that direct firstly, the migration of neutrophils followed by the infiltration of 
macrophages. Two distinct populations of macrophages (M1 and M2) have been 
identified in injured muscle tissue [28]. M1 macrophages secrete pro-inflammatory 
cytokines like tumor necrosis factor alpha (TNF-α) and interleukin-1 beta (IL-1β) and 
phagocytose the necrotic tissue. M2 macrophages cease the inflammation reaction by 
releasing anti-inflammatory cytokines like IL-10 and promote myoblast proliferation and 
differentiation by releasing growth factors like platelet derived growth factor (PDGF), 
basic fibroblast growth factor (bFGF) and other cytokines at the injury site [29-31] 
2. Repair phase: Activation of muscle precursor cells leads to the formation of new 
muscle fibres and a simultaneous formation of scar tissue. Following muscle injury, 
multiple signals trigger the activation of satellite cells. Sphingosine-1 seems to trigger 
the initial activation, as when it is not present, satellite cells cannot enter the cell cycle 
and the repair process is defective [32]. Hepatocyte growth factor (HGF) also plays a 
role in satellite cell activation by binding to its receptor, c-met, on satellite cells and 
thereby inhibiting their differentiation into myotubes [33]. Activated satellite cells 
undergo asymmetric division to form two groups of cells, quiescent new stem cells and 
myogenic precursor cells (MPCs). MPCs will migrate through the damaged basal lamina 
and differentiate, fusing either with existing myoblasts or with damaged myofiber ends 
to form new muscle fibres. Simultaneously, infiltration of fibroblasts into the wound site 
with an excessive deposition of ECM molecules, mainly collagens, leads to the 
formation of a connective tissue scar. Scar tissue develops in between the stumps of two 
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regenerating myofibres and myotendinous junctions are formed within the scar tissue 
[9]. 
3. Remodelling phase: Reorganization of the muscle fibres is the next step and muscle 
function is restored by the remodelling of the scar tissue. Here in this phase, regenerated 
fibres are marked by the presence of centrally located nuclei and an intact basal lamina 
plays a major role in this stage of the repair process. Satellite cells and myotubes can 
fuse to form a myofibre if the basal lamina is intact. New muscle fibres develop 
connections with the surrounding ECM and their morphology changes during the 
process, forming forked or split fibres outside the basal lamina [34]. It is also essential 
for newly developed muscle fibres to develop neuromuscular junctions to avoid muscle 
atrophy.  
1.2.2.3 Growth factors for myoblast proliferation and differentiation 
Muscle ECM contains a multitude of growth factors which are secreted by the muscle 
cells and progenitor cells in response to an injury. Immune cells, neurons and associated 
vasculature also release growth factors to the injury site and this complex mix of growth 
factors plays a key role in determining the outcome of the muscle repair process. Key 
factors involve in the proliferation and differentiation of the myoblasts includes: 
hepatocyte growth factor (HGF) [35], insulin like growth factor-1 (IGF-1) [36], platelet 
derived growth factor (PDGF-AA, PDGF-BB), basic fibroblast growth factor (bFGF) 
[37], vascular endothelial growth factor (VEGF) and nerve growth factor (NGF).  
In vitro studies have proposed a major role for IGF-1 in myoblast proliferation and 
muscle growth. IGF-1 promotes the proliferation of satellite cells thereby altering a 
range of myogenic markers. Interestingly, direct injection of IGF-1 into the muscle 
enhances muscle regeneration potential while systemic injection leads to muscle 
hypertrophy [36, 38]. Although the exact molecular mechanism of how IGF-1 interacts 
with other molecules and affects the proliferation of satellite cells is not known, there is 
one study which shows the involvement of PI3K pathway and Akt activation in this 
process [39]. Other studies have shown HGF is involved in satellite cell proliferation 
[33, 35] and the expression of HGF increases with the severity of the muscle injury [40, 
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41]. However, an inhibitory role for HGF has also been suggested because if it is 
injected directly into the muscle at its differentiation stage, it inhibits myotube formation 
and does not support muscle repair and regeneration [42].  
In addition to growth promoting factors there are growth inhibiting factors residing 
among the molecules within the muscle ECM. Major growth inhibitory factors are 
transforming growth factor-α and –β1 (TGF-α, TGF-β1) and myostatin which is a 
member of the TGF-β superfamily [43]. TGF-β1 primarily acts to inhibit the 
proliferation and differentiation of myoblasts by blocking their recruitment to the injury 
site [44, 45]. It also induces the formation of scar tissue at the site of muscle injury 
which further hampers the muscle regeneration process [9].  
1.2.2.4 Different genes involved in muscle differentiation 
Formation of myofibers during embryonic development and muscle regeneration is a 
complex process and a number of different genes are involved in the process of muscle 
differentiation. The Myogenic regulatory factors (MRFs) are a group of basic helix-
loop-helix factors which were discovered in the late 1980’s [46-48]. They acts as 
transcriptional regulators by binding to DNA consensus sites called E- boxes; the basic 
domain of the MRF binds to DNA and the helix-loop-helix heterodimerizes with E 
proteins which are transcriptional activator proteins [49]. These factors are the master 
regulators of skeletal myogenesis and are highly conserved along the skeletal muscle 
lineage. Four MRFs regulate myogenesis: MyoD, myogenic regulatory factor 5 (Myf5), 
Myogenin (MyoG) and MRF4. Myf5 is the first regulatory factor to be expressed during 
mouse embryogenesis at day 8 [50], followed by myogenin and MRF4 at days 8.5 and 9 
respectively. MyoD is the last to be expressed at day 10.5 [51]. MRF null mutations and 
MRF knockouts in different mouse models have increased our understanding of how 
these factors function in vivo. Rudnicki et al (1992) demonstrated that myoD null mice 
(myoD
-/-
) showed normal muscle development with no adverse effects on the physiology 
and morphology of skeletal muscles [52]. However, the mutation led to a prolonged 
increase in the expression levels of myf5 [52]. Similarly, myf5 null mice (myf5
-/-
) also 
displayed a normal muscle phenotype with no change in the levels of myoD, myogenin 
or MRF4. However, these mice died perinatally due to their abnormal rib development 
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and an inability to breathe [53]. The above mouse models and a myoD/myf5 double 
knockout suggest a functional redundancy in these two genes as only the absence of both 
genes cause an abnormality in skeletal muscle formation [54]. Myogenin knockout mice 
(myoG
-/-
) suggest a possible role for myogenin in the later stages of differentiation as 
these mice were capable of forming myoblasts but were unable to form myotubes [55].  
1.3 Extracellular matrix (ECM) in skeletal muscle:   
ECM is the structural scaffold of the connective tissue and comprises a dense meshwork 
of interacting molecules including structural proteins like collagen and elastin, 
glycoproteins like fibronectin, vitronectin and laminin; proteoglycans such as biglycan, 
decorin and tenascin, as well as signalling molecules like cytokines and growth factors. 
The composition of the ECM varies from one tissue type to another; different proteins 
and proteoglycans combine in various proportions to provide a specific organization to 
the tissue. For example, a tissue like skin has more elastic ECM than bone which has a 
very stiff ECM. The interstitial connective tissue around muscle fibres accounts for 
between 1 and 10% of muscle mass. It assists in the proper alignment of muscle cells, 
provides a scaffold for nerves, blood and lymphatic vessels [4], and transfers force 
generated within the muscle fibres to move the skeleton [56]. Anatomically, muscle 
ECM can be divided into endomysium (around the muscle cell), perimysium (around 
groups of muscle cells) and epimysium (around the whole muscle) (Figure 1.2). 
1.3.1 Endomysium 
Each muscle fibre is surrounded by a layer of highly ordered connective tissue, the 
endomysium. It is composed of a dense meshwork of collagen fibres that are 60nm-
120nm in diameter and it forms a continuous sheath covering the full length of the 
myofibres [57]. The basic understanding of muscle cell endomysium structure and 
function comes from the work of Purslow and Trotter (1992, 1994) with feline and 
bovine muscle [58, 59]. They showed that the endomysium is responsible for 
transmitting force generated within the sarcomeres of myofibres to the tendon and 
adjacent myofibres. Jarvinen and colleagues (2002) studied the connective tissue 
arrangement in three rat muscles (soleus, tibialis anterior and gastrocnemius) under  
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Figure 1.2 Scanning electron micrographs showing skeletal muscle ECM from the 
quadriceps muscle of 3 month old Sprague Dawley rats. Muscles were cryo-
sectioned and formaldehyde fixed, dehydrated in graded series of ethanol, dried and 
observed under a scanning electron microscope. (A) Group of muscle fascicles showing 
the underlying arrangement of perimysium (white box) and endomysium (short white 
arrows). (B) Enlarged view of white box in the subsequent image reveals meshwork of 
collagen fibrils (white arrows) between the muscle fibres. (C) Longitudinal muscle 
fibres connected with discrete patches of ECM along the length (white arrows). Scale 
bar-20µm for A-C.  
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normal conditions and when rats were immobilized for three weeks [60]. Scanning 
electron microscopy revealed three separate networks of collagen fibres in the 
endomysium; (a) collagen fibres running along the surface of muscle fibres in parallel to 
the orientation of muscle fibres, (b) collagen fibres running perpendicularly to the 
muscle fibres and connecting two adjacent fibres, and (c) collagen fibres connected to 
neural and vascular networks. Immobilization led to an increase in (a) endomysial 
collagen, mainly deposited on the sarcolemma of muscle fibres and (b) number of 
perpendicular collagen fibres in the endomysium [60].  
1.3.2 Perimysium 
The perimysium encloses a number of myofibres into bundles or fascicles and it contains 
capillaries, nerves and lymphatics that run through the muscle. Arterioles and venules 
are found in this region along with intramuscular nerve branches. Compared to the 
collagen fibres in endomysium, perimysial collagen fibres are tightly woven, have a 
thicker diameter (600nm-1800nm) and extend along and across the muscle fibres [57]. 
Passeurix and colleagues (2006) analysed the structural organization of perimysium in 
bovine skeletal muscles and they found structures, 150µm-200µm long, called 
perimysial junctional plates (PJPs). These PJPs connect the endomysium to the 
perimysium [61]. The higher order arrangement of perimysium remains unknown as 
there are very few studies that strictly define these structures [62].  
1.3.3 Epimysium 
The entire muscle is encircled by a sheath of dense, irregular connective tissue, the 
epimysium, which protects muscles against friction from other muscles and bones. This 
layer can be dissected from the muscle allowing it to be mechanically tested. Gao et al 
(2008) developed a micromechanical model to describe the age related changes in the 
epimysium of old and young rats [63]. They found that the epimysium from old rats was 
much stiffer than that of the young rats. This finding may have implications in 
understanding the role of muscle ECM in ageing populations and under some 
pathophysiological conditions [63].  
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1.4 Components of the ECM in skeletal muscle: 
The ECM in skeletal muscle is composed of structural and adhesion proteins such as 
collagens, laminins, fibronectin, vitronectin and a variety of proteoglycans (PGs). The 
ECM is an important constituent of the satellite cell niche and it also plays an 
indispensable role in skeletal muscle repair processes.  
1.4.1 Collagen 
Collagen is the most abundant protein in mammals and comprises 25% -35% of the total 
body protein content [64]. It is also the major structural protein in skeletal muscle ECM 
and accounts for 1-10% of muscle mass dry weight and nearly 90% of the dry weight of 
most muscle ECM. To date, twenty eight different types of collagens composed of at 
least 46 different polypeptide chains, have been identified in vertebrates [65]. A 
polypeptide chain in a collagen molecule consists mainly of a regular sequence of amino 
acids Gly-X-Y where X is often proline and Y is hydroxyproline. Each polypeptide 
chain in turn forms an extended left-handed polyproline type-II helix, stabilized by its 
high imino-acid content. All collagens share a basic molecular structure comprised of 3 
polypeptide alpha (α) chains wound in a right-handed triple-helical conformation to 
form a coiled coil [64]. This repeat occurs in all types of collagen, although it is 
disrupted at some locations within the triple helical domain of non-fibrillar collagens 
[66].  
Fibrillar collagens include Type I, II and III and the minor types V and XI. Two 
additional members of the collagen family, XXIV and XXVI have recently been 
identified [67]. Type I and III collagen fibrils predominate in adult endo-, peri-, and 
epimysium. Type I collagen is predominantly present in the perimysium, whereas Type 
III is more evenly distributed between epimysium and endomysium [68]. These studies 
were primarily qualitative and it is unclear whether collagen ratios differ in muscles with 
different functions. This is in part due to difficulties in isolating various regions of ECM. 
Currently available biochemical techniques do not quantify or differentiate collagen 
types very accurately. In addition to their structural biomechanical function, collagens 
also bind to growth factors like transforming growth factor β (TGF-β) and IGF-1 and -2, 
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and affect cell functions such as proliferation and differentiation through these 
interactions [69]. 
1.4.2 Fibronectin  
Fibronectin is a high molecular weight glycoprotein that exists as a 450 kDa dimer of 
two identical chains, with molecular weight of 220-230 kDa each, which are covalently 
linked in an antiparallel manner by two interchain disulfide bridges at the C-terminal end 
[70]. Fibronectin exists mainly in 2 forms: 
1. A soluble dimeric form known as plasma fibronectin is present in the blood and other 
body fluids. Blood plasma contains 300-400 µg/ml of fibronectin [71] which is produced 
by hepatocytes.   
2. A highly insoluble matrix form exists as disulfide-bonded multimers and is plentiful 
in most embryonic and adult mesenchymal tissues, and particularly in loose connective 
tissue. Fibronectin’s role in embryonic development is critical as it has been shown that 
inactivation of the fibronectin gene leads to embryonic lethality in mice [72]. Integrins, 
the key receptors that link the ECM to the internal cellular environment and help in 
signalling bidirectionally across the plasma membrane may bind to fibronectin. Integrin-
fibronectin binding interactions are key regulators of cell-matrix interactions [73]. 
Fibronectin binds to collagen, laminin and other molecules of the ECM and it plays a 
key role in cell adhesion, migration and differentiation [74].  
1.4.3 Laminin  
The laminins are large heterotrimeric molecules (400-900 kDa) composed of three 
chains:  α, β and γ each of which occur in multiple forms and variously combine to 
generate 16 different laminin subtypes. These molecules have a cruciform or T-shaped 
appearance and are a major component of all basement membranes [75]. In skeletal 
muscle, laminins containing the α2 chain are a major component of basement 
membrane, with laminin-2 (α2β1γ1) being the major form around the sarcolemma of 
mature myofibres, while laminin-4 (α2β2γ1) occurs at neuromuscular junctions (where 
the synapses connects nerves to muscle) and myotendinous junctions (where myofibers 
are connected to the tendon) [76]. 
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Laminins play a key role in transmitting the contractile force from the muscle fibre to 
the ECM through binding to the dystrophin glycoprotein complex [77]. In the absence of 
laminin, transfer of the contractile force of the myofibre to the interstitial connective 
tissue fails to occur. Laminin α2 is of central importance as it is required for maintaining 
the stability and structural organization of mature muscle. Genetic defects in the laminin 
α2 chain can cause severe congenital muscular dystrophy in humans [78]. Cell surface 
receptors or integrins also binds to laminin and mediate cell signalling across the cell 
membrane [76].  
1.4.4 Elastin 
Elastic fibres are essential components of an ECM that imparts flexibility and elasticity 
to several organs including skin, lungs, tendon, ligaments, arteries, cartilage and blood 
vessels in all vertebrates [79, 80]. Elastin constitutes 90 % of the elastic fibre with the 
remaining 10 % constituting of microfibrils including proteins like fibrillin-1, fibrillin-2 
and membrane associated glycoprotein [79]. Elastin is formed by cross-linking of 
tropoelastin, a 60-70 kDa molecule which exists as a monomer in solution [81]. Various 
molecules such as glycosaminoglycans bind to tropoelastin [82] and proteoglycans 
(PGs) like biglycan and decorin also interact with tropoelastin [83] 
1.4.5 Proteoglycans (PGs) 
Proteoglycans are proteins modified by the covalent attachment of one or more 
glycosaminoglycan (GAG) chains. They include molecules such as perlecan, decorin 
biglycan and syndecans [74]. GAG molecules are attached to their protein core by a 
specific trisaccharide composed of two galactose residues and a xylose residue. The 
trisaccharide linker is coupled to the protein core through an O-glycosidic bond to a 
serine residue in a serine-glycine motif in the protein. Proteoglycans are structurally 
diverse, some PGs like syndecans are integral membrane glycoproteins where as others 
like perlecan are ECM components. As well as differing in the amino acid sequence of 
their core protein, they also possess different numbers of GAG chains attached to the 
protein core. Proteoglycans are found in all connective tissues, in the ECM and on 
the surfaces of many cell types. They perform a multitude of functions and the major 
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ones include: assisting in the maturation of specialized tissues, influencing cell growth 
and modulating growth-factor activities [84].    
1.4.5.1 Glycosaminoglycans (GAGs) 
GAGs are large complex carbohydrate molecules comprising long unbranched chains of 
repeating disaccharide units composed of an amino sugar (N-acetyl glucosamine or N-
acetyl galactosamine) and a uronic acid (glucuronic acid or iduronic acid). The most 
common GAGs in muscle are heparan sulfates (HS), chondroitin sulfates (CS) and 
dermatan sulfates (DS) [74], and these are found both within the matrix and on the 
surface of muscle cells. Chondroitin sulfate contains the disaccharide unit N-
acetylgalactosamine and glucuronate with on average one sulphate group per 
disaccharide, while DS chains contain different proportions of iduronic acid in place of 
glucuronate and a similar degree of sulfation [85]. 
Heparin is a hydrophilic, linear unbranched GAG consisting of repeating units of uronic 
acid, either L-iduronic or D glucuronic acid in a proportion of approximately 9:1, which 
is linked to glucosamine residues via 1-4 linkage [86]. Heparan Sulphate is similar to 
heparin in its structure and contains the disaccharide unit of N-acetylglucosamine 
alternating with a uronic acid, however the degree of sulfation is much less in HS than in 
heparin. During biosynthesis, the HS chains are covalently linked to their core proteins 
to form heparan sulphate proteoglycans (HSPGs) and HSPGs are the major PGs in the 
basement membrane and on cell surface in skeletal muscle [86].  
Glycosaminoglycans have been implicated in cell behaviours such as proliferation, 
differentiation, adhesion and migration due to their ability to bind growth factors and 
cytokines. The binding of growth factors to GAGs is primarily an electrostatic 
interaction whereby the negative charge of the GAG chain binds basic regions of growth 
factors and cytokines. The binding of growth factors and cytokines to GAGs protects 
these proteins from degradation and presents them to their cell surface receptors [87]. 
Spatiotemporal regulation of PGs in the ECM and on the cell surface creates a specific 
environment around muscle cells that regulates myogenesis; in particular by regulating 
the availability of different growth factors. Barbosa et al (2004) quantified the 
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composition of different GAGs during myogenesis of C2.7 mouse cells and found that 
during myogenic differentiation, levels of HS GAGs were increased [88]. They also 
investigated the effect of a dextran polymer, ReGeneraTing Agent (RGTA) which is a 
GAG mimetic on the amount of GAG species during myoblast growth and 
differentiation and found that RGTA increased the total amount of GAGs without 
affecting their degree of sulfation [88].  
1.4.5.2 Biglycan 
Biglycan is a member of the small leucine rich proteoglycan (SLRP) family and consists 
of a core protein of 42 kDa and two CS chains [89]. Biglycan is highly expressed in 
young and regenerating muscles of both mice and humans [90, 91]. In addition to 
skeletal myofibres it is also expressed in the pericellular region of a variety of other 
tissues like articular cartilage, sub-perichondral regions, periosteum and renal tubular 
epithelia [89]. Previous studies have shown that biglycan plays a role in matrix 
organization followed by muscle remodelling by binding to various growth factors like 
TNF-α, and TGF-β [92, 93]. Biglycan also binds to α-dystroglycan of the dystrophin 
associated protein complex through its two GAG chains [94]. The implications of this 
interaction have not yet been elucidated; however, it may play a role in localizing 
signalling molecules to the plasmalemma of the muscle fibre. Other studies have shown 
that biglycan interacts with other matrix molecules like collagen I [95], collagen VI [96] 
and the elastin microfibril network (i.e. tropoelastin) [97] suggesting a role for this 
proteoglycan in matrix assembly.  
1.4.5.3 Perlecan 
Perlecan is a member of the heparan sulphate proteoglycan (HSPG) family and consists 
of a protein-core of about 400 kDa and three 100 nm long heparan sulfate chains of 35-
40 kDa each [98]. It was the first basement membrane proteoglycan to be characterized, 
and was first isolated from the mouse Englebroth-Holmes-Swarm (EHS) tumor [99] 
[98]. Hassell and colleagues (1980) coined the term Perlecan (Perl-beads and can-
Glycosaminoglycan) due to its appearance like ‘beads on a string’[100]. It has been 
shown that perlecan binds to the acetyl-cholinesterase (AChE) and is essential for its 
localization to the NMJs [101-103]. Although, it is difficult to study the developmental 
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role of perlecan in placental mammals because of embryonic lethality of perlecan gene 
knockouts [104], the work of Zoeller et al (2008) suggests a potential role of perlecan in 
human myopathies. In addition, perlecan has been shown to play a role in muscle 
development in other systems. Using zebrafish as a model system, perlecan morphants 
showed a severe myopathy characterized by abnormal orientation and reduced amounts 
of actin filaments and disorganized sarcomeres [105]. Recent studies in drosophila have 
shown that perlecan regulates Wnt signalling at the NMJs [106]. 
1.4.5.4 Decorin 
Decorin is also a member of the SLRP family and shares 57% homology, and is 
somewhat similar in structure, to biglycan except that it contains, either a CS chain or 
DS chain at its N-terminal end [107]. In vitro studies have shown that decorin binds to 
myostatin and entraps it in the ECM. Myostatin is a member of the TGF- β family of 
proteins and is a negative regulator of skeletal muscle growth [108, 109]. Recently, Li et 
al (2007) demonstrated using mouse models that decorin activated the differentiation of 
the murine myoblast cells, C2C12 in vitro and enhanced muscle regeneration by 
upregulating the expression of p21, follistatin, peroxisome proliferator-activated 
receptor gamma coactivator-1-alpha (PGC-1α) and downregulating myostatin expression 
[110]. The core protein of decorin contains binding sites for collagen I and fibronectin 
[111]. Goetsch et al (2011) showed that decorin modulated C2C12 migration in an in 
vitro wound repair model and has a synergistic effect on the migration of myoblasts 
when added in combination with collagen I [112].  
1.5 Role of native extracellular matrix in muscle repair and regeneration: 
The first report to imply a role of ECM in muscle repair and regeneration was published 
in 1966 by Hauschka and Konigsberg [113]. This study showed there was an enhanced 
proliferation of embryonic chick myoblasts on a collagen substrate compared to cells 
grown on tissue culture plastic. Later, Hartley et al (1990) showed that Matrigel (a 
commercially available ECM) enhanced myoblast attachment and differentiation, but 
not proliferation [114]. Although ECM molecules play important structural and 
mechanical roles in muscle tissue, it has become clear that the interactions between 
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muscle cells and the surrounding ECM are critical for normal muscle homeostasis as 
well as the activation of satellite cells and subsequent repair and regeneration of muscle 
tissue [74]. Although it is well known that the ECM is essential for normal myogenesis 
and muscle regeneration, few studies have attempted to identify the specific factors that 
are critical to these processes. There are a few reports that describe the interaction 
between the ECM and growth factors in muscle. Kricker et al (2003) showed the 
interaction of HS-proteoglycans with growth factors such as fibroblast growth factors 
(FGFs), hepatocyte growth factor (HGF) and TGF-β [115]. Fiorotto et al (2003) found 
that the large family of IGF-1 binding proteins (IGF-BPs) in the ECM varies with age 
and gender [116]. It has also been shown that hyaluronan (a non-sulfated 
glycosaminoglycan) acts as an inhibitor of myoblast differentiation with no effect on 
myoblast attachment or proliferation [117].  
1.6 Tissue engineering of skeletal muscle:  
Skeletal muscle tissue comprises 40-50% of the human body mass and may be lost due 
to traumatic injury, surgical ablations or as a result of a musculoskeletal disorder [118]. 
When a traumatic injury results in a significant loss of muscle, the natural repair 
processes are unable to bridge the gap between the remaining muscle tissue, leading to 
the accumulation of scar tissue, cosmetic deformity and a loss of muscle function. A 
current treatment option available for repairing the damaged muscle tissue is 
“autologous grafting” which is the relocation of muscle tissue from an autologous site to 
the site of the defect. However, autologous transfers are not completely successful due to 
limitations in the supply of tissue and can result in donor-site morbidity, causing 
functional loss and volume deficiency [119]. Another method of muscle repair is the 
injection of a suspension of satellite cells or myoblasts to the site of injury but this was 
found to also have a modest therapeutic outcome due to poor retention, survival and 
integration of grafted cells [120]. Skeletal muscle tissue engineering provides a 
promising alternative for these treatments with minimal functional loss. Bach et al 
(2004) defined skeletal muscle tissue engineering as “an interdisciplinary approach, 
using cell biology and engineering principles to generate functional muscle tissue by 
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initiating neo-organogenesis from mononucleated stem cells (e.g. myoblasts) to 
differentiated myofibres” [119]. 
1.6.1 Bioscaffolds  
An important pre-requisite for skeletal muscle tissue engineering is a scaffold to support 
the organization, growth and differentiation of cells in the process of forming a 
functional tissue. It is a great challenge to find a suitable matrix or scaffold for skeletal 
muscle TE purposes. An ideal skeletal muscle scaffold should be biocompatible, 
biodegradable (with non-toxic degradation products), porous and have the correct 
balance of stability and elasticity [121, 122]. Scaffolds should also mimic the ECM of 
skeletal muscle, thereby increasing the probability that surrounding cells will be 
stimulated to proliferate, migrate and differentiate correctly [123]. Currently, there are 
limited materials available that both meet these criteria and are easy to manufacture. A 
range of bio-degradable and non-biodegradable materials have been developed and 
tested in skeletal muscle tissue engineering applications. These can be classified into: 
natural and synthetic scaffolds. In the past decade, there have been significant 
advancements in the development of such scaffolds.   
1.6.1.1 Natural scaffolds 
Natural scaffolds consist of proteins and polysaccharides. These include natural 
structural proteins such as collagen, fibronectin, elastin, fibrin, and laminin and 
polysaccharides like chitosan, alginate and hyaluronan [124]. Alginate is a 
polysaccharide from marine organisms that can be prepared into three-dimensional 
porous scaffolds. Fibroblasts seeded on these scaffolds remained spherical in contrast to 
the flat morphology seen when they are seeded onto culture dishes [125].  Guerret et al. 
(2003) used collagen as a scaffold for dermal tissue engineering. They implanted 
Apligraf
®
 (a bioengineered skin composed of a bovine collagen network containing 
living human fibroblasts overlaid with a human keratinocyte derived differentiated 
epithelium) into athymic mice. Examination of the implant by immunohistochemistry 
(IHC) and transmission electron microscopy (TEM) revealed that the graft provided 
living and bioactive cells to the wound site even after one year past grafting [126]. Other 
clinical studies have similarly shown that collagen can be a useful scaffold for 
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regenerating cells [126-128]. In addition to these purified natural products, natural 
ECMs such as that derived from decellularized porcine small intestinal submucosa (SIS) 
has been used with some success to repair muscle defects in abdominal wall and load 
bearing skeletal muscle [129, 130].  
Natural scaffolds have advantages over their synthetic counterparts in terms of their 
excellent physiological and mechanical properties that resemble natural tissues and their 
biodegradability. However, potential limitations of these scaffolds include a risk of viral 
infection from animal derived products, an unstable material supply and deterioration 
which accompanies long term implantation [131]. In recent years, natural silk has 
become an emerging biomaterial for TE purposes.   
1.6.1.2 Natural Silk as a Biomaterial  
Silk is a natural biopolymer produced by the silk glands of some arthropods. Although 
spiders, fleas, bees and scorpions produce silk the main source is from the larvae of 
silkworms of various Lepidoptera. Two major groups of silkworm are economically and 
commercially important, namely bombycidae (mulberry) and saturniidae (non-mulberry) 
[132]. The domesticated mulberry species Bombyx mori, the major species used in the 
textile industry, is found throughout the world, whereas the wild non-mulberry species 
are found in specific geographical regions. The widely available non-mulberry varieties 
are Antheraea mylitta (Tropical tasar), Antheraea assamensis/assama (Muga) and 
Philosamia/Samia ricini (Eri); all of which are found in the Indian subcontinents. Some 
other species like A. pernyi (Chinese temperate oak tasar) and A. yamamai (Japanese oak 
tasar) are also important. Silk proteins obtained from cocoon of B. mori are of two types: 
the hydrophilic water soluble protein called sericin, which uniformly covers the fibrous 
hydrophobic protein fibroin. It is the fibroin protein that makes up textile fibers. Sericin 
is a glycoprotein with a molecular weight in the range of 24-400 kDa and constitutes 20-
30% of the total weight of the cocoon [133]. Silk fibroin is a semi-crystalline fibrous 
protein; it is the key component of silk and constitutes 78 % of the total cocoon weight. 
The B. mori fibroin consists of a heavy (H) chain (390 kDa) and a light (L) chain (26 
kDa) connected by a disulphide bond formed between cysteine-20 at the carboxyl 
terminal of the heavy chain (C20) and cysteins-172 of the light chain (C172) [134]. A 30 
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kDa glycoprotein, P-25, is non-covalently linked to the H-L chain complex through 
hydrophobic interactions [135]. The sequence of the H chain reveals a highly repetitive 
glycine rich core flanked by non-repetitive sequences. It is the repeating GAGAGS 
motif that is the main component of the highly ordered β-sheet crystalline units which 
give rise to the strength and toughness of silk, whilst the non-crystalline regions 
contribute to silk’s elasticity [136].   
Fibroin proteins from other silkworm species have slightly different structures. For 
example, A. mylitta fibroin is a homodimer of a H-chain of 197 kDa, A. assama fibroin 
is a heterodimer comprising chains of 220 kDa and 20 kDa and fibroin from S. ricini 
consists of a heterodimer of chains of approximately 245 kDa and 210 kDa [137, 138]. 
These differences as well as the underlying amino acid sequence differences between the 
mulberry and non-mulberry species contribute to the different properties of these silk 
fibroin proteins. In contrast to B. mori the β-sheets of non-mulberry species generally 
arise from poly-alanine repeats which give rise to their very high tensile strength and 
when in aqueous solution -helical as well as random coil structures are found, whereas 
B. mori silk fibroin in aqueous solution is primarily random coils [138]. In addition, 
fibroin from A. mylitta possesses RGD sequences, but B. mori fibroin does not. Probably 
as a consequence the organisation of the actin cytoskeleton, cell spreading and the 
binding force between cells and substratum was higher on films of A. mylitta fibroin 
compared to cells on B. mori fibroin films [139].   
Traditionally silk is mainly used in the textile industry; however silk also has medical 
applications, particularly for making sutures. Properties such as high tensile strength, 
elasticity, thermal stability and biocompatibility make silk a useful biomaterial. Silk 
proteins have also been used by the biomedical field for applications like implantable 
biomaterials, drug delivery vehicles and medical devices because of their mechanical 
robustness, inertness and biodegradability. 
 
Most of the commercial silk used for textiles and sutures is obtained from B. mori. 
However, attention is gradually focusing on the indigenous species (A. mylitta, A. 
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assamensis/assama and S. ricini) as an alternative source of silk proteins. These species 
can be naturally reared and the water based processing and easy formatting of the silk 
proteins from these species make them very attractive to the tissue engineering and 
biomedical fields [138, 140, 141]. Fibroin scaffolds and materials, prepared from 
regenerated protein solutions possess characteristics which are key requirements of a 
standard biomaterial. These matrices can be engineered and employed as constructs for 
different applications in tissue engineering such as for bone [142-144], cartilage [145, 
146], cardiac [141], liver [147] and skin tissue engineering. Three-dimensional (3D) 
fibroin scaffolds are also utilized as in vitro tumor and metastasis model [148, 149]. Silk 
biomaterials can be moulded in various forms such as hydrogels, membranes, nets, 
sponges and scaffolds. Useful information about cell interactions with silk is mostly 
gathered by coating thin films of solubilised silk in two-dimensional (2D) in vitro cell 
culture however, 3D silk scaffolds provides a better alternate, which mimics the in situ 
cell-matrix interactions and other microenvironments [148].  
1.6.1.3 Bio-compatibilty and bio-degradability of Silk  
Any foreign material before being used as a biomedical implant needs to be tested for its 
immuno-modulatory properties, with silk being no exception. The immunogenic 
potential of silk fibroin and sericin proteins have been tested using both, in vitro and in 
vivo model systems. Panilaitis et al (2003) investigated the innate immune response of 
solubilised silk extracts and intact silk fibres using murine macrophage cells (RAW 
264.7) in an in vitro system for 1 and 7 days [150]. Silk fibres or solubilised silk failed 
to elicit an immune response measured by TNF-α release. Even sericin proteins were not 
able to activate the macrophages. However, a suspension of irregularly shaped silk 
fibroin particulates measuring 10 µm-200 µm in diameter resulted in an increased 
expression of TNF-α in a dose dependent manner [150].   
For any biological implant to be a successful candidate for tissue transplantation 
purposes, it should be bio-degradable without releasing any toxic products during the 
degradation process. In-vivo degradation rates and inflammatory responses to 3D silk 
fibroin scaffolds implanted in muscle pouches of nude and Lewis rats have been 
investigated by Wang et al (2008) [151]. Scaffolds used in this study were either 
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prepared using an all-aqueous process or using an organic solvent, 
hexafluoroisopropanol (HFIP). The results showed that aqueous derived scaffolds 
degraded completely between 2-6 months while HFIP-derived scaffolds were stable for 
more than a year. Interestingly, the immune responses to both the scaffolds were mild 
and the implants were well tolerated by the rats [151]. Another study showed a time 
dependent degradation of electrospun silk fibroin scaffolds when the scaffolds were 
treated with an enzyme solution of protease XIV in vitro. The same scaffolds when 
implanted intramuscularly and subcutaneously were degraded within 8 weeks [152].   
1.6.2 Commercially supplied Natural Scaffolds for 2D and 3D TE applications in 
culture 
A number of natural scaffolds have made their way from bench to bedside in recent 
years and are now commercially available. A popular natural scaffold for 3D TE is 
Matrigel (Becton Dickinson Biosciences, San Jose, CA, USA) which is derived from the 
murine EHS tumor. It is a basement membrane preparation and primarily consists of 
laminin, collagen IV and entactin. It is mainly used for 3D culture in vitro. For example, 
it has been used as a substrate for culturing endothelial cells to study the role of various 
growth factors during angiogenesis [153]. Although, Matrigel supports cell growth and 
differentiation, its composition has not been well-defined and it varies from batch to 
batch. Hence, it is not an appropriate matrix for in vivo TE applications.   
Hyaluronic acid (HA) hydrogel scaffolds include HyStem for culturing stem cells and 
Extracel (Glycosan BioSystems, Salt Lake City, UT, USA) for general cell culture. 
Other natural scaffolds include different alginate-based systems such as AlgiMatrix 
(Invitrogen) or the peptide based self-assembling-gel, Puramatrix developed in the 
laboratory of Shuguang Zhang at Massachusetts Institute of Technology and marketed 
by 3D Matrix Inc. (Waltham, MA, USA). PuraMatrix is an amino acid–based hydrogel 
consisting of 16-mer oligopeptides that self-assemble into nanofibers and form a matrix 
under physiological salt concentrations [154].  
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1.6.3 Synthetic scaffolds 
Synthetic scaffolds are materials which are chemically synthesized in the laboratory. 
[123, 155]. The number of synthetic scaffolds on the market has been increasing 
annually [156]. Their material properties of flexibility and controlled manufacture make 
them attractive for TE applications. Additionally, they can be manufactured cheaply and 
there is minimum batch to batch variation [157]. However, they lack cell-recognition 
signals and unless modified with cell-recognition sequences do not support the growth 
of cells. The most widely used synthetic polymers for skeletal muscle applications are 
poly (α-hydroxy acids), e.g. poly-lactic acid (PLA), poly-glycolic acid (PGA), poly-
caprolactone (PCL) and their copolymers [124, 158]. 
1.6.4 Developing hybrid materials as scaffolds  
Natural scaffolds like Matrigel support cell growth but due to the complexity of these ill-
defined matrices, it is difficult to understand the underlying cell-signalling mechanisms. 
Synthetic materials are chemically well-defined but they do not support cell adhesion 
and proliferation on their own. Therefore, there is a need to design synthetic materials 
that are well defined and their mechanical and material properties can be controlled to 
achieve a desired outcome. The combination of synthetic polymers with ECM proteins 
may be a suitable option. Here, the material properties of the synthetic materials are 
controlled and constant, and bioactivity is provided by the ECM proteins. Examples 
include powdered small intestinal submucosa (SIS) combined with poly (D, L-lactide-
co-glycolide) to create tissue-engineered bone [159] and the combination of urinary 
bladder matrix (UBM) with a poly (ester-urethane) urea (PEEU) to create an elastomeric 
scaffold [160].  
Gilmore and colleagues (2009) used the conducting polymer, polypyrrole, coated with 
ECM GAG components like HA and CS to stimulate the proliferation of C2C12 
myoblasts in vitro and compared the effects with those of non-ECM coated materials 
[161]. They showed that Polypyrrole/HA based substrates supported the proliferation of 
C2C12 myoblasts but did not support their adhesion and differentiation. On the other 
hand Polypyrrole/CS based substrates effectively supported both proliferation and 
differentiation of myoblasts [161]. This study suggests that different physical properties 
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of the material support different stages of skeletal muscle myogenesis and that GAGs 
attached to synthetic materials can be a viable option for skeletal muscle TE. It is 
possible that GAG components like heparin and HS, when coated on a substrate could 
impart a higher degree of support for myoblast proliferation and differentiation as HS 
binds and presents various growth factors to their cell surface receptors. Although HS 
coated polycaprolactone (PCL) has been used for bone tissue engineering with 
mesenchymal stem cells [162], to date, there are no reports of HS coated materials being 
used for skeletal muscle TE. 
Kaji et al (2010) developed an alumina based scaffold for skeletal muscle TE [163]. 
They demonstrated electrically induced contraction of C2C12 myotubes when C2C12 
myoblasts were cultured on an alumina based substrate, containing an atelocollagen top 
layer and a PDMS (poly-dimethylsiloxane) layer below the surface of the alumina 
membrane [163]. This micropoous substrate has a Young’s modulus (measurement of 
elasticity) of 14.8 kPa which closely resembles that of normal muscle. Previous studies 
also showed that myotubes differentiate and striate on substrates with muscle-tissue like 
stiffness [164]. As contraction plays a pivotal role in muscle functionality [12], it is 
important to design materials that support the contractility of muscle, so that 
functionality is restored.  
Recently, an alginate gel based scaffold was developed, and used to treat muscle injury 
in an ischaemic mouse model [165]. In this case, C2C12 cells and myogenic progenitor 
cells were mixed with this gel, which contained the growth factors, vascular endothelial 
growth factor (VEGF) and IGF-1 and implanted into the injury site. The controlled 
release of VEGF and IGF-1 from these scaffolds enhanced the repair process of the 
muscle, improved contractile function and stimulated neovascularization. 
1.7 Extracellular matrix materials as a biological scaffold 
The use of the ECM as a scaffold for constructive tissue remodelling has been supported 
by both, preclinical animal studies and human clinical applications. A number of clinical 
products now on the market are composed of ECM derived from xenogenic or allogenic 
tissues. A recent review by Crapo et al (2011) provides a list of all biologic ECM 
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derived materials used in clinics for a wide number of applications from treating 
irreparable wounds or severe burns to heart valve replacements [166].  
There is a considerable list of tissues from which ECM can be derived and it ranges 
from vascular tissues like heart valves [167-169] and blood vessels [170, 171] to skeletal 
tissues like tendons [172], ligaments [173], skeletal muscle [174-176] and skin [177]. 
SIS-ECM and UBM are the most comprehensively studied and their mechanical, 
structural and biological properties have been well defined. Although the exact 
mechanism by which ECM enhances site specific tissue remodelling is unknown, it is 
clear the composition and structure of the ECM plays a pivotal role in determining the 
outcome of the repair process [166].  
1.8 Decellularization of tissues 
Decellularization (removal of cells) of tissues and organs is a promising, relatively new 
technique to obtain an ECM from tissues, where the complex 3D ultrastructure of the 
matrix is largely retained [178] (Figure 1.3). To obtain a 3D ECM suitable for 
implantation, it is essential to remove all cellular components from the tissue so that 
only the ECM remains. The efficiency of decellularization depends upon the origin of 
the tissue, its thickness, lipid content, density and the methods (physical, chemical or 
enzymatic) used to remove the cells [166]. Preferably, the method should not adversely 
affect the composition, biological activity and mechanical integrity of the remaining 
matrix. Incomplete decellularization can elicit adverse immune reactions due to 
remnants of cell membrane epitopes or allogenic DNA [179]. The presence of DNA can 
also hinder subsequent quantification of the cell population seeded on the matrix. 
Complete (100%) decellularization of a tissue or organ is not feasible; therefore the 
emphasis is on maximising the loss of cells from the tissue and minimizing the damage 
to the ECM, so it remains as close to its native structure and composition as possible. 
Several methods have been used to decellularize different tissues.  
1.8.1 Chemical decellularization methods 
To decellularize organs and tissues, the most commonly used chemical agents are 
detergents. These detergents may be ionic like sodium dodecyl sulphate (SDS) and 
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Sodium deoxycholate, non-ionic (Triton X-100) or zwitterionic (CHAPS). They 
solubilize cell membranes and disrupt the DNA-protein or lipid-protein interactions. 
 
Figure 1.3 Schematic representation of the decellularisation procedure. 
Decellularisation (removal of cells) is a relatively new technique to obtain ECM 
from tissues while retaining the complex 3D ultrastructure of the matrix. Tissues 
can be decellularised using physical, chemical or enzymatic methods. 
Preferably, the decellularization method should not adversely affect the 
composition, biological activity and mechanical integrity of the remaining matrix. 
However, it should effectively remove all the cellular material from the tissues to 
avoid immune reactions.   
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Alcohols (ethanol and methanol) and other solvents (acetone) have also been used for 
removing cells from lipid predominant tissues like adipose tissue [180], and heart valves 
[181]. However, alcohols will fix the tissue, which can alter the mechanical properties 
and ultrastructure of the remaining ECM.     
1.8.2 Physical  
Decellularization can also be achieved by a temperature shock to the cells. There are a 
few reports of using temperature differences or freeze-thaw cycles for effective cell 
lysis, although subsequent processing is required to clear the cellular and membranous 
remains from the tissues [182, 183]. Several cycles of freeze-thaw are required for 
effective decellularization and this seems to only partly affect the topology and structure 
of the remaining ECM [184]. High hydrostatic pressure (>600MPa) treatment has also 
been used to decellularize porcine aortic blood vessels [185].  
1.8.3 Biological 
Biological agents include enzymes like trypsin, collagenase, nucleases, lipase, dispase, 
thermolysin and non-enzymatic agents including chelating agents like EDTA and 
EGTA. Trypsin is most commonly used as a decellularization agent due to its ability to 
cleave multiple proteins because of its serine protease activity, but when preservation of 
GAG components in the ECM is an aim, trypsin is not the preferred choice as it can 
cleave the core protein of proteoglycans and so release the GAG chains [175]. Trypsin 
can also cleave some of the collagens [168]. Nucleases (DNases and RNases) also form 
an integral part of decellularization protocols as they help in the removal of nucleotides 
after cell lysis.  
There are reports suggesting the use of chelating agents like EDTA and EGTA in 
decellularization protocols but these agents are seldom effective in removing cells when 
used alone [186]. They are usually used in combination with enzymes [185, 187, 188] or 
detergents [189, 190]. The advantage of using these chelating agents is that they 
sequester metal ions like Mg
2+
 required for matrix metalloproteinase (MMP) activity and 
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hence they help to protect the ECM from MMPs released from the cells, which may 
damage the ECM ultrastructure and remove growth factors.   
1.8.4 Whole organ decellularization 
The idea of whole organ regeneration was first proposed by Langer and Vacanti (1993) 
and recently, there has been considerable development in new techniques for whole 
organ decellularization. Preservation of ECM molecules in a 3D form may provide 
valuable insights about the cell-ECM interactions and the role ECM molecules play in 
vivo. Recent progress in whole organ decellularization techniques are a leap forward in 
this area. Three groups have successfully used a whole organ perfusion decellularization 
technique to produce scaffolds for a bioartificial heart [191], a bioartificial liver [192] 
and a bioartificial lung [193]. The decellularized liver, when recellularized with 
hepatocytes and cultured in vitro, showed normal expression levels of cytochrome P450 
and metabolic activity including urea synthesis and albumin secretion [192]. The heart 
scaffold, when connected to a bioreactor, showed sustained contractions and when 
stimulated electrically it could generate pump functions equivalent to 2% of a normal 
heart [191]. Interestingly, when the decellularized lung was orthotopically transplanted 
in rats, it supported gas exchange from 45 min to 2 hours [193]. Encouragingly, all three 
decellularized organs regained significant normal physiological activity. These organs 
are highly vascularized and need to be connected to the blood supply to provide 
metabolic function; therefore it is vital to obtain these matrices in a 3D form. However, 
obtaining a skeletal muscle matrix in the form of a whole organ is difficult due to the 
presence of long muscle fibres and the complexity of the muscle connective tissue.  
1.8.5 Decellularization of skeletal muscle 
Decellularized skeletal muscle is a promising system to study the role of extracellular 
matrix in muscle regeneration. After removal of the muscle cells, the ECM ultrastructure 
should retain the remnants of endomysial tubes, and neural and vascular pathways that 
can promote alignment and fusion of myoblasts and stimulate neurovascular growth 
[194]. Early attempts to decellularize skeletal muscles have incorporated harsh physical 
methods with enzymes like trypsin [175] and strong detergents like SDS [174]. Stern et 
al (2009) used trypsin and Triton X-100 to decellularize hamstring and quadriceps 
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muscles of rats and they showed that with this method the levels of GAGs in the 
decellularized matrix were below the limits of detection. DeQuach et al (2010) used 1% 
SDS as decellularizing agent and showed loss of most of the basement proteins, for 
example, collagen IV, fibronectin and laminin from the matrix. Recently, however, 
Gillies et al (2011) published a method for decellularizing skeletal muscle without 
detergents or proteolytic enzymes  and in this case there was only a slight reduction in 
the GAG content of the matrix [176]. 
Following all of the above mentioned methods of decellularization, the sulfated GAGs in 
the matrix were measured but to our knowledge, which extracellular matrix 
proteoglycans (decorin, biglycan, perlecan) were retained after decellularization has not 
been examined. Considering the significance of proteoglycans and their GAG chains in 
skeletal muscle repair and regeneration, it is imperative to develop new methods of 
decellularization where most of the ECM molecules including the GAGs are preserved.  
1.8.5.1 Powdered form  
In recent years several research groups have presented techniques where skeletal muscle 
ECM has been extracted, converted to a powdered form and used as a substrate to 
promote the growth and differentiation of myoblasts ex vivo. Stern et al (2009) extracted 
skeletal muscle ECM from thigh muscles (quadriceps and hamstring) of 4-7 month old 
adult rats and used it as a surface coating to study the influence of skeletal muscle ECM 
on the regenerative potential of myogenic cells [175]. To make an ECM extract suitable 
for coating surfaces, muscle tissue was frozen at -80ºC and cut into thin slices of 500 µm 
followed by washing in ultrapure water for 2 days. After washing, the tissue was 
incubated in 0.05% trypsin/EDTA for 1 h and trypsin neutralized overnight by 
DMEM/10% FBS. Finally the tissue was washed in Triton X-100 for 5 days and then 
rinsed in water and PBS for 2 days and 1 day respectively. After decellularization, tissue 
was cut into small pieces, lyophilized, and powdered into a matrix. Powdered matrix 
was then dissolved in 2M urea for 3 days and dialyzed against water for 3 days. Finally, 
the matrix solution was lyophilized until dry and then dissolved in 0.1 % acetic acid for 
use as a coating [175].  
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Surfaces coated with muscle ECM prepared as described promoted the growth and 
differentiation of muscle progenitor cells and myoblasts in culture. Western blot 
analyses of extracts from these cells revealed higher expression levels of phospho-Erk 1 
and 2, myogenin and MyHC on ECM coated surfaces compared to extracts of cells 
cultured on uncoated surfaces [175]. Erk 1 and 2 are members of the mitogen activated 
protein kinase (MAPK) family of proteins and have been shown to play a role in the 
proliferation and differentiation of muscle cells [195, 196]. Myogenin is a member of a 
family of transcription factors involved in early stage myogenic differentiation, while 
MyHC is a marker of the final stage of myogenic differentiation after the fusion of cells 
into multinucleated myotubes [197]. Alhough the decellularization method was effective 
in removing cells from the muscle it did lead to a loss of GAG components from the 
matrix. Thus while the ECM extract used in this study had a desirable effect on the 
proliferation and differentiation of myogenic cells, these effects may be further 
enhanced by developing a method that preserves skeletal muscle ECM in a more native 
state where the GAGs have remained attached to the matrix [175].  
DeQuach et al (2010) developed a different method to obtain a powdered ECM from 
porcine skeletal and cardiac muscles suitable for coating on tissue culture dishes [174]. 
Muscle tissue was cut into pieces of 1cm
3
, rinsed briefly in deionized water and 1% SDS 
in PBS was used to decellularize the muscle tissues until the tissue became transparent. 
It was then rinsed thoroughly with PBS to remove the detergents. Decellularization was 
confirmed by the absence of nuclei as revealed by haematoxylin and eosin staining. The 
decellularized matrix was lyophilized, milled into a powder, digested with pepsin 
solubilised through pepsin digestion and dissolved in 0.1M acetic acid to prevent self-
assembly. Characterization of this skeletal muscle matrix preparation using Time-of-
Flight Secondary Ion Mass Spectrometry (TOF-SIMS) showed the presence of collagen 
I, II, VI and  proteoglycans like decorin as well as heparan sulfates in the matrix [174].  
The basement membrane is a highly specialized ECM that is sandwiched between 
parenchymal cells and connective tissue. Collagen IV is the major component of the 
basement membrane while laminin and fibronectin function as linker molecules between 
type IV collagen in the basement membrane and the sarcolemma (muscle fibre 
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membrane) [62]. Although De Quach et al (2010) also showed enhanced differentiation 
of mouse C2C12 myoblasts on surfaces coated with this ECM preparation when 
compared to collagen coated surfaces [174], they did not investigate the contractile 
properties of the myoblasts. This would have been interesting given the lack of basement 
membrane components in their acellular matrix and particularly the laminins, as 
laminins play a key role in transmitting the contractile force to the ECM through binding 
to the dystrophin glycoprotein complex [74]. These examples clearly suggest that there 
is a need to develop new methods to decellularize skeletal muscles where the key 
components of ECM are preserved.  
1.9 Other approaches used for skeletal muscle TE 
1.9.1 Micropatterned substrates and self-assembled monolayers 
Huang et al (2004) cultured C2C12 myoblasts on micropatterned PDMS substrates with 
10 µm wide grooves and found that C2C12 cells aligned themselves along the direction 
of the microgrooves, fused to form long and unbranched myotubes with uniform 
diameter [198]. In contrast, on non-patterned surfaces C2C12 cells were randomly 
oriented and the myotubes formed were non-uniform in diameter and oriented along 
various directions [198]. Gingras et al (2009) used different micropatterned 
polydimethylsiloxane substrates (fabricated by photolithography) for culturing C2C12 
myoblasts in vitro and demonstrated that all substrates with varying geometries allowed 
fusion of myoblasts, but only a few substrates allowed proper alignment and orientation 
of myotubes [199].   
1.9.2 Magnetic force based techniques 
Yamamoto et al (2009) developed a method for culturing aligned myotubes (C2C12) in 
culture using magnetic force [200]. In this method, C2C12 cells were cultured in the 
presence of magnetite cationic liposomes (MCLs) with a magnet attached at the bottom 
of each well and a linear magnetic field was applied to the wells [200]. Although, it led 
to the formation of multi-layered thin sheets (250 µm) of cells, the cell sheets shrank 
considerably and failed to maintain their shape until differentiation. Positioning of a 
silicon plug at the centre of each well allowed the sheets to grow for 6 days without 
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breakage and immunohistochemical analysis revealed that the cells were properly 
aligned around the silicone rings. Further culturing of the cell sheets for 6 days in 
differentiation medium caused multinucleated myotubes to form [200].  
1.9.3 Hydrogels 
Photo-polymerizable HA based hydrogels containing satellite cells (SCs) or myogenic 
progenitor cells (MPCs) have been successfully used to engineer functional skeletal 
muscle in vivo [201]. In this study, Tibialis anterior muscles of C57Bl/6J mice were 
partially amputated and photo-cross-linked HA based gels (HA-PI), loaded with either 
freshly isolated SCs or MPCs, or isolated single muscle fibers were implanted at the 
injured site. Histological and morphological assessment of the repaired muscle showed a 
higher number of regenerated muscle fibers, characterized by centrally located nuclei, 
when fibers or SCs were used with HA-PI. Myogenic progenitor cells also yielded more 
regenerating fibers than HA-PI alone [201]. Functionality of the repaired muscle was 
also assessed after 6 weeks by measuring the absolute tetanic force (150 Hz) and these 
results showed that HA-PI loaded with SCs yielded the maximum force and hence the 
best functional recovery. Further, immunolabelling of the repaired muscle by α-
bungarotoxin and von Willebrand factor revealed respectively formation of NMJs and 
blood vessels at the repair site [201].   
1.10 Translational applications of the ECM scaffolds 
Over the years, ECM based biomaterials derived from animal (xenograft) or human 
sources (allograft) have been successfully used to treat burns [202-205], wounds [206-
208], abdominal wall defects [209-211] and ruptured tendons [212, 213].  
1.10.1 Small intestinal submucosa (SIS) ECM 
Studies in the past have shown that SIS-ECM scaffolds promote functional skeletal 
muscle regeneration in a rat-abdominal wall defect [130] and musculotendinous junction 
repair of gastrocnemius muscles [214] in a canine model. However, the extent of injury 
was minimal in both cases. The anatomical location and the extent of the muscle injury 
may also play a major role in the regenerative response. Recently, Turner et al (2012) 
showed that a complex quadriceps injury in a canine model can significantly alter the 
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repair process of the skeletal muscle [215]. Quadriceps is a complex muscle comprising 
four parts: rectus femoris, vastus lateralis, vastus medialis and vastus intermedius. The 
complex injury to the quadriceps muscle of dogs included removal of the distal one-third 
of vastus lateralis, removal of the medial half of the vastus medialis (distal one-third) 
and the associated quadriceps tendon (proximal half). A SIS-ECM scaffold was 
implanted into the site of defect and the regenerative response was monitored for 6 
months after implantation. Histochemical analyses revealed that the initial phase of 
muscle regeneration (1 month) showed similar results to previous studies [214] and was 
marked by infiltration of mononuclear and spindle shaped cells. However, the final 
response (after 6 months) included deposition of dense connective tissue (mainly 
collagen) and the formation of bony and cartilaginous structures within the graft  [215].  
It appears the age of the animal from which the ECM is harvested affects the ECM 
scaffold properties and plays a crucial part in determining the outcome of the repair 
process. Recently, Tottey et al (2011) showed that SIS-ECM isolated from pigs of 
different ages (3, 12, 26 or >52 weeks) showed distinct mechanical, structural and 
biological properties [216]. Growth factor analysis for the amount of bFGF and VEGF 
revealed that SIS-ECM derived from 12 week old animals had the most bFGF (per mg 
dry weight) while SIS-ECM derived from 3 week old animals had the lowest. The 
VEGF content was equivalent in SIS-ECM from 12 and 26 week old animals, but in 
SIS-ECM from 3 week and >52 week old animals it was much lower [216]. The elastic 
modulus of SIS-ECM derived from 12 or 26 weeks old animals was much higher than 
that derived from 3 or >52 weeks old animals. 
Taken together, age of the animal (from which ECM is harvested) and anatomical 
location of the injury (Tibialis Anterior vs Quadricpes/Soleus vs Gastrocnemius) may 
have different effects on the regenerative response of a muscle. There is no indication 
that these two factors (age and location of injury) have been explored together. 
Designing animal models with both factors in mind would help to improve our 
knowledge about differential treatment response at different ages.   
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Although SIS-ECM has been used for various clinical studies in the past, there is one 
study which suggests that SIS-ECM is not a complete acellular matrix. Zheng et al 
(2005) investigated Restore
TM 
SIS membrane for the presence of DNA and other cellular 
remnants [217] using histological and PCR methods and thus showed the presence of 
DNA and mast cells in the SIS-ECM. Further, when this SIS-ECM was implanted into 
mice or rabbits, it elicited an immune response characterized by fibrosis and infiltration 
of lymphocytes into the implant site [217]. This study suggests that although SIS-ECM 
has been approved by the Food and Drug Administration (FDA) for clinical use, further 
preclinical investigation needs to be done before it is used as a surgical material.  
For any muscle graft to be compatible and successful, the engineered muscle graft 
should mimic the structure of the native muscle at the cellular and molecular level. The 
muscle fibres should be uniformly aligned and densely packed within an appropriate and 
well organized ECM [218]. In addition to the parallel alignment of muscle fibres, 
innervation of the engineered tissue and formation of functional vascular bundles is 
indispensable for a functional graft [194]. Despite the promising applications for tissue 
engineered skeletal muscle that have been described, culturing functional and mature 
muscle tissue still remains an unsolved puzzle. An important hurdle that has yet to be 
overcome is the inability of skeletal muscle cells to develop into fully mature muscle 
fibres within engineered muscle constructs.  
1.10.2 Clinical studies involving ECM scaffold for TE of muscle 
There have been very few clinical studies on the application of ECM based biomaterials 
for skeletal muscle TE. Currently, there is only one clinical report of the successful 
implantation of a biological scaffold in a patient for the purpose of regenerating 
functional muscle tissue [129]. The patient was 19-year old military person who 
sustained injuries in the right thigh as a result of a bomb explosion. This type of injury 
characteristically leads to volumetric muscle loss. The patient suffered a right-femur 
fracture associated with large quadriceps muscle loss. At first, the treatment involved an 
autologous bone graft and a latissimus muscle flap was also grafted to the damaged area. 
Over time, the fracture healed, but even after 3 years of surgery, the patient was not able 
to recover completely and reported muscle weakness in the right leg [129]. 
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Seemingly, the muscle loss was irreparable by normal muscle regeneration or 
autologous grafting. Finally, the surgeons used a tissue engineering approach and 
implanted a biological scaffold composed of a multilayered porcine SIS-ECM into the 
damaged muscle area. A 15 cm incision was made on the right thigh exposing vastus 
medialis and 5 sheets of SIS-ECM were implanted into 12x10 cm pockets created 
between the muscle belly. The patient was discharged on the 5
th
 day post-surgery and 
after 4 weeks resumed physical therapy. Post-operatively, computer tomography (CT) 
scans showed new tissue growth at the implant site and the patient showed a marked 
increase in the isokinetic muscle function (peak torque, total work and average power) in 
the repaired limb [129]. This example is encouraging for developing muscle specific 
scaffolds which might provide better repair.  
1.11 Investigating Cell-Scaffold Interactions 
Although the ultimate goal of developing a muscle-specific scaffold is to support the 
growth and repair of a muscle in vivo, important cues can be obtained by developing an 
artificial microenvironment in vitro for muscle growth. Thus, in recent years there have 
been several technological advancements in the field of skeletal muscle TE which 
includes development of (a) serum free culture, (b) sensitive methods such as 
quantitative real-time polymerase chain reaction (qRT-PCR) to measure cell 
differentiation, and (c) atomic force microscopy to visualize and quantify cell-scaffold 
interactions at nanometre resolution.   
1.11.1 Serum free culture 
Currently, foetal bovine and horse sera are used for respectively myoblast proliferation 
and differentiation in tissue culture systems. However, these sera provide an ill-defined 
mixture of growth factors to the medium which makes it difficult to assess the 
contribution of individual growth factors and ECM molecules on myoblast growth and 
differentiation. By developing a serum-free media formulation, the effect of specific 
ECM molecules, cytokines and growth factors on muscle development in culture can be 
studied.  
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Only a few studies have attempted to study the role of different growth factors in 
skeletal muscle differentiation by developing a serum free culture system [219]. Das et 
al (2009) used a serum free culture system for in vitro skeletal muscle TE. In this study, 
C2C12 rat myoblasts were cultured in a defined serum free environment with known 
amounts of growth factors. The cells differentiated and the myotubes were able to 
maintain their phenotype for 70-90 days in culture [220]. This long term maintenance of 
the cultured myotubes was due to the presence of NBactiv4 media, a formulation created 
by adding creatinine, oestrogen and cholesterol to B27/Neuro-basal media, a media 
which was originally used for increasing the lifespan of foetal hippocampal neurons 
[221].  
 
Although, studies have been done previously using ECM as a coating material to 
promote the proliferation and differentiation of myoblasts in culture, traditional serum 
supplemented media was used to support myoblast growth. In these cases it is difficult to 
assess that whether the growth of myoblasts is due to the ECM coating or due to factors 
present in the serum. To date, there are no reports of using a serum free culture system to 
assess the effect of decellularized skeletal muscle ECM on myoblast proliferation and 
differentiation.  
1.11.2 Atomic Force Microscopy 
Visualization of 3D cell-scaffold interactions presents a challenge to standard light and 
confocal scanning microscopy methods most often used by cell biologists. To better 
understand the role of scaffolds in muscle repair and regeneration, the 3D ultrastructure 
of these materials, as well as cell-scaffold interactions at nanometer levels should be 
determined. For decades, electron microscopy (EM) has been used to visualize tissue 
ultrastructure, but routine EM methods irreversibly denature biomolecules both during 
specimen preparation because of the use of harsh chemical fixation procedures and 
during imaging because of the interaction of electron beam with the tissue [222] .  
 
Atomic force microscopy, an alternative to EM, was invented in the mid-1980s. Atomic 
force microsopes (AFMs) belong to a class of scanning probe microscopes that record 
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interactions between a probe and a surface. A typical AFM consists of a silicon or 
silicon nitride cantilever with a sharp tip (or probe) at the end to scan a specimen 
surface. When the tip scans the surface, molecular interactions between the tip and the 
surface cause a deflection in the cantilever which is measured by an array of 
photodiodes. Since AFMs operate in physiologically appropriate solution conditions and 
can perform quantitative, non-destructive, high resolution imaging [223], they have 
obvious advantages over EM.  
 
Atomic force microscopy can be used to characterize the topography of both synthetic 
and natural scaffold materials, and the interaction of cells with these scaffolds. Graham 
et al. (2010) recently developed a new method using cyropreservation and 
cryosectioning of tissue samples to preserve and visualize bio-molecular structures, 
including ECMs in situ [224]. Using this technique, it was possible to visualize the 
macromolecular structures of fibrillar collagens in skin, cartilage and intervertrebal disc; 
elastic fibres in the aorta and lung; as well as desmosomes and mitochondria. We 
envisage this method being particularly useful for analyses of both natural muscle ECM 
as well as synthetic scaffolds that have been modified, with ECM proteins to enhance 
their functional attributes.  
 
Atomic force microscopy images yield information about the shape and volume of the 
molecule being imaged, but information about the type of molecule is missing. A 
possible solution can be provided by simultaneous topography and receptor imaging 
[225]. Using this technique, it is possible to generate single molecule maps of specific 
types of molecules in a complex sample while simultaneously carrying out high-
resolution topography imaging [225]. In this mode the AFM tip contains a covalently 
coupled antibody molecule so that it will function as a molecular sensor. A highly 
developed feedback loop allows sample topography measurement with the simultaneous 
mapping of antibody recognition sites on the surface of the sample. This imaging mode 
may be used to investigate receptor binding sites and their distribution on natural 
biological surfaces. 
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In addition to imaging biological samples AFM can also be used to measure the elastic 
properties of a cell or a tissue by a process of force measurement. The first report of 
force measurements by AFM was by Paul Hansma and colleagues in 1992 [226]. They 
measured the interaction forces between the cantilever and a glass surface in water. 
Later, Tao et al (1992) investigated the elastic properties of bone and cartilage. Their 
method was quantitative in nature and gave a direct correlation between the elastic 
properties of the material and its force distance curves [227]. Engler et al (2004) 
investigated the elastic properties of myoblasts cultured on different substrates of 
varying stiffness using AFM [164]. Myoblasts were cultured on collagen strips attached 
to glass or polymer gels of different elasticity. Although the myoblasts fused into 
myotubes irrespective of substrate flexibility, actin/myosin striations appeared only in 
myotubes cultured on gels with stiffness closer to normal muscle (passive Young’s 
modulus, E ~ 12 kPa). Myoblasts did not fuse and striate on much stiffer or softer gels 
than that of normal muscle hence, indicating that substrate stiffness is a critical factor for 
differentiation of striated muscle [164]. Later, the same group demonstrated the 
significance of matrix elasticity on stem cell fate [228]. Mesenchymal stem cells (MSCs) 
were cultured on collagen coated gels of varying elasticity that mimicked brain, muscle 
and bone matrix in their stiffness. The MSCs differentiated into a neuronal morphology 
with filopodia branching and spreading when cultured on soft matrices that mimic brain 
elasticity; medium stiffness gels promoted the differentiation of MSCs to spindle shaped 
myogenic cells and the high stiffness gels led to osteogenic differentiation [228]. 
Limited work has been done in this field of AFM and it has only occasionally been 
applied to measure the elastic forces of muscle samples. Designing scaffolds of 
matching stiffness to muscle tissue and implanting these scaffolds at the muscle injury 
site may improve cell-scaffold interactions to enhance the outcome of the muscle repair 
processes.  
1.12 Conclusion 
The idea of “dynamic reciprocity” or cell-ECM crosstalk was first proposed by Bissel et 
al in 1982 [229], where she postulated that ECM alters gene expression in cells and 
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thereby regulates cell growth and differentiation. Cells are in contact with the ECM via 
cell surface receptors called integrins that signal or transmit the message from outside of 
the cell to inside the cell [230]. Traditional 2D tissue culture has been a useful model 
system to study cell-matrix interactions and the associated factors which modulate these 
interactions. However, there is a need to improve our understanding of cell-matrix 
interactions and designing 3D culture systems, which closely mimic the in-vivo cell 
microenvironment, will help in this regard. Studies have shown that cell-adhesion 
complexes in “3D matrices” differ markedly in terms of structure and function from 
their counterparts on 2D substrates. Cell-signalling events also differ between 3D 
matrices and 2D flat substrates [231]. Another study measured the gene expression 
levels of three integrin subunits (α1, β1 and β3) and ECM molecules (collagen I, 
collagen III and tropoelastin) of vascular smooth muscle cells cultured on 2D substrates 
and 3D matrices composed of pure collagen type I and fibrin. On all 3D matrices, a 
marked increase in gene expression was observed as compared to that on 2D substrates 
[232].  
Constructing 3D artificial microenvironments may provide valuable insights into cell-
material interactions. Although the idea sounds interesting, constructing these materials 
poses a significant challenge in terms of material elasticity, pore size and biophysical 
constraints which may inhibit cell migration. For tissue repair and regeneration, 
migration of cells is necessary for angiogenesis and vascularization. Microarchitecture 
of a scaffold can affect the migratory capabilities of a cell which in turn may affect the 
remodelling response of an injured tissue. Harley et al (2008) showed that mouse 
fibroblast migration rate decreased as the pore size of “collagen-GAG” scaffolds 
increased from 90 to 150 µm [233].  
For several years, the importance of ECM in tissue regeneration has been well known. 
However, there is still paucity of information on the underlying mechanism that how 
cell-matrix interactions contribute towards the regenerative response of an injured tissue. 
There is an unmet need to develop better 3D cell-based models which can replicate the 
in vivo settings very closely and can bridge the gap between 2D cell culture studies and 
in vivo animal models. Developing better 3D skeletal muscle tissue based models will 
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also be very helpful in identifying suitable therapeutic drug targets and testing candidate 
drugs for their ability to improve muscle function. These models will also enable us to 
better understand cell-matrix interactions and furthermore provide valuable insights for a 
clinical setting.   
1.13 Aims of this project 
This thesis aimed to investigate the contribution of ECM in regulating myoblast 
proliferation and differentiation by: 
 Development of a novel method of skeletal muscle decellularization. 
 Functional characterization of the solubilised and whole muscle decellularised 
ECM using C2C12 murine myoblasts in 2D and 3D serum free cultures.  
 Use of silk fibroin as an alternative biomaterial using primary human skeletal 
muscle myoblasts in 2D and 3D cultures. 
 
1.14 Hypothesis 
Natural skeletal muscle matrices and silk bio-scaffolds provide information about ECM 
components that promote growth and differentiation of muscle precursor cells.  
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Chapter 2: 
Materials and Methods 
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2.1 Muscle sampling (mice and rats) 
Female C57Bl/6J mice aged 3 months were obtained from the Animal Resource Centre 
(Perth, Australia). The mice were delivered to Curtin University and allowed to 
acclimate for one week. All animal procedures were carried out in strict accordance with 
the guidelines of the National Health and Medical Research Council of Australia and 
approved by the Curtin Animal Ethics Committee (AEC 2011-73A). Mice were 
anesthetized with 2% isoflurane and euthanized by cervical dislocation. Rats were 
euthanized by intraperitoneal overdose (50mg/100g body weight) of pentobarbitone 
sodium (Lethabarb) and obtained, post- euthanasia, from Dr Christine Cooper, Curtin 
University. Following euthanasia, the quadriceps, gastrocnemius, soleus, tibialis anterior 
and extensor digitorum longus muscles from both legs of the mice and rats were 
removed. Muscles were either snap frozen in liquid nitrogen, or embedded for 
cryosectioning and frozen using isopentane cooled with liquid nitrogen. All samples 
were stored at -80ºC. 
 
2.2 Decellularisation  
2.2.1 Buffers and reagents 
All chemical reagents for buffers used in decellularisation of skeletal muscle and 
solubilisation of the muscle extract were purchased from Sigma Aldrich (St Louis, MO) 
unless otherwise stated. 
 
Phosphate Buffered Saline (PBS) 
1x PBS (137 mM NaCl, 2.0 mM KCl, 10.0 mM Na2HPO4, 1.8 mM KH2PO4) was 
prepared by dissolving 80.0 g NaCl, 2.0 g KCl, 14.4 g Na2HPO4 and 2.4 g KH2PO4 in 
800 ml of double distilled water (ddH2O). pH was adjusted to 7.4 using HCl and volume 
made up to 1 litre using  ddH2O and sterilized by autoclaving. 
 
1M Tris buffer (TB) (pH 8.0) stock solution 
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12.11 g of Tris base (Amresco, Solon, OH) was dissolved in 100 ml of ddH2O and pH 
was adjusted to 8.0 using HCl.  
 
0.5 % Sodium deoxycholate (w/v) in 20 mM Tris buffer 
0.5 g sodium deoxycholate was dissolved in 80 ml of 20 mM Tris buffer (pH 8.0) and 
the final volume adjusted to 100 ml using 20 mM Tris buffer (pH 8.0) 
 
3.4 M Sodium Chloride in Tris buffer 
19.86 g of NaCl (Amresco) was dissolved in 80 ml of 20 mM Tris buffer (pH 8.0) and 
the final volume adjusted to 100 ml using 20 mM Tris buffer (pH 8.0) 
 
2.0 M NaCl in PBS 
11.7 g of NaCl was dissolved in 80 ml of 1x PBS (pH 7.4) and the final volume was 
made up to 100 ml using PBS  
 
0.1 M Ethylenediaminetetraacetic acid (EDTA)  
1.86 g of EDTA was dissolved in 40 ml of ddH2O, NaOH was added to dissolve EDTA 
and pH was adjusted to 7.4. The final volume was made up to 50 ml using ddH2O.   
 
0.2 % Sodium-dodecyl-sulphate (SDS) (w/v) 
0.2 g of SDS (APS, Auckland, New Zealand) was dissolved in 80 ml of ddH2O and the 
final volume was made up to 100 ml using ddH2O. 
 
1.0 % Triton X-100 (v/v) in PBS 
1.0 ml Triton X-100 (Amresco) was dissolved in 80 ml of PBS and the final volume was 
made up to 100 ml using PBS. 
 
DNase I reaction buffer (10X)  
DNase I reaction buffer (10x) (Promega) consisted of 400 mM Tris-HCl (pH 8.0), 
100mM MgSO4 and 10mM CaCl2. To prepare a 1x buffer solution, DNase I reaction 
buffer (10x) was diluted in ddH2O. 
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Radioimmunoprecipitation assay (RIPA) buffer 
RIPA buffer consisted of 20 mM Tris HCl (pH 7.5), 150 mM NaCl, 1.0 mM EDTA, 1.0 
mM EGTA (Sigma Aldrich), 1% NP-40 (Sigma Aldrich), and 1% sodium deoxycholate. 
Buffer was kept ice cold and supplemented with 1x cOmplete protease inhibitor cocktail 
(Roche) immediately prior to use.  
 
Urea buffer 
UREA buffer consisted of 40.0 mM Tris HCl (pH 7.5), 5M urea, 2M thiourea (Sigma 
Aldrich), 0.1% SDS and 1% CHAPS (Sigma Aldrich). Buffer was kept ice cold and 
supplemented with 1x cOmplete protease inhibitor cocktail (Roche) immediately prior to 
use. 
 
Acetic acid buffer (0.1 M) 
57 µL of glacial acetic acid (17.4 M) was added to 10 ml of ddH2O.  
 
2.2.2 Decellularization of mouse skeletal muscle sections 
2.2.2.1 Trypsin method 
Muscle sections were rinsed in PBS for 2 h, incubated in 0.05 % trypsin (Sigma-
Aldrich) for 20 min before the trypsin was inhibited by Dulbecco’s modified eagles 
medium (DMEM, Life Technologies, Carlsbad, CA) containing 10 % fetal bovine serum 
(FBS, HyClone, Thermo Fisher Scientific, Waltham, MA) for 1 h. Sections were then 
washed in PBS/1 % Triton X-100 (Sigma-Aldrich) for 30 min and then with PBS for 1 
h. 
2.2.2.2 Sodium dodecyl sulphate (SDS) method 
Muscle sections were rinsed in distilled water for 2 h and treated with 0.2 % SDS in PBS 
containing 50 mM EDTA and 1 x cOmplete protease inhibitor (Roche, Mannheim, 
Germany) for 75 min at 4
o
C with buffer replaced every 20 min. Sections were then 
washed with 2 M NaCl/50 mM EDTA/1x protease inhibitors/20 mM Tris, pH 7.4 for 10 
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min at 4
º
C followed by 100 mM NaCl/20 mM Tris for 1 h at 4
º
C. Finally, sections were 
washed twice with 20 mM Tris/0.15M NaCl buffer for 30 min each. 
2.2.2.3 Phospholipase method 
Muscle sections were rinsed in PBS for 30 min followed by incubation in a 
phospholipase A2 (PLA2, 170 U/ml)(Sigma-Aldrich), 0.5 % sodium deoxycholate 
(Sigma-Aldrich) solution in 20 mM Tris buffer (pH 8.0)/0.15M NaCl containing 1x 
cOmplete protease inhibitor for 30 min. Muscle sections were then washed in 3.4 M 
NaCl/20mM Tris for 2 h, rinsed 2x in PBS for 5 min each, treated with DNaseI (75 
U/ml) (Promega, Madison, WI) in 1x DNase I reaction buffer for 1 h at 37
o
C and then 
washed 3x in PBS for 15 min each.   
2.2.3 Whole muscle decellularization  
Rat tissue was used for whole muscle decellularization to produce sufficient material for 
analysis and tissue culture studies. The muscle was weighed, sliced into 0.5 mm pieces 
and rinsed in PBS containing 1x cOmplete protease inhibitor for 2 h at 4ºC. After 
washing, sections were treated with PLA2 (170 U/ml), 0.5 % sodium deoxycholate in 20 
mM Tris buffer (pH 8.0)/0.15M NaCl containing 1x cOmplete protease inhibitor 
(Roche) for 18 h at room temperature (RT) until the tissue appeared transparent. The 
tissue samples were washed with 3.4 M NaCl/20 mM Tris/1x protease inhibitor for 24 h 
at 4ºC (buffer changed every 8 h) and then rinsed in PBS for 1 h at 4ºC. The samples 
were treated with DNAse I (75 U/ml) in 1x DNase I reaction buffer at 37ºC for 24 h and 
washed in PBS for 12 h at 4ºC (3 buffer changes) and stored at 4ºC until further use. 
Decellularised muscle samples were used in two- or three-dimensional culture (2D/3D). 
For 2D culture experiments, decellularized muscle samples were air dried on tissue 
paper and weighed before and after vacuum drying for 3 h (Integrated SpeedVac
R
, 
Thermo Fisher Scientific). The ECM was then solubilized in 0.1 M acetic acid/20 mM 
EDTA for 7 days at 4ºC with mixing and the protein concentration was measured using 
the Pierce BCA protein assay kit (Pierce Biotechnology, Rockford, IL). For 3D culture, 
decellularised muscle samples were stored in PBS and sterilised before use (Section 
2.7.8) 
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2.2.4 Solubilisation of acellular skeletal muscle 
2.2.4.1 Urea and RIPA buffer solubilisation 
Untreated and PLA2 decellularised muscles were solubilised either in urea or RIPA 
buffers for 4 h or O/N at 4ºC. After incubation, the tissue lysate was centrifuged at 
12,000 rpm for 20 min at 4ºC. The supernatant was carefully aspirated without 
disturbing the insoluble tissue debris and transferred to a clean microtube and stored at -
20ºC. Protein concentrations were then measured by either BCA (Pierce Biotechnology, 
Rockford, IL) or Non- Interfering (NI) protein assay (G-Biosciences, St Louis, MO) (see 
Section 2.3.2.1 for the protocol).  
2.2.4.2 Acetic acid solubilisation 
Decellularized muscle samples were air dried on tissue paper and weighed (wet weight) 
in eppendorf tubes. The muscle samples were dried using an Integrated SpeedVac
R
 
apparatus (Thermo Fisher Scientific) for 3 h and then weighed again (semi-dry weight). 
The dried ECM was solubilized using 0.1 M acetic acid/20 mM EDTA for 7 days at 4ºC 
with mixing. After incubation, the tissue lysate was centrifuged at 12,000 rpm for 20 
min at 4ºC. The supernatant was carefully aspirated without disturbing the insoluble 
tissue debris and transferred to a clean microtube, before storing at 4
o
C. The protein 
concentration was measured at days 1, 3, 5 and 7 using the Pierce BCA protein assay kit 
(Pierce Biotechnology, Rockford, IL) (see Section 2.3.2.2 for the protocol).                                                                                                                                                                                                                                                                                                                                                                                                       
 
2.3 Protein Analysis 
2.3.1 Gels, buffers and solutions for protein analysis 
All chemical reagents for buffers used for protein analysis were purchased from Sigma 
Aldrich unless otherwise stated. 
 
SDS-PAGE resolving and stacking gels 
SDS-PAGE resolving gels were prepared by combining an acrylamide/bis-acrylamide 
solution (29:1 ratio, Bio-Rad laboratories, Hercules, CA) with 0.375 M Tris-HCl (pH 
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8.8), 0.1% w/v SDS and ddH2O. The acrylamide/bis-acrylamide was added in sufficient 
quantities to produce gel solutions of 6%, 7.5%, 10% or 12% acrylamide. Just prior to 
pouring, 0.1% w/v ammonium persulfate and 0.2% (v/v) TEMED (both from Amresco) 
were added to the gel solution. The gel mixture was immediately poured between two 
glass plates (mini-gel) assembled in a gel caster (Hoefer, San Fransisco, CA) leaving 2 
cm space at the top of the glass plates for the stacking gel. The resolving gel was 
overlaid with 25% ethanol and allowed to polymerize at room temperature (RT). 
 
Stacking gels were prepared by combining 4 - 5% acrylamide/bis-acrylamide (29:1), 
125mM Tris-HCl (pH 6.8), 0.1% w/v SDS and ddH2O.
  
Just prior to pouring, 0.1% v/v 
ammonium persulfate and 0.2% (v/v) TEMED were added to the gel mixture.
 
The 
stacking gel solution was immediately poured between the glass plates on top of the 
polymerized resolving gel and the well casting comb put in place. The stacking gel was 
left to polymerize at room temperature before removing the comb.  Wells were washed 
with ddH2O to remove any unpolymerized gel.    
 
SDS-PAGE running buffer 
SDS-PAGE running buffer was prepared as a 10x stock solution containing 250mM 
Tris-HCl, 2M glycine and 1% (v/v) SDS diluted in ddH2O; adjusted to pH 8.3 using 1M 
NaOH. 1x gel running buffer was prepared fresh for each run by diluting the stock 
solution 1:10 with ddH2O.  
 
Sample loading buffer  
Sample loading buffer was prepared as a 2x stock consisted of 160mM Tris-HCl (pH 
6.8), 4% (v/v) SDS, 20% (v/v) glycerol and 0.2% (v/v) bromophenol blue (Bio-Rad, 
Hercules, California) in ddH2O.  
 
Coomassie Brilliant Blue (CBB) staining solutions 
Coomassie staining solution was prepared by dissolving 50 mg of Coomassie Brilliant 
Blue-R 250 (Bio-Rad) in a solution consisting of 40 ml methanol, 10 ml glacial acetic 
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acid and 50 ml ddH2O. The solution was filtered prior to use. The de-staining solution 
consisted of 40 ml methanol, 10 ml glacial acetic acid and 50 ml ddH2O.  
 
Western blotting electrotransfer buffer 
Western blotting transfer buffer was prepared as a 10x stock solution containing 250mM 
Tris-HCl and 2M glycine and the pH adjusted to 8.3 using 1M NaOH. 1x blotting buffer 
was prepared fresh for each electrotransfer by diluting 10x stock solution with ddH2O, 
and then adding 20% of methanol to the diluted solution. 
 
PBS-Tween (PBST) buffer 
0.1 ml of Tween-20 was added to 100 ml of 1xPBS buffer to yield a 0.1% (v/v) PBST 
buffer. 
 
Blocking buffer (Western blotting buffer) 
Blocking buffer was prepared by dissolving 5.0 g of skimmed milk powder in 90 ml of 
PBST buffer and the volume was made up to 100 ml using PBST buffer to yield a 
solution of 5% (w/v) skimmed milk in PBST. This buffer was freshly prepared for each 
use.  
2.3.2 Protein quantification 
2.3.2.1  Bicinchoninic acid (BCA) assay  
The working reagent (WR) was prepared by mixing 50 parts of BCA Reagent A with 1 
part of BCA Reagent B (50:1, Reagent A: B). Bovine serum albumin (BSA)(Sigma 
Aldrich) was used as a standard. 10 mg of BSA was dissolved in 1 ml of 1x PBS or 
0.1M acetic acid to yield a 10.0 mg/ml stock, and serially diluted to yield concentrations 
ranging from 0.1 mg/ml to 4.0 mg/ml. 10 µL of each sample (standard or unknown 
sample) was pipetted into a 96 well plate (Nunc, Thermo Fisher Scientific) and 200µL 
of the WR was added to each well and mixed thoroughly. The plate was covered and 
incubated at 37°C for 30 minutes before being brought to RT. Absorbance was measured 
at 590 nm on an Enspire plate reader (Perkin Elmer, Waltham, MA). A standard curve 
was generated by plotting the mean absorbance for each BSA standard versus its 
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concentration in mg/mL and this curve used to determine the protein concentration of 
each unknown sample. 
2.3.2.2  Non-Interfering (NI) protein assay  
The NI protein assay (GBiosciences) was performed according to the manufacturer’s 
instructions. Briefly, a set of BSA protein standards was prepared from a BSA stock (2.0 
mg/ml) to yield concentrations ranging from 0 - 50 µg/ml. 10 µl of protein sample 
(unknown concentration) was aliquoted into a 1.5 ml microtube containing 0.5 ml of 
universal protein precipitation agent (UPPA I) buffer . The mixture was vortexed briefly 
and incubated at RT for 5 min before the addition of 0.5 ml of UPPA II. The mixture 
was then, vortexed briefly and centrifuged at 10,000 g for 5 min to pellet the precipitated 
protein. The supernatant was discarded and 100 µl of copper solution (Reagent I) and 
400 µl of deionized water were added to the pellet and vortexed until the protein pellet 
dissolved. Finally, 1 ml of reagent II was added to the tube, mixed thoroughly, incubated 
at RT for 20 min and absorbance was measured at 480 nm. A standard curve was 
prepared by plotting the average measurement for each BSA standard versus its 
concentration in mg/mL. The standard curve was used to determine the protein 
concentration of each unknown sample (see below). 
 
2.3.3 SDS-PAGE 
Solubilised ECM extracts of decellularised muscle were separated by electrophoresis on 
a 7.5 % SDS-PAGE using 10 µg of collagen I (Sigma Aldrich) as a control standard. 
Proteins were separated on the basis of molecular weight under non-reducing conditions 
using SDS-PAGE as described by Laemmli (1970)[234]. The polyacrylamide gels (7.5% 
running, 5% stack) were placed in a Mighty Small SE250 apparatus (Hoefer, Scientific 
Instruments, CA, USA) and the chamber filled with 1x running buffer. Before loading 
the protein samples, 1 volume of 6x loading buffer was added to 5 volumes of protein 
samples and heated at 95ºC for 10 min. Pre-stained high molecular weight markers 
(Spectra multicolour broad range protein ladder, Thermo Fisher Scientific) were also 
loaded on each gel. The proteins were electrophoresed at a constant current of 120V for 
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90 min. Following electrophoresis; gels were either stained with Coomassie blue or 
transferred to a PVDF membrane via electroblotting. 
 
2.3.4 Coomassie blue staining 
SDS-PAGE gels were incubated overnight in Coomassie staining solution at room 
temperature with gentle rocking. The stained gel was transferred into a destaining 
solution and gently agitated until the background became clear. The gel was then imaged 
using the ChemiDoc
TM
 MP System (Bio-Rad) or placed between two moistened sheets 
of clear cellophane film, clamped between two plastic frames and allowed to dry 
overnight.  
 
2.3.5   Electroblotting (protein transfer) 
Following electrophoresis, proteins separated via SDS-PAGE were transferred to a 
Immobilon-P PVDF membrane (Millipore, Bedford, MA, USA) using a wet blotting 
apparatus (Hoefer, Scientific Instruments, CA, USA). Electroblotting was either 
performed at 400 mAmp for 1 h at 4ºC and 20V for overnight at 4ºC, or at 200 mAmp 
for 2 h at room temperature (RT). The membrane was then blocked for 2 h at RT or 
overnight at 4ºC in blocking buffer. 
 
2.3.6 Western blotting  
Following blocking, the membrane was incubated in primary antibodies diluted in 
blocking buffer. Antibodies used were against collagen I (1:1500), collagen VI (1:2500), 
fibronectin (1:1500), perlecan (1:5000) and laminin α2 (1:3000), myosin (1:1000) and β-
tubulin (1:1500) for 2h at RT. Collagen I, collagen VI and perlecan were all rabbit 
polyclonal antibodies. Fibronectin (EP5) and laminin α2 (4H8-2) were mouse and rat 
monoclonal antibodies respectively (Refer Table 2.1). Membranes were washed 4 times 
in 0.1 % Tween-20 in PBS (PBST) for 5 min each and incubated in 0.1 % PBST 
containing anti-rabbit, anti-mouse or anti-rat horseradish peroxidase (HRP) conjugated 
secondary antibodies at (1:2000, 1:1000 and 1:1000 dilutions respectively)(Refer Table 
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2.2). Membranes were washed 4 times in 0.1% PBST for 5 min each and incubated in 
Western Lightning® Plus-ECL substrate (Perkin Elmer, Waltham, MA) for 5 min. 
Membranes were scanned and imaged using the ChemiDoc
TM
 MP System (Bio-Rad). 
 
2.4.   DNA analysis 
2.4.1  Gels, buffers and solutions for DNA analysis 
All chemical reagents for buffers used for DNA analysis were purchased from Sigma 
Aldrich unless otherwise stated. 
 
Tris-Acetate-EDTA (TAE) gel running buffer    
Tris-Acetate-EDTA (TAE) buffer was prepared as a 50x stock by combining 242 g Tris 
base, 57.1 ml glacial acetic acid and 100 ml 0.5M EDTA  (pH 8.0) in ddH2O to a 
volume of 1 litre. 1x TAE buffer (pH 8.0) was prepared by diluting the stock solution 
1:50 with ddH2O.  
 
DNA gel loading buffer (6x) 
DNA gel loading buffer (6x) was prepared by adding 3.9 mL glycerol, 500 μL 10% 
(w/v) SDS, 200 μL 0.5 M EDTA (pH 8.0), 0.025 g bromophenol blue (Bio-Rad) and 
0.025 g xylene cyanol to 5 ml of ddH2O and the volume was made upto 10 ml using 
ddH2O. 
 
Agarose gels 
Agarose gels (1, 1.5 or 2%) were prepared by dissolving molecular biology grade 
agarose in 1x TAE buffer and bringing the solution to the boil. 2µl of Midori Green 
(Nippon Genetics, Deuren, Germany) was added per 50 ml of gel solution to detect 
DNA.  
2.4.2 Agarose gel electrophoresis 
Agarose gels were made to the desired concentration and samples were mixed with 6x 
gel loading buffer prior to loading in the wells of the gel. Samples were then 
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electrophoresed in 1x TAE buffer using a Wide Mini Sub Cell and Power Pack (Bio-
Rad) until the marker was completely resolved. The gel was visualized using a UV 
trans-illuminator and imaged using a Gel Doc Imaging System (Vilber, Adelab 
Scientific, Adelaide, Australia) 
2.4.3 DNA extraction and quantification  
DNA was extracted from 10 µm thick control and decellularized muscle sections by 
scraping 40 sections off glass slides using a total volume of 300µl of 1x PBS for 40 
sections. Muscle sections (control and decellularized) from mid belly regions of the 
muscle were selected to minimize the variation in the starting amount of DNA. The 
material was collected in a 1.5 ml microtube and centrifuged at 12,000g for 10 min. 
DNA was extracted using the Master Pure kit (Epicentre, Illumina, Madison, WI) 
according to the manufacturer’s instructions. Briefly, control and decellularised muscle 
sections were incubated in 600µl of tissue and cell lysis solution containing 2.0 µl of 
proteinase K (50 mg/ml)(Sigma Aldrich) and incubated at 65ºC for 45 min until the 
tissue was digested. Samples were cooled to 37ºC and 2.0 µl of 5.0 µg/ml RNase A was 
added to the sample and incubated at 37ºC for 30 min. Samples were kept on ice for 5 
min, 300 µl of MasterPure complete (MPC) protein precipitation reagent was added and 
the mixture centrifuged at 10,000 g for 10 min at 4ºC. The supernatant was collected and 
DNA precipitated by adding 1 ml of isopropanol to the supernatant and centrifuging at 
10,000g for 10 min at 4ºC. The pellet was rinsed in 70% ethanol twice, dried and 
dissolved in 35 µl of TE buffer. DNA was quantified using the Nanodrop (Thermo 
Fisher Scientific) by measuring the absorbance at A260 and visualised on a 1.5% agarose 
gel to check the DNA quality.  
2.5  Immunofluorescence  
2.5.1  Buffers, solutions and antibodies 
 
4% Paraformaldehyde   
4.0 g of paraformaldehyde (PFA) powder was added to 100 ml of 1x PBS and heated at 
65ºC for 5 min. 1 drop of 10M NaOH was added to the above solution to enable the PFA 
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to dissolve into solution. The solution was then cooled to RT, the pH was adjusted to 7.3 
using dilute HCl and solution stored at 4ºC. The solution was stored only for 2 weeks at 
4ºC and prepared fresh thereafter.  
 
Antibody blocking solution 
Fetal bovine serum (FBS) and BSA were added to 1 x PBS at 10% (v/v) and 1% (v/v), 
respectively. 
 
Antibodies 
See Tables 2.1, 2.2 and 2.3 
 
Antibody isotype controls 
Antibody isotype controls and only secondary antibody controls for respective 
antibodies verified the lack of non-specific staining (Figure 2.1) for all the three 
methods.  
2.5.2   Immunofluorescence staining procedure  
Muscle sections were fixed in 4% paraformaldehyde in PBS for 10 minutes and then 
incubated in antibody blocking solution overnight at 4
o
C. Sections were washed 3 times 
with PBS (5 min each) and incubated in primary antibody (Table 2.1) diluted in antibody 
blocking solution for 2 h at RT. All the antibodies used for immunofluorescence 
experiments were tested at different dilutions (1:50, 1:100 and 1:200) before selecting 
1:100 as the dilution used for all further experiments. Following incubation in primary 
antibody, sections were washed 3 times with PBS (5 min each) and incubated in 
secondary antibody (Table 2.2) diluted in blocking solution for 1 hour. The samples 
were then washed in PBS and mounted in a DAPI-containing mounting media 
(Vectashield, Vector Laboratories, Burlingame, CA). Images were captured with a Zeiss 
Axioskop fluorescent microscope (Carl Zeiss, Oberkochen, Germany) using Spot 
Advanced software (SPOT Imaging Solutions, Sterling Heights, MI). All the images 
were acquired at the same gain and exposure settings and were processed using the same   
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     Isotype control secondary antibody 
 control  
Mouse IgG1 
Rabbit IgG 
Rat IgG2a 
Goat IgG 
a b 
c d 
e f 
g h 
Figure 2.1 Immunofluorescence labeling of untreated triceps muscle 
sections of 3 month old female C57/black mice. Muscle sections were 
fixed using 4% paraformaldehyde and stained with antibodies against 
isotype controls: mouse IgG1 (a), Rabbit IgG (c), Rat IgG2a (e) and Goat 
IgG (g). Secondary antibodies were: goat anti-mouse alexa fluor 488 
antibody (a, b); goat anti-rabbit FITC conjugated antibody (c, d); goat anti-
rat FITC conjugated antibody (e, f) and Dylight 549 conjugated anti-goat 
IgG antibody (g, h). Nuclei are stained with DAPI (blue).  
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parameters to refine the images. The blocking solution for anti-decorin antibody was 
10% normal donkey serum in PBS. Antibody isotype controls and secondary antibody 
controls were used to verify the specificity of each primary antibody. FBS was used for 
blocking in immunohistochemistry experiments and it contains high levels of soluble 
ECM proteins like fibronectin and other proteoglycans. The results described in Figure 
3.2 and Figure 3.6. show that there is no evident staining for fibronectin (Fig 3.2) and 
decorin and biglycan (Fig 3.6) which suggest that FBS was not contributing to any false 
positives.    
 
The presence of DNA in decellularized sections (section 2.2.2) was assessed 
qualitatively using DAPI (4',6-diamidino-2-phenylindole) (1.0µg/ml in PBS). Control 
and decellularized sections were mounted in a Vectashield and images captured as 
described above. 
 
2.6   Scanning electron microscopy  
Control and decellularised muscle sections were fixed in 4% paraformaldehyde for 30 
min at RT and subsequently dehydrated in ethanol solutions of increasing concentration 
(30% to 100% in ddH2O), for 15 mins per concentration. Muscle sections were then 
dried at room temperature and sputter coated with platinum (5 nm) using an Emitech 
K575 × Sputter Coater (Cressington, Redding, CA) and data collected using an EVO 
Scanning Electron Microscope (Carl Zeiss). Sample coating and the scanning electron 
microscopy was performed with the technical assistance of Mrs. Elaine Miller at the 
Curtin University Electron Microscope Facility. 
 
Table 2.1.  Primary antibodies 
 
Antibody Species, 
Isotype 
Reacts against Clonality, 
Clone name 
Applications Manufacturer, 
catalogue no. 
collagen type I Rabbit IgG 
 
Mouse, Rat, 
Horse, Human 
Polyclonal 
 
IHC, ICC, 
WB 
Abcam (ab292) 
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collagen type 
III 
 
Rabbit IgG 
 
Mouse, Rat, 
Cow, Human 
 
Polyclonal 
 
IHC,  WB 
 
Abcam (ab7778) 
collagen type 
IV 
 
Rabbit IgG 
 
Mouse, Rat, 
Cow, Human 
 
Polyclonal 
 
IHC, ICC, 
WB 
 
Abcam (ab6586) 
collagen type 
VI 
 
Rabbit IgG 
 
Mouse, Rat, 
Cow, Human 
 
Polyclonal 
 
IHC, ICC, 
WB 
 
Abcam (ab6588) 
Fibronectin 
 
Rabbit IgG 
 
Mouse, Rat, 
Cow, Human 
 
Polyclonal 
 
IHC, ICC, Abcam (ab2413) 
Fibronectin 
 
Mouse IgG1 Rat, Human Monoclonal, 
EP5 
WB SantaCruz (SC-8422) 
Laminin α2 
 
Rat IgG1 
 
Mouse, Human 
 
Monoclonal, 
4H8-2 
 
IHC, ICC, 
WB 
 
Abcam (ab11576) 
Desmin 
 
Mouse IgG1 
 
Rat, Cow, 
Human 
 
Monoclonal, 
DE-U-10 
 
IHC, ICC Abcam (ab6322) 
Myosin (slow 
muscle) 
 
Mouse IgG 
 
Human, rat, 
feline 
 
Monoclonal, 
NOQ7.4.D 
 
IHC, ICC, 
WB 
 
Millipore(MAB1628) 
Biglycan 
 
 
Goat  Ig 
Mouse, Rat 
 
Polyclonal 
 
IHC 
 
Abcam (ab58562) 
Decorin 
 
Sheep IgG Chicken, Cow, 
Human 
 
Polyclonal 
 
IHC 
 
Abcam (ab35378) 
Perlecan Rabbit IgG Mouse, Rat, 
Human 
Polyclonal IHC, ICC, 
WB 
Prof. John Whitelock 
University of NSW, 
Sydney 
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EV3C3 Mouse Rat, Human Monoclonal IHC Prof Toin Van 
Kuppeveldt 
Radboud University, 
The Netherlands 
β-tubulin 
 
Rabbit IgG 
 
Mouse, Rat, 
Human, 
 
Polyclonal 
 
WB Abcam (ab6046) 
Vinculin Mouse IgG1 Human, Rat, 
Bovine 
Monoclonal 
hVIN-1 
ICC Sigma (V 9131) 
Table 2.2  Secondary antibodies 
 
Name, species, 
isotype 
Reacts against Conjugated Applications Manufacturer, 
Catalogue no. 
Goat anti-mouse Ig mouse Ig, mainly 
IgG 
HRP WB Dako (P0447) 
Goat anti-rabbit Ig rabbit Ig, mainly 
IgG 
HRP WB Dako (P0448) 
Rabbit anti-rat Ig rat Ig, mainly IgG HRP WB Dako (P0450) 
Goat anti-rabbit Ig Rabbit Ig FITC IHC Sigma (F9887) 
Goat anti-rabbit Ig Rabbit Ig Alexa-fluor 488 IHC, ICC MP (A-11008) 
Goat anti-rabbit Ig Rabbit Ig Alexa-fluor 546 IHC MP (A-11035) 
Goat anti-rat Ig Rat Ig FITC IHC Sigma (F6258) 
Goat anti-mouse Ig Mouse Ig Alexa-fluor 488 ICC MP (A-11001) 
Goat anti-mouse Ig Mouse Ig, mainly 
IgG 
unconjugated Blocking Dako  
Donkey anti-goat Ig Mouse Ig Dylight 549 IHC Jackson 
Immunoresearch 
Donkey anti-sheep Ig Mouse Ig Dylight 549 IHC Jackson 
Immunoresearch 
 
Table 2.3  Isotype Control antibodies  
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Name, species, isotype Applications Manufacturer, Catalogue no. 
Rat IgG2a IHC, ICC Zymed (02-9688) 
Rabbit IgG IHC, ICC Invitrogen (02-6102) 
Sheep IgG IHC Jackson Immunologicals (D13-000-003) 
Mouse IgG2a IHC, ICC Dako (X0943) 
Mouse IgG1 IHC, ICC Dako (X0931) 
 
2.7  Tissue culture and cell based assays 
2.7.1 Cell lines 
The C2C12 murine myoblast cell line was purchased from the American Type Culture 
Collection (ATCC, Manassas, VA). Human skeletal muscle myoblasts (HSMMs) were 
purchased from Lonza (Basel, Switzerland). HSMMs were obtained from normal human 
donors usually from the quadriceps or psoas muscles. 
 
2.7.2 Basic Tissue Culture Media and supplements  
Dulbecco’s modified Eagle’s medium (DMEM) was purchased in 500 ml bottles (pre-
prepared, without L-Glutamine) from Life Technologies (Carlsbad, CA). Skeletal 
Muscle Growth Media-2 (SkGM™-2 Medium) was purchased from Lonza. Ham’s F-10 
and Ham’s F-12 media, both without L-Glutamine were purchased from Sigma-Aldrich.  
Stock solutions of HEPES (1M), L-Glutamine (200mM) and sodium pyruvate (100mM) 
were purchased from Life Technologies. Fetal Bovine Serum (FBS) was purchased from 
HyClone (Thermo Fisher Scientific). DMEM working media solutions were prepared by 
adding the stock solutions of HEPES, L-Glutamine and sodium pyruvate at a 1:100 
dilution into DMEM, and supplementing with 10% FBS to produce a final media 
solution containing DMEM, 10 mM HEPES, 1 mM sodium pyruvate, 2 mM glutamine 
and 10% FBS. 
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2.7.3 Serum free media 
Serum free base media was prepared by adding DMEM and Ham’s F10 in a 1:1 ratio, 
supplemented with HEPES, L-Glutamine and sodium pyruvate as described above. 
Monothioglycerol (MTG) was added to the media to a final concentration of 0.1 mM. 
Serum free media (SF) proliferation media was prepared by supplementing serum free 
base media with 50 ng/ml epidermal growth factor (EGF), 25 ng/ml fibroblast growth 
factor (bFGF), 1.0 µM/ml dexamethasone, 0.12 IU/ml insulin, 1.0  µg/ml heparin and 
0.5% BSA. Serum free differentiation medium consisted of DMEM/F10 in a ratio of 1:1 
supplemented with 50 ng/ml epidermal growth factor (EGF), 25 ng/ml insulin growth 
factor (IGF-1), 1.0 µM/ml dexamethasone and 0.5% BSA. Growth factors were 
purchased from from Peprotech (Rocky Hill, NJ), dexamethasone, insulin and BSA were 
all from Sigma-Aldrich and heparin was from Celsus Laboratories (Cincinnati, OH). 
 
2.7.4 Freezing and thawing cell lines 
Freezing  
Cells were harvested, resuspended in appropriate FBS containing tissue culture media 
(see sections 2.7.5.1, 2.7.5.2) and then pelleted by centrifugation at 1000 rpm for 5 min. 
Media was carefully removed from the cell pellet by pipetting. The cell pellet was gently 
resuspended in 0.5 ml of freeze media (50% DMEM or SkGM-2, 40% FCS, 10% 
DMSO) and transferred into cryogenic vials (Corning, Tewksbury, MA). The cryogenic 
vials were then placed at -80ºC before being transferred to a liquid N2 cylinder.   
 
Thawing  
Cells in cryogenic vials were warmed quickly by immersing the vial in a 37ºC water 
bath. 1 ml of warm complete tissue culture media (either DMEM or SkGM-2) was added 
drop wise to the cells. The cell solution was then transferred into a 25cm
2 
tissue culture 
flask (Nunc, Thermo Fisher Scientific) and a further 4 ml of warm tissue culture media 
was slowly added. The flask was monitored every 2 hours and media was changed after 
the cells attached to the flask (4-6 h). 
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2.7.5 Cell culture and maintenance 
2.7.5.1 C2C12 murine myoblasts 
C2C12 myoblasts were subcultured in DMEM complete media and housed in a 
humidified 37
o
C incubator equilibrated at 5 % CO2. C2C12 myoblasts were passaged 
when they reached 60-70% confluence and cells less than 20 passages old were used for 
all experiments. Briefly, media was discarded from the T25 flask and cells were washed 
with PBS before 500 µl of 0.05% trypsin-EDTA (Life Technologies) was added to the 
flask and incubated at 37ºC for 5 min or until the cells detached. Cells were pelleted by 
centrifugation at 1000 rpm for 5 min in DMEM complete media. Media was removed; 
cells were resuspended in 1 ml of DMEM complete media and counted using a 
haemocytometer. C2C12 myoolasts were at 4 x 10
4
 cells per T25 flask for maintenance, 
or at 3500 - 7000 cells/cm
2 
in a well for further experiments. 
 
2.7.5.2 HSMMs 
HSMM were maintained in SkGM™-2 Medium containing human epidermal growth 
factor (hEGF), Dexamethasone, L-glutamine and 10% FBS. SkGM-2 media was 
prepared and used according to the manufacturer’s instructions. Cells were subcultured 
once they reached 50-70% confluency. Briefly, media was discarded from the flask and 
cells were washed with PBS (HyClone, Ca
2+
 and Mg
2+
 free). PBS was removed and 750 
µl of TE (trypsin-EDTA) was added to the T25 flask and incubated at 37ºC for 5 min or 
until the cells detached. Cells were pelleted by centrifugation at 1000 rpm for 5 min in 5 
ml of SKGM-2 media. Media was removed and cells were counted using a 
haemocytometer. Cells were seeded at a density of 3500 cells/cm
2
 for a T25 flask or at 1 
x 10
4
-1.5 x 10
4 
cells/cm
2
 for seeding in wells. HSMM cells less than 6 passages old were 
used in all further experiments. 
 
2.7.5.3 Serum free culture of C2C12 cells 
C2C12 cells were harvested from serum-containing media using the following protocol. 
Briefly, media was removed from the flask and cells were rinsed with 5 ml PBS and then 
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5 ml of 2.5mM EDTA. 0.5 ml of warm 0.05% trypsin/EDTA diluted 1:10 in 2.5mM 
EDTA (0.9 ml EDTA+0.1 ml trypsin/EDTA) was then added per T25 flask and 
incubated at 37ºC for 5 min. Cells were pelleted down with 4.5 ml DMEM/10% FCS at 
1100 rpm for 5 min. Pellet was washed thrice with 5 ml of DMEM/F10 base media + 0.5 
% BSA by centrifuging at 1100 rpm for 5 min to remove any remaining serum. Cells 
were counted in 2 ml of base media and seeded at required densities in serum free 
proliferation media (section 2.7.3). 
 
2.7.6 Proliferation and Differentiation of C2C12 cells on different matrices 
Wells of a 24 well plate (Nunc) were coated with 10µg/cm
2
 of the solubilised ECM 
derived from skeletal muscle (section 2.2.3), 10µg/cm
2
 of collagen I (Sigma C8919) and 
10.0µg/cm
2
 of fibronectin (Sigma F0895) diluted in PBS (1x), incubated at 37ºC for 2 h, 
washed twice with PBS and then sterilized under UV light for 20 min. C2C12 myoblasts 
were plated at a density of 7,000 cells/well in serum free medium and maintained at 
37ºC and 5% CO2. Myoblasts were maintained in the serum supplemented or serum free 
proliferation medium for the first three days, after which they were transferred to serum 
supplemented or serum free differentiation medium. Cells were monitored for 
morphological changes and phase contrast images were taken on days 1, 3, 5 and 7 
following the addition of differentiation medium. Control wells contained cells grown in 
serum free proliferation media supplemented with 10% foetal calf serum (FCS) and 
serum free differentiation media containing 2% horse serum (HS).  
 
2.7.7 Cell Proliferation (direct cell count) 
Direct cell counts were performed from cells cultured in 24 well plates unless otherwise 
stated. Cells were counted using the Z™ Series COULTER COUNTER® (Beckmann 
Coulter, Indianapolis, IN) and cell concentrations were calculated from a live cell count 
only, as gates were set to remove dead cells and cellular debris from the analysis. To 
count, cells were harvested from the plastic using 0.05% trypsin/EDTA and resuspended 
in DMEM/10% FBS (0.5 ml or 1 ml, depending on the number of cells). 100µl, 200 µl 
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or 400 µl of this cell suspension was diluted in 10 ml of isotonic saline and 500 µl of this 
sample counted. The cell concentration was then calculated after adjusting for the 
dilution factor. 
 
2.7.8  Chloroform sterilisation of decellularised muscle scaffolds 
10 ml chloroform was combined with sterile 1x PBS to make a 2L solution. Whole, 
decellularised scaffolds were placed in pre-wetted dialysis tubing containing 5 ml tissue 
culture grade PBS and sealed at both ends. The dialysis bag containing the scaffolds was 
dialysed against 2L of chloroform/PBS at 4ºC overnight. The scaffolds were then 
dialysed against an additional 2 changes of chilled chloroform/PBS, each for 30 min at 
4ºC. Next, the scaffolds were removed from the dialysis tubing using sterilised tweezers 
and stored in 10 ml of sterile tissue culture grade PBS at 4ºC until required. 
 
2.7.9 Three-dimensional cell culture (C2C12 and HSMM) 
Longitudinal and transverse samples of decellurarised rat muscle scaffolds were cut 
using a sterilized razor blade and placed into the wells of a 24 well plate. C2C12 or 
HSMM were harvested and re-suspended in SF media (C2C12) or SKGM-2 plus FBS 
(HSMM). Media (50 μl) containing 1x104 cells was dripped gently onto the scaffold, to 
minimise dispersal of cells into the well, and the cells were allowed to adhere to the 
scaffold for 30 min in a tissue culture incubator. Following this, the scaffolds were 
carefully transferred to a new well, 1.5 ml of media (SF or SKGM-2) was added and 
cells were cultured for 7 and 14 days, with media replaced after every third day. After 7 
and 14 days of culture, cells and scaffolds were stained with Kwik Diff stain (Thermo 
Fisher Scientific) 
 
2.7.10 Kwik Diff staining and imaging 
Kwik-Diff staining of the decellularised scaffolds was performed according to the 
manufacturer’s instructions. In brief, media was removed from each well and 500 μl of 
solution 1 (fixative) was added. Scaffolds were incubated at RT for 1 min and then 
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solution 1 replaced by solution 2 (eosin) for 30 sec. Solution 2 was removed and 500 μl 
of solution 3 (methylene blue) was added to each well and plate incubated for 1 min at 
RT. Wells were washed with ddH2O three times (1 min each). Samples were left in 
ddH2O water to de-stain for 3 days, with water replaced regularly. Samples were imaged 
using Zeiss Axioskop bright field microscope (Carl Zeiss) using Spot Advanced 
software (SPOT Imaging solutions). Images were taken at 100x, 200x and 400x 
magnification. 
 
2.7.11 Click-iT EdU cell proliferation assay  
Click-iT® EdU (Life Technologies) cell proliferation assay was performed on the whole 
muscle scaffolds seeded with C2C12 myoblasts. This assay labels recently synthesized 
DNA of cell nuclei with the coloured thymidine analogue EdU. Detection is based on a 
covalent reaction between an alkyne (EdU) and an azide (Alexa Fluor 488), catalyzed by 
copper. At day 3 of proliferation and day 6 of differentiation, half of the serum-free 
proliferation media was replaced fresh media containing 20 µM EdU and incubated for 
24 h. The media was then removed and scaffolds fixed in 4 % paraformaldehyde in PBS 
for 10 min, washed twice with 3% BSA and permeabilized with 0.5 % Triton X-100 for 
10 min. After permeabilization, the scaffolds were washed twice with 3 % BSA and 
incubated in 100 µl of Click-iT reaction cocktail (1X Click-iT reaction buffer - 90 µl, 
CuSO4 - 2 µl, Alexa fluor azide - 0.25 µl and reaction buffer additive - 10 µl) for 30 min 
at RT in the dark. After incubation, the scaffolds were washed with 3% BSA and 
incubated in DAPI/PBS (1 µg/ml) for 10 min. Scaffolds were imaged using a Nikon 
A1+ confocal microscope (Nikon, Tokyo, Japan) using NIS-Elements AR analysis 
version 4.10 software. 69 z-stack images (2 µm each) were taken and merged to generate 
a single image showing the distribution of cells across the scaffold.   
 
2.7.12  Immunofluorescence for myosin (differentiation marker) 
Differentiation of C2C12 myoblasts was assessed by immunoflourescence. C2C12 
myoblasts were cultured on etched glass coverslips and on Day 4 and 8 of differentiation 
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were fixed in 4 % paraformaldehyde in PBS for 10 min, permeabilized in 0.1 % Triton 
X-100/PBS for 5 min at RT and then blocked in 10 % FBS/1% BSA in PBS for 1 h at 
RT. Cells were washed 3 times with PBS (5 min each) and incubated in primary 
antibody (Slow Muscle Myosin, Millipore, Table 2.1) diluted in blocking solution (10 % 
FBS/1% BSA) in PBS for 2 h at RT before being washed 3 times with PBS (5 min each) 
and incubated in secondary antibody (anti-mouse Alexa Flour 488) diluted  in blocking 
solution (10 % FBS/1% BSA) in PBS for 1 h at RT. The samples were then washed 3 
times in PBS for 5 min each and incubated in DAPI (1µg/ml in PBS) solution for 5 min. 
The coverslips were then mounted in a mounting media (Vectashield) and sealed with 
nail varnish. Images were captured with a (Zeiss Axioskop) fluorescent microscope 
using Spot Advanced software.  
 
2.7.13 Myotube width measurements (Image J) 
Phase contrast images of myotubes with a scale bar of 100 µm were imported in ImageJ. 
A line was drawn along the scale bar by clicking on the “straight line drawing tool” 
followed by “Analyze” and “Measure”, which indicated the pixel length (134) that 
corresponded to the 100 µm scale bar. The straight line drawing tool was then used to 
measure the width of each myotube in pixels before converting to a length in µm. For 
each myotube, three measurements were made along the myotube and a mean width 
generated. 25 independent myotubes were measured from 5 different images for each 
time point. The values were exported to Microsoft excel and plotted as bar graphs with 
standard errors.  
 
2.8 RNA extraction and quantitative reverse transcription PCR 
(qRT-PCR) analysis 
2.8.1 RNA extraction 
RNA was isolated from cells cultured in SF proliferation or differentiation media in 
wells coated with collagen I (10µg/cm
2
), fibronectin (10µg/cm
2
) or solubilised muscle 
matrix (10µg/cm
2
), using the ISOLATE RNA KIT (Bioline, Alexandria, Australia). Cell 
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culture medium was removed from the wells and 450 μl Lysis Buffer R was added to 
each well. The sample was resuspended by gently mixing with a pipette and incubated at 
RT for 3 min. The sample was then pipetted into a spin column (R1) in a 2ml collection 
tube and centrifuged at 12,000 rpm for 2 min. DNase I (1U/sample) was added to the 
filtrate and incubated at 25º C for 10 min. 450 μl of 70% ethanol was added to the 
filtrate and mixed well by pipetting before the filtrate/ethanol mixture was applied to a 
spin column (R2) in a 2ml collection tube and centrifuged at 12,000 rpm for 2 min. The 
filtrate was discarded and spin column R2 was placed in a new collection tube. The spin 
column was washed with 500 μl buffer AR, centrifuged at 10000 rpm for 1 min and 
transferred to a new collection tube before being washed with 700 μl buffer BR, 
centrifuged at 10000 rpm for 1 min and transferred to an elution tube. To elute the RNA, 
50μl RNase-free water was added directly to the spin column membrane, incubated at 
RT for 1 min and centrifuged at 8000 rpm for 1 min.  
 
2.8.2 RNA quantification and quality analysis 
The yield and purity of RNA was measured by light absorption at 260nm using a 
Nanodrop DN-100 spectrophotometer (Thermo Fisher Scientific). RNA was also 
analysed using a LabChip GXII (Perkin Elmer) according to the manufacturer’s 
instructions. Briefly, 75 µl of HT RNA Dye concentrate was mixed with 425 µl of HT 
RNA gel matrix and vortexed to mix. The gel-dye mix was then carefully transferred to 
a spin filter and centrifuged at 9200 rpm for 10 min at RT and stored at 4°C until further 
use. Sample buffer was prepared (for 96 samples) by adding 620 µl RNA sample buffer 
to 5580 µl of RNAse free water. 4 µl of RNA ladder and 2 µl of each sample was 
pipetted into individual wells of a microtiter plate (Axygen) and heated at 70°C for 2 
min, then immediately snap cooled on ice for 5 min. 46 µl of sample buffer was added to 
each well and the plate centrifuged at 1250 rpm for 1 min at RT. 96 µl of sample buffer 
was added to the RNA ladder well. The ladder tube was inserted into the ladder slot on 
the LabChip GX instrument. 750 µl of sample buffer was added to the buffer tube, 
which was placed into the buffer slot on the instrument. The chip was allowed to come 
to room temperature, the foil cover removed and the chip surfaces dried using a pipette 
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tip attached to a vacuum line. Active wells of the chip (1, 3, 4, 7, 8 and 10) were 
thoroughly rinsed with nuclease free water twice. 75 µl of Gel-Dye solution was added 
to chip well 3, 7 and 8 and 120 µl of Gel-Dye was added to chip well 10. 120 µl of HT 
RNA marker was added to well 4 and the chip was placed in the instrument to start the 
assay.                                                                                                                                            
  
2.8.3 cDNA synthesis  
RNA (300 ng) was reverse transcribed using the Tetro cDNA synthesis kit (Bioline) to 
according to the manufacturer’s instructions. 20 µl reactions were performed, each 
containing 300 ng of total RNA, 0.5 µl each of Oligo (dT) and Random Hexamer, 1µl 
10mM dNTP mix, 4µl  RT Buffer (5x), 1µl Ribosafe RNase Inhibitor and 1µl Tetro 
Reverse Transcriptase (200u/µl), with the final volume made up to 20µl with DEPC-
treated water. Samples incubated for 10 min at 25°C followed by 30 min at 45°C. The 
reaction was terminated by incubating the samples at 85°C for 5 min before the samples 
were immediately chilled on ice. 30 µl of RNase free water was then added to make a 50 
µl solution (neat cDNA) which was further serially diluted to produce 1/5, 1/10, 1/25, 
1/125 and 1/625 dilutions for use in quantitative reverse transcriptase PCR (qRT-PCR) 
reactions.  
 
2.8.4 Primers for qPCR 
Primers were selected for four reference genes (RG) and seven genes of interest (GOI) 
(Table 2.4) primarily using the PrimerBank database [235] and purchased from 
Geneworks (Hindmarsh, Australia). 
                                                                
                                                       Table 2.4 Primers used in qPCR 
Gene  Sequence (5’-3’) NCBI ref PrimerBank 
ID 
TM 
(°C) 
Length  
(bp) 
SDHA F 
R 
TGG GGA GTG CCG TGG TGT CA  
TGC CCC GTA GCC CCC AGT AG 
NM_023281  60 
60 
100 
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ACTAB F 
R 
GTG ACG TTG ACA TCC GTA AAG A 
GCC GGA CTC ATC GTA CTC C 
NM_007393 145966868c1 60 
61 
245 
TBP F 
R 
CCT TGT ACC CTT CAC CAA TGA C 
ACA GCC AAG ATT CAC GGT AGA 
NM_013684 172073170c2 61 
61 
119 
GAPDH F 
R 
AGG TCG GTG TGA ACG GAT TTG TGT 
AGA CCA TGT AGT TGA GGT C 
NM_008084  54 
50 
139 
MYOG F 
R 
CGA TCT CCG CTA CAG AGG C 
GTT GGG ACC GAA CTC CAG T 
NM_031189 162287254c3 62 
61 
137 
MYF5 F 
R 
GCC TTC GGA GCA CAC AAA G 
TGA CCT TCT TCA GGC GTC TAC 
NM_008656 240120094c2 61 
61 
187 
ACTA1 F 
R 
CCC AAA GCT AAC CGG GAG AAG 
GAC AGC ACC GCC TGG ATA G 
NM_009606 133893192c1 62 
62 
89 
ACTAC1 F 
R 
CTG GAT TCT GGC GAT GGT GTA 
CGG ACA ATT TCA CGT TCA GCA 
NM_009608 14192922a1 54 
52 
173 
MYH1 F 
R 
CGG AGT CAG GTG AAT ACT CAC G 
GAG CAT GAG CTA AGG CAC TCT 
NM_030679 82524273c2 57 
54 
153 
MYH3 F 
R 
ATG AGT AGC GAC ACC GAG ATG 
ACA AAG CAG TAG GTT TTG GCA T 
NM_001099635 153792648c1 61 
61 
119 
MYH7 F 
R 
ACT GTC AAC ACT AAG AGG GTC A 
TTG GAT GAT TTG ATC TTC CAG GG 
NM_080728 18859641a1 53 
53 
114 
SDHA- Succinate dehydrogenase complex, subunit A; ACTAB- β-actin; TBP- Tata binding 
protein; GAPDH- Glyceraldehyde-3 phosphate dehydrogenase; MYF5- Myogenic factor 5; 
MYOG-Myogenin; ACTA1- Actin, alpha 1, skeletal muscle; ACTAC1- Actin, alpha 1, cardiac 
muscle; MYH1- Myosin heavy chain-1; MYH3- Myosin heavy chain-3; MYH7- Myosin heavy 
chain-1 
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2.8.5 qRT-PCR and melt curve analysis 
qRT-PCR reactions (10 µl total volume) consisted of 5 µl SyBr Green Lo-RoX Mix 
(Bioline), 2 µl template cDNA, 1 µl forward/reverse primer (20 ng/µl) and 2 µl RNase 
free H2O. Reactions were performed on a ViiA™ 7 Real-Time PCR system (Applied 
Biosystems) with fast 96-well block using the following cycling conditions: initial 
denaturation at 95ºC for 2 min, 40 cycles of denaturation at 95ºC for 5 sec and annealing 
and extension together in 1 step at 60ºC for 20 sec, followed by a melt step ranging from 
55-95ºC.  The 4 RG and 7 GOI (Table 2.4) were analysed in C2C12 cells cultured on col 
I (10 µg/cm
2
) and matrix (10 µg/cm
2
) coated wells in serum free media, at days day 1, 4 
and 8 of differentiation.  
 
To assess the specificity of the primers, melt curve analysis was performed for all genes 
by heating the completed qPCR reactions from 55°C to 95°C and a fluorescence reading 
taken every 0.5°C. The rate of change of the relative fluorescence units (RFU) with time 
(T) (-d(RFU)/dT) was plotted on the Y-axis, versus the temperature on the X-axis. A 
peak was generated at the melting temperature (Tm) of each amplified product. 
 
2.8.6  Primer efficiency calculation 
Five-fold dilutions of neat cDNA were prepared to yield dilutions of 1/5, 1/25, 1/125 
and 1/625. Each dilution was amplified for each primer pair to create an efficiency 
curve. The log template dilution (x-axis) was plotted against the cycle threshold (CT) 
value obtained for each dilution (y-axis) using Microsoft Excel. Efficiency (E) of each 
primer in the exponential phase was calculated by substituting the slope of the line in the 
equation E=10
(-1/slope)
. All reactions were performed in triplicates with the mean CT value 
used in the statistical analysis. 
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2.8.7 Validation of reference genes 
For selection of the most stable gene(s), all four reference genes were tested using 
Normfinder [236] and Bestkeeper [237] software. Briefly, the qRT-PCR of four 
reference genes was performed as described above. CT values obtained from qPCR were 
exported into Microsoft Excel. The most stable gene was SDHA. 
 
2.8.8 Gene expression analysis 
Gene expression (fold change) was calculated using the 2
-delta delta CT
 method as described 
by Livak and Schmittgen [238]. Briefly, the qPCR of different genes was performed as 
described above and CT values obtained exported into Microsoft Excel. Expression 
levels for MyoG, Myf5, MYH1, MYH3, MYH7, ACTA1 and ACTAC1 were normalized to 
SDHA expression values and fold change determined using 2
-deltadeltaCT
method, according 
to the equation below. Day x is either 4 or 8 days of differentiation and day 1 represents 
the 1X expression of the target gene normalized to reference gene SDHA. 
  
Fold changes in gene expression were log transformed as the gene expression data is 
normally log distributed [239]. Mean  SE of 4 replicates were shown. A Wilcoxon 
signed rank test was performed comparing the ΔCT data from day 1 of differentiation to 
day 4 and day 8 of differentiation to determine whether the differences in expression 
observed were statistically significant.  
 
2.9 Collection of silkworm species  
Bombyx mori (B. mori) cocoons were collected from Debra Sericulture Farm, 
Midnapore, West Bengal. Antheraea mylitta (A. mylitta) 5
th
 instar late larvae collected 
just before spinning were obtained from our IIT Kharagpur Farm. Antheraea. 
assamensis (A. assamensis) and Samia. ricini (S. ricini) 5
th
 instar larvae were collected 
from Jorhat, Assam and Coochbehar, West Bengal, India. 
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2.9.1 Silk protein fibroin processing  
The regenerated fibroin solution was prepared from both mulberry and the different non-
mulberry sources using two distinct methods. Schematic representation of silk protein 
fibroin isolation from mulberry and non-mulberry species, and the preparation of 3D 
fibroin scaffolds are shown in Fig 5.1. Fibroin was isolated from B. mori cocoons using 
a standard protocol described elsewhere [240], whereas fibroin from non-mulberry 
sources was isolated by squeezing the glands of 5
th
 instar larva immediately prior to the 
spinning of their cocoons, before following the steps described previously [138, 140, 
241]. The regenerated 2% fibroin solutions from the four species were used to fabricate 
3D porous sponges using the described freeze drying technique [242]. Collection of the 
silkworm species and silk processing was performed by Professor Subhash C Kundu and 
colleagues at IIT, Kharagpur, INDIA.  
 
2.9.2 Solubilisation of silk from freeze dried scaffolds for 2D culture 
The silk fibroin scaffolds were solubilised in PBS to produce a fibroin solution used to 
coat tissue culture polystyrene plates. Scaffolds were placed in 1.5 ml microtubes and 
weighed. 500 µl PBS was added to each tube, incubated at 42ºC for 30 min with 
rocking, and then centrifuged at 9000 rpm for 10 min at 4ºC. Supernatants were 
transferred to a fresh tube and re-centrifuged. Protein content of the supernatants was 
measured using a BCA protein assay (Pierce Biotechnology). The solubilised silk was 
stored at 4ºC until used.  Routinely, 10 µg/cm
2
 silk fibroin was used to coat either tissue 
culture plastic (TCP) or etched glass surfaces. 
 
2.10 Cell culture and 2D cell based assays 
All cells were housed in a humidified 37
o
C incubator equilibrated at 5 % CO2. The 
murine myoblast cell line, C2C12 (ATCC, Manassas, VA) and HSMM cells were 
routinely cultured as previously described (section 2.7.5). 
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2.10.1 Proliferation and Differentiation assays  
Wells of a 24 well tissue culture plate (Nunc) were coated with 10 µg/cm
2
 of either B. 
mori, A. mylitta, A. assamensis or S. ricni solubilised silk fibroin; or collagen I or 
fibronectin (Sigma-Aldrich). Plates were incubated at 37ºC for 2 h, washed with PBS 
and sterilized under UV light for 20 min. C2C12 myoblasts were plated at a density of 
7,000 cells/well in SF growth medium and cultured for 3 days before being transferred 
to SF differentiation medium. Phase contrast images were taken using a Zeiss Axiovert 
(Carl Zeiss) microscope and Spot Advanced software (SPOT
TM
 Imaging solutions) on 
days 1, 2 and 4 of proliferation as well as days 1, 4, 6 and 7 in SF differentiation media.  
 
2.10.2 alamarBlue dye assay for C2C12/HSMM cell proliferation 
C2C12 cells were seeded in 96-well plates (Nunc) at a density of 1x10
3
 cells per well in 
SF growth media (200 µl) and
 
cultured for 3 days. After 24, 48 and 72 h in culture, 20 µl 
of alamarBlue reagent was added and the cells were incubated at 37
o
C with 5% CO2 for 
4 h. The fluorescence intensity of each well was then measured at excitation and 
emission wavelengths of 560 nm and 600 nm respectively (EnSpire Multimode plate 
reader, Perkin Elmer). Similarly, HSMMs were cultured in a 48-well plate (Corning Inc., 
Corning, NY) at a seeding density of 1x10
3
 cells per well in SkGM-2 media/10% FCS 
(500 µl) and cultured for 10 days. After 2, 5, 8 and 10 days of proliferation, 50 µl of 
alamarBlue reagent was added to the wells and fluorescence measured as described. 
Blank media served as a negative control and relative cell numbers were represented as 
relative fluorescence units (RFU) per well. Previous experiments indicated the cell 
numbers obtained were in the linear range of an alamarBlue standard curve.  
 
2.11 Immunofluorescence of 2D cultures 
2.11.1 Etching of glass coverslips 
Round glass coverslips (13 mm diameter) (ProScitech, Thuringowa, Australia) were 
stored in 100% ethanol. Coverslips were treated with freshly prepared etch solution (6.0 
g NaOH dissolved in 24 ml ddH2O, with the volume made up to 60 ml using 95% 
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ethanol) for 30 min at RT. After treatment coverslips were washed extensively with 
ddH2O dried at RT, sterilised by UV light and used in experiments.  
 
Atomic force microscopy (AFM) was used to examine the surface topography of the 
etched glass coverslips. The coverslips were washed and dried under a stream of 
nitrogen, mounted on magnetic steel stubs and AFM imaging was performed using a 
Nanoscope IIIa (Digital Instruments Inc., Santa Barbara, CA) atomic force microscope 
with V-shaped silicon nitride cantilevers, using contact mode and a long range scanner. 
A variety of scans (5µm x 5µm) were performed at random locations on the glass 
surface. Untreated coverslips washed with ethanol were used as a control.                      
2.11.2 Matrix protein expression 
The expression of matrix proteins by C2C12 myoblasts was investigated by seeding 3.5 
x 10
3
 cells/cm
2
 cells on etched glass coverslips either uncoated or coated with collagen 
type I or solubilized muscle matrix. Cells were cultured for 3 days, washed with PBS 
and coverslips were fixed with 4% paraformaldehyde in PBS (PFA/PBS), then blocked 
in 10 % FBS/1% BSA/PBS for 1h at RT. Cells were washed in PBS and incubated in 
primary antibodies recognising the extracellular matrix molecules: collagen I, collagen 
IV, collagen VI, fibronectin and perlecan (refer Table 2.1). Primary antibodies were 
used at a concentration between 2 µg – 4 µg. Cells were washed with PBS and incubated 
in secondary antibody (anti-rabbit Alexa Flour 488) diluted in blocking solution for 1 h. 
Coverslips were washed extensively in PBS and mounted in a DAPI-containing 
mounting media (Vectashield, Vector Laboratories). The control antibodies were rabbit 
IgG and mouse IgG (Life Technologies). Images were captured with a Nikon A1+ 
confocal microscope (Nikon, Tokyo, Japan) using NIS-Elements AR analysis version 
4.10 software. All images were acquired at the same gain and exposure settings and 
were modified using same brightness and contrast settings. 
 
The expression of matrix proteins by C2C12 myoblasts was examined by seeding cells 
on etched glass coverslips in a 12-well plate in DMEM/F10 SF and allowing the cells to 
grow for 3 days in proliferation medium. After 3 days, the media was changed to a 
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differentiation medium and the cells were cultured for another 6 days. At day 3 of 
roliferation and day 6 of differentiation, immunostaining was then performed as 
described above.  
 
The deposition of matrix proteins was explored by immunofluorescent staining of 
matrices following removal of the cells. For these experiments, C2C12 myoblasts (3.5 x 
10
3
 cells/cm
2
) were seeded on etched glass coverslips placed in a 12-well polystyrene 
plate in SF growth medium. Cells were maintained for 3 days in culture, allowing the 
cells to deposit ECM on the coverslips. After 3 days in culture, cells were removed by 
treating the coverslips with 0.5 % Triton X-100/PBS and 20mM NH4OH for 2 min at 
RT, before washing three times with ice cold PBS to remove any cell debris. The 
coverslips were then fixed with 4% paraformaldehyde and incubated in primary 
antibodies recognising collagen I, collagen IV, collagen VI, fibronectin and perlecan as 
described above, but omitting the permeabilization step. 
 
The deposition of matrix proteins on silk fibroin substrates was explored by culturing 
C2C12 myoblasts on either B. mori, A. mylitta, A. assamensis or S. ricni soluble silk 
fibroin (all at 10 µg/cm
2
) on an etched glass coverslip placed in a 12-well polystyrene 
plate in SF growth medium. Immunostaining was then performed as described above. 
 
2.11.3 Differentiation of C2C12 and HSMM on silk - myosin expression  
C2C12 anti-myosin immunostaining was performed as described earlier (refer to section 
2.7.12). Similarly, HSMMs were seeded at a density of 15x10
3
/cm
2 
on etched coverslips 
coated with a fibroin protein, collagen I or fibronectin (all at 10 µg/cm
2
) in SkGM-2 
media and cultured for 3 days. The media was then changed to differentiation media 
(DMEM/F12/2%HS) and after day 7 and day 10 in differentiation media, HSMMs were 
fixed and immunostained for slow muscle myosin and GLUT 4 (Table 2.1) as described 
for the C2C12 myoblasts (section 2.7.12). Images were captured using fluorescent 
microscopy (Zeiss Axioskop) and Spot Advanced software with a 40 x objective. Total 
number of nuclei and number of myotubes were counted in 6 random fields of view 
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(>250 nuclei) and Fusion index (FI) was calculated according to the formula = (No. of 
nuclei within myotubes with two or more nuclei/ Total no. of nuclei) * 100. At least two 
independent experiments were performed for FI and myotube number calculations and 
the data represented here is from one of those experiments.  
 
2.12 qPCR on 2D silk fibroin substrates  
2.12.1 Gene expression analysis  
For gene expression analysis, HSMMs were seeded on B. mori and A. assamensis 
scaffolds at a cell concentration (6 x 10
3 
cells/cm
2
) in a 12-well plate and cultured for 4 
days in proliferation medium. Then the medium was changed to a differentiation one 
and cells were cultured for another 14 days in differentiation medium, with cells 
harvested at day 1, day 7 and day 14 of differentiation.  
 
2.12.2 RNA Isolation 
RNA was isolated usin the ISOLATE RNA KIT as described before (section 2.8.1).  
 
2.12.3 cDNA synthesis and qRT-PCR analysis 
Reverse transcription was performed on 500 ng of HSMM RNA using the Tetro cDNA 
synthesis kit (Bioline) according to the manufacturer’s instructions. qPCR reactions 
were performed using SensiFAST SYBR Lo-Rox kit (Bioline), with triplicate reactions 
containing 5 µl SYBR Green Lo-RoX Mix, 2 µl template cDNA, 1 µl forward/reverse 
primer (25 ng/µl) and 2 µl RNase free H2O. Reactions were performed on a ViiA™ 7 
Real-Time PCR system (Applied Biosystems) with fast 96-well block using the cycling 
conditions: denaturation at 95ºC for 2 min, 40 cycles of denaturation at 95ºC for 5 sec 
and annealing and extension together in 1 step at 60ºC for 20 sec, followed by a melt 
step ranging from 55-95ºC. Primers were selected for three reference genes and five 
genes of interest (Table 4.1) using the PrimerBank database [235] and purchased from 
Geneworks (Hindmarsh, Australia). Of the three reference genes, TBP was found to 
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have the most stable expression according to Normfinder [236] and Bestkeeper [237] 
software. Expression levels for MyoD1, Myf5, MYH1, MYH7, and ACTA1 were 
normalized to TBP expression values and fold change determined using 2
-delta delta Ct
 
method with baseline expression at day 1 of differentiation. Mean  SE of 4 replicates 
are shown. 
 
                              Table 2.5 Primers used in HSMM qRT-PCR 
Gene  Sequence (5’-3’) NCBI ref PrimerBank 
ID 
TM 
(°C) 
Length  
(bp) 
SDHA F 
R 
TGG CAT TTC TAC GAC ACC GTG  
GCC TGC TCC GTC ATG TAG TG 
NM_004168 156416002c3 54 
56 
77 
ACTAB F 
R 
TCC CTG GAG AAG AGC TAC G 
GTA GTT TCG TGG ATG CCA CA 
NM_001101  53 
52 
 
TBP F 
R 
CCC GAA  ACG CCG AAT ATA 
ATC C 
AAT CAG TGC CGT GGT TCG TG  
NM_003194 285026518c2 55 
54 
80 
MYOD1 F 
R 
CGG CAT GAT GGA CTA CAG CG 
CAG GCA GTC TAG GCT CGA C 
NM_002478 77695919c2 56 
55 
133 
MYF5 F 
R 
CTG CCA GTT CTC ACC TTC TGA 
AAC TCG TCC CCA AAT TCA CCC 
NM_005593 156104905c1 54 
54 
78 
ACTA1 F 
R 
GGC ATT CAC GAG ACC ACC TAC 
CGA CAT GAC GTT GTT GGC ATA 
C 
NM_002478 47078293c1 56 
55 
84 
MYH1 F 
R 
GGG AGA CCT AAA ATT GGC TCA 
A 
NM_005963 115527081c2 53 
50 
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TTG CAG ACC GCT CAT TTC AAA 
MYH7 F 
R 
TGG ATG TGA GTG AAC TTG GGG 
GCA CCC AGA CTC GCT TCT T 
NM_020884 291045202c2 54 
53 
108 
 
2.13 3D cell based assays 
2.13.1 Preparation of 3D silk scaffolds and HSMMs proliferation and 
differentiation 
The 3D silk scaffolds were fixed by treating with 90% ethanol for 1 h and then with 70 
% and 50 % ethanol for 30 min each. Scaffolds were washed twice in PBS for 30 min 
each and placed in a 24-well plate in SkGM-2 media for 2 h at 37ºC for pre-
conditioning. The scaffolds were air dried under UV light for 20 min then placed in the 
wells of a 24-well plate. HSMMs in SkGM-2 media (25 μl, containing 7.5 x 104 cells) 
were added onto the scaffold and allowed to adhere for 30 min in a CO2 incubator. 
Scaffolds were then transferred to a new well, 2 ml of SkGM-2 medium was added and 
the cells were cultured for either 2 or 5 days with the SkGM-2 media being replaced 
every third day. 
 
Following 5 days of proliferation, HSMMs were switched to differentiation medium 
(DMEM/F10/2% HS) and cultured for a further 10 or 11 days, with the differentiation 
medium replaced every third day. The scaffolds were fixed and processed either for 
Scanning Electron Microscopy (SEM) or immunofluorescence. 
 
For HSMM differentiation and myosin immunostaining, cells were seeded at a higher 
cell density (5 x 10
5 
cells/scaffold) and cultured for 4 or 7 days in proliferation medium 
and then the medium was changed to a differentiation medium and cells were cultured 
for a further 10 days.  
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2.13.2 Immunofluorescence of filamentous actin (F-actin) and myosin 
3D scaffolds processed as described above were stained with either Rhodamine 
phalloidin (10 Units/ml, Molecular Probes) diluted in PBS or slow muscle myosin 
(Table 2.1) antibody, counterstained with DAPI and placed on a glass slide. For 3D 
imaging of scaffolds, 15-25 z-stack images (either 5 µm or 10 µm stack) were taken 
using a Nikon A1+ confocal microscope (Nikon, Tokyo, Japan) and merged to generate 
a single image. For each scaffold, six images were captured at different locations and 
representative images are shown.  
For myosin immunostaining and imaging large areas of the silk scaffold, 50 z-stack 
images (2.5 µm stack) were taken using an UltraVIEW VoX Spinning Disc Confocal 
Microscope (PerkinElmer) and the images were stitched together using the Volocity 
software (PerkinElmer). The length of the myotubes was measured using the line tool 
measurement.  
2.13.3 Scanning Electron Microscopy of 3D silk scaffolds (+/- HSMM cells) 
All four 3D silk scaffolds (with or without HSMM cells) were fixed in 4 % PFA for 30 
min at RT and then dehydrated in ethanol solutions of increasing concentration (30 % - 
100 %) for 20 min per concentration, freeze dried using a ScanVac (LaboGene, Lynge, 
Denmark), mounted on aluminium stubs and sputter coated with platinum (10 nm) using 
a 208HR sputter coater (Cressington, Redding, CA). Data were collected using either a 
Neon 40EsB Scanning Electron Microscope (Carl Zeiss) or MIRA SEM (TESCAN, 
Brno, Czech Republic). Sample coating and imaging was performed with the assistance 
of technical staff at the Curtin Electron Microscope Facility.  
2.13.4 Gene expression analysis of 3D cultures 
For gene expression analysis, HSMMs were seeded on B. mori and A. mylitta scaffolds 
at a cell concentration (5 x 10
5
 cells/scaffold), cultured for either 4 or 7 days in 
proliferation medium and 4 or 10 days in differentiation medium, with cells harvested at 
day 4 of proliferation, day 2 and day 10 of differentiation.  
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2.13.4.1    RNA extraction 
RNA was isolated using TRI Reagent (Sigma-Aldrich), as per the manufacturer’s 
instructions, as the protein content of the silk scaffold meant the spin column extraction 
method used in 2D culture was unsuitable. Briefly, the media was discarded and the silk 
scaffolds were placed in a 2 ml eppendorf tube. The scaffolds were then homogenized in 
1.5 ml of TRIzol reagent by repeated pipetting and incubated at -80ºC overnight. The 
next day, the samples were thawed at RT for 15 min and 0.3 ml of chloroform was 
added to each tube, before vortexing for 10 sec and incubating at RT for 5 min. Tubes 
were then centrifuged at 12, 000 g for 20 min to separate the lower phenol-chloroform 
phase from the upper aqueous phase. The aqueous phase was transferred to a new tube, 
0.75 ml of 100% isopropanol was added, and the mixture was incubated for 15 min at 
RT. Tubes were then centrifuged at 12,000 g for 10 min, the supernatant was removed 
and the RNA pellet was washed with 1 ml of 75 % ethanol. Samples were vortexed 
briefly, centrifuged at 12,000 g for 5 min, the supernatant removed and the pellet was air 
dried for 10 min at RT. The RNA pellet was resuspended in 40 µl-60 µl of RNase free 
water and incubated at 55 ºC for 15 min. RNA concentration and purity was assessed 
using a Nanodrop spectrophotometer. All RNA samples had an A260/A280 ratio of > 
1.8 
2.13.4.2 cDNA synthesis and qRT-PCR analysis 
cDNA synthesis was performed as described in section 2.12.3. Expression levels for 
MyoD1, Myf5, MYH1, MYH7, and ACTA1 were normalized to TBP expression values 
and fold change determined using 2
-delta delta Ct
 method with baseline expression either at 
day 4 of proliferation or day 2 of differentiation. Mean  SE of 4 replicates are shown. 
2.14 Statistical analysis 
Data were collected with 3-4 independent replicates per data point from 2 representative 
experiments and represented as mean ± standard deviation (SD). Analysis for cell 
proliferation experiments were performed using one-way analysis of variance (ANOVA) 
followed by Tukey’s post-hoc test with SPSS statistics software v22.0 (IBM corporation, 
NY). P-value (p<0.05) was considered statistically significant. For qPCR data analysis, 
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Wilcoxon’s signed-rank test was performed and significance (P) values shown at each 
time point with *P<0.05. 
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Chapter 3:  
Development and characterization of an acellular skeletal 
muscle matrix with well-preserved extracellular matrix 
(ECM) components 
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3.1 Introduction 
The ECM is the non-cellular material surrounding cells in tissues. It provides both a 
structural scaffold and biochemical cues for tissue morphogenesis. It comprises of a 
dense meshwork of interacting molecules including structural proteins like collagen and 
elastin, glycoproteins like fibronectin, vitronectin and laminin; proteoglycans such as 
biglycan, decorin and tenascin, and signalling molecules, like cytokines and growth 
factors. To obtain a three-dimensional ECM suitable for either implantation as a bio-
scaffold or to study cell-matrix interactions in a laboratory, removal of all cellular 
components from the tissue is necessary so that only the ECM remains. 
Decellularization (removal of cells) is a promising and relatively new technique to 
obtain ECM from tissues. The efficiency of decellularization depends upon the origin of 
the tissue, its thickness, lipid content, density and the methods (physical, chemical or 
enzymatic) that are used to remove the cells [166]. Preferably, the method should not 
adversely affect the composition, biological activity and mechanical integrity of the 
remaining matrix while effectively removing DNA and cellular remnants. It should be 
understood that complete decellularization of a tissue or organ is not feasible, therefore 
the emphasis is on maximising the loss of cells from the tissue and minimizing the 
damage to the ECM, so the ECM remains as close to its native structure and 
composition as possible. 
Perfusion of organs/tissues with decellularizing agents is a commonly used technique to 
remove the majority of immunogenic cellular and nuclear material and to obtain bio-
scaffolds with well-preserved ECM components. Perfusion of the decellularizing fluid 
through relevant vasculature, for example: pulmonary artery and trachea in lung [193] 
and portal vein in liver [243], enables cellular components of the tissue to be removed 
relatively quickly (within a few hours) leading to an isolated matrix bio-scaffold. In 
addition, tracks previously occupied by the vasculature of the organs/tissues are also 
well preserved, which has further implications in revascularization of the scaffold when 
used for implantation in vivo. However, obtaining a skeletal muscle matrix in the form 
of a whole organ is difficult due to the presence of long muscle fibres and the 
complexity of the muscle connective tissue. A possible solution is to decellularize 
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skeletal muscle by cutting small pieces of muscle and immersing in decellularizing 
agents to increase the surface area of tissue interacting with buffers.   
Muscle ECM prepared by decellularizing skeletal muscle can be used to study the role 
of ECM in muscle formation. This ECM can be used as a three-dimensional bio-scaffold 
or it may be lyophilized and solubilized to use as a coating on coverslips to test the 
ability of the matrix to support cell growth and formation of muscle fibres in vitro. A 
variety of published protocols have been used to decellularize skeletal muscle to obtain a 
functionalized ECM scaffold [174-176]. Generally these protocols have incorporated 
enzymes like trypsin [175] and strong detergents like SDS [174]. Recently, a method for 
decellularizing skeletal muscle without detergents or proteolytic enzymes was described 
[176], and using this method although there was a slight reduction in the GAG content 
of the matrix other ECM components remained intact. These published studies measured 
the sulfated GAGs in the matrix but, to our knowledge, none have investigated which 
ECM proteoglycans (decorin, biglycan, perlecan) are retained after decellularization.  
The aim of the study described in this chapter is the development of a method to obtain a 
three dimensional muscle scaffold with well-preserved ECM components which can be 
utilized in subsequent studies (next chapter) to understand the role of the ECM proteins 
in regulating muscle myoblast behaviour. Described here is the development of a 
method to effectively remove the cells from muscle ECM and characterization of the 
ECM components remaining after decellularisation. Three methods (Trypsin, SDS and 
Phospholipase A2) were compared with respect to efficacy of decellularization and 
retention of matrix proteins.  
3.2 Results 
3.2.1 Trypsin method 
The trypsin method was initially attempted using triceps muscles harvested from 3 
months old Duchenne muscular dystrophic (mdx) female mice. These mice have a point 
mutation in the dystrophin gene, which causes the gene to stop synthesis of dystrophin.  
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Figure 3.1 Qualitative and quantitative analysis of cellular material after 
trypsin decellularisation from quadriceps muscle sections of 3 month old 
female C57 black mice. (A) DAPI staining in untreated and decellularised 
muscle sections treated with trypsin. Scale bar-100μm. (B) Gel showing DNA 
isolated from equal quantities (40 sections) of untreated muscle and muscle 
decellularised using trypsin. Genomic DNA was separated on a 1.5% agarose 
gel. Lane 1= 1 kb plus DNA ladder; Lane 2= Untreated muscle; Lane 3= 
decellularised muscle. 
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Figure 3.2 Immunofluorescence labeling of untreated and trypsin  
decellularised triceps muscle sections of 3 month old female mdx mice. 
Sections were fixed and stained with antibodies against structural and basement 
membrane components of ECM collagen I (a, b), collagen IV (c, d) and 
fibronectin (e, f). The antibodies recognising collagen I, collagen IV or fibronectin 
were all rabbit polyclonal antibodies. The secondary antibody was a goat anti-
rabbit FITC conjugated antibody. Nuclei are stained with DAPI (blue). Scale bar-
100μm.  
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As a result, in early stages of their life, these mice exhibit muscle degeneration followed 
by regeneration and fibrosis as they age. The archival tissue was provided by Prof. 
Miranda Grounds, School of Anatomy, Physiology and Human Biology, University of 
Western Australia. Briefly, triceps muscle sections from mdx mice and quadriceps 
muscle sections from C57/black mice were treated with trypsin and Triton-X 100 and 
washed with PBS to decellularize the muscle tissue (see detailed method in section 
2.2.2.1).   
3.2.1.1 DNA remaining after decellularization 
A dye, DAPI which stains DNA and RNA was used to assess the loss of cells from the 
muscle tissue. The trypsin method of decellularization was effective in complete 
removal of cells as indicated by the loss of DAPI staining in the decellularized tissue 
when compared to normal muscle samples (Figure 3.1 A). Decellularization was further 
confirmed by quantitative analysis of the DNA extracted from native and decelluralized 
muscle sections (see methods in section 2.4.3). The DNA extracted from a total of 40 
native and decellularized sections was pooled in 40 µl of TE buffer and the 
concentration of DNA was determined using a spectrophotometer. Quantitative analysis 
of the DNA content show that the amount of DNA was reduced from 120.2 ng/µl in 
native muscle to 46.0 ng/µl after decellularization (62% decrease). When run on a 1.5% 
agarose gel (section 2.4.2), native muscle DNA showed a clear band of genomic DNA 
while there was nothing visible in the lane where DNA from decellularized sections was 
loaded, suggesting that any DNA present was degraded (Figure 3.1 B).  
3.2.1.2 Retention of matrix proteins after decellularization 
Immunohistochemistry was used to determine the ECM molecules remaining following 
decellularisation (see methods in section 2.5.2). Stronger staining of the collagen type I 
and collagen type IV antibodies was apparent in the decellularized matrices (Figure 3.2 
b, d) compared to the normal muscle samples (Figure 3.2 a, c). The epitopes recognised 
by the anti-fibronectin antibody were completely lost in the decellularized matrix 
suggesting that trypsin treatment was removing/degrading fibronectin in the matrix  
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Figure 3.3 Immunofluorescence labeling of untreated and trypsin  
decellularised quadriceps muscle sections of 3 month old female C57 
black mice. Sections were fixed and stained with antibodies against structural 
and basement membrane components of ECM collagen I (a, b), collagen IV (c, 
d), Collagen VI (e, f) and fibronectin (g, h). The antibodies recognising Collagen 
I, Collagen IV, Collagen VI and Fibronectin were all rabbit polyclonal antibodies. 
The secondary antibody was a goat anti-rabbit alexa fluor 488 conjugated 
antibody. Nuclei are stained with DAPI (blue). Scale bar-100μm.  
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(Figure 3.2 f). These experiments were repeated using quadriceps muscle harvested from 
3 month old C57/black female mice. Immunohistochemistry similarly showed epitopes 
for collagens type I, IV and VI were preserved in the decellularised muscle matrix but 
fibronectin epitopes were lost (Figure 3.3). Since, fibronectin appeared to be lost during 
trypsin decellularization and the goal was to preserve most of the matrix components in 
the decellularised matrix including the glycoproteins, the SDS method was tried. 
3.2.2 SDS method 
In brief, triceps muscle sections from mdx mice and quadriceps muscle sections from 
C57/black mice were decellularised using a combination of SDS/EDTA and then 
washed in a solution of NaCl (2M) before finally washing with PBS (see methods in 
section 2.2.2.2).  
3.2.2.1 DNA remaining after decellularization   
As DAPI staining showed traces of DNA in the decellularized sections (Figure 3.4 A) it 
appeared the 0.2 % SDS method was not effective in completely removing all cellular 
components. DNA was extracted from the decellularized sections and resuspended in 40 
µl of TE buffer (see methods in section 2.4.3). Quantitative analysis of the DNA content 
showed that the amount of DNA was reduced from 106.2 ng/µl in native muscle to 56.0 
ng/µl after decellularization. Although, there was a decrease (48%) in the amount of 
DNA remaining in the decellularised tissue, when run on a 1.5 % agarose gel, a clear 
band of genomic DNA can be seen in both control and decellularised tissue lanes 
(Figure 3.4 B).  
3.2.2.2 Retention of matrix proteins after decellularization  
Results from immunostaining experiments showed that collagens type I, IV and VI 
appeared to be staining more strongly in the decellularized sections (Figure 3.5 b, d, f) 
than in the normal muscle sections (Figure 3.5 a, c, e). The glycoprotein, fibronectin was 
also well preserved in both the normal (Figure 3.5 g) and decellularized muscle matrix 
(Figure 3.5 h). Epitopes on the heparan sulphate proteoglycan, perlecan were preserved  
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Figure 3.4. Qualitative and quantitative analysis of cellular material after 
SDS decellularisation from quadricpes muscle of 3 month old female C57 
black mice. (A) DAPI staining in untreated and decellularised muscle sections 
treated with 0.2% SDS. Scale bar-100μm. (B) Gels showing DNA isolated from 
equal quantities (40 sections) of untreated muscle and muscle decellularised 
using SDS. Genomic DNA was separated on a 1.5% agarose gel. Lane 1= 1 kb 
plus DNA ladder; Lane 2= Untreated muscle; Lane 3= decellularised muscle. 
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Figure 3.5 Immunofluorescence labeling of untreated and SDS 
decellularised triceps muscle sections of 3 month old female mdx mice. 
Muscle sections were fixed and stained with antibodies against structural and 
basement membrane components collagen I (a, b), collagen IV (c, d), Collagen 
VI (e, f) and fibronectin (g, h). The antibodies recognising Collagen I, Collagen 
IV, collagen VI and Fibronectin were all rabbit polyclonal antibodies. The 
secondary antibody was a goat anti-rabbit FITC conjugated antibody. Nuclei are 
stained with DAPI (blue). Scale bar-100μm.  
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Figure 3.6. Immunofluorescence labeling of untreated and SDS 
decellularised triceps muscle sections of 3 month old female mdx mice. 
Muscle sections were fixed and stained with antibodies against proteoglycan 
components of ECM: decorin (a, b), biglycan (c, d) and perlecan (e, f). The 
antibodies recognising decorin, biglycan and perlecan were sheep, goat and 
rabbit polyclonal antibodies respectively. Secondary antibodies were: Dylight 
549-conjugated donkey anti-sheep antibody (a, b); Dylight 549 conjugated anti-
goat IgG antibody (c, d), and goat anti-rabbit FITC conjugated antibody (e, f). 
Nuclei are stained with DAPI (blue). Scale bar-100μm. 
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in the decellularized matrix as is evident from the comparable levels of immunostaining 
in decellularised and control sections (Figure 3.6 e-f), but immunostaining of small 
leucine rich proteoglycans, decorin and biglycan in the decellularized sections (Fig 3.6 
b, d) was markedly less compared to the controls (Figure 3.6 a, c). 
3.2.3 Phospholipase method 
Briefly, gastrocnemius and quadriceps muscle sections from C57/black mice were 
decellularized using combination of an enzyme (Phospholipase A2) and a detergent 
sodium deoxycholate (see methods section 2.2.2.3).  
3.2.3.1 DNA remaining after decellularization   
DAPI staining revealed a loss of punctate nuclei in the treated muscle (Figure 3.7 A). 
Decellularization was further confirmed by a quantitative analysis of the DNA extracted 
from native and decellularized sections (see methods in section 2.4.3). Quantitative 
analyses showed that the amount of DNA was reduced from 161.35 ng/µl in native 
muscle to 39.35 ng/µl after decellularization (76.6 % decrease). When run on a 1.5% 
agarose gel, DNA extracted from native muscle gave a clear band of genomic DNA, 
while nothing was visible in the lane where DNA extracted from decellularized sections 
was loaded (Figure 3.7 B). DNA was also extracted from untreated and decellularized 
pieces of quadriceps muscle (of equal weights before treatment) from C57/black mice. 
The amount of DNA were quantified spectrophotometrically and normalized to the wet 
weight of muscle (before and after treatment). Quantitative analysis revealed an 81.0 % 
loss after decellularisation (Figure 3.7 C). Further, the PLA2 method was also used to 
decellularise gastrocnemius muscle from C57/black mice and DNA quantification 
results showed a 87.7 % decrease in the amount of DNA after decellularisation (data not 
shown).  
3.2.3.2 Loss of cytoskeletal proteins following decellularization 
Since, there was a greater reduction in the amount of DNA remaining after 
decellularisation with the PLA2 method compared to that seen following the trypsin and  
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Figure 3.7. Qualitative and quantitative analysis of cellular material after 
PLA2 decellularised quadriceps muscle sections of 3 month old C57 black 
mice. (A) DAPI staining in untreated and decellularised muscle sections treated 
with PLA2. Scale bar-100μm. (B) Gels showing DNA isolated from equal 
quantities of untreated muscle and muscle decellularised using PLA2. Genomic 
DNA was separated on a 1.5% agarose gel. Lane 1= 1 kb plus DNA ladder; 
Lane 2= Untreated muscle; Lane 3= decellularised muscle. (C) Quantification of 
DNA present in the muscle before and after decellularisation. Mean values are 
shown. 
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Figure 3.8 Loss of cytoskeletal proteins after PLA2 decellularisation.  A. 
Immunofluorescence labelling of untreated and PLA2 decellularised muscle 
sections for myosin (slow muscle). B Untreated and PLA2 -treated muscle 
extracts were solubilized in urea buffer and equal amounts of protein were 
separated by SDS-PAGE and Western blot analysis was performed using 
antibodies against the intracellular proteins myosin and β-tubulin. Anti-myosin 
(NOQ7.5.4D) and anti-β-tubulin were mouse monoclonal and rabbit polyclonal 
antibodies respectively. The conjugated secondary antibodies: IHC, a goat anti-
mouse alexa fluor 488 antibody, Western blots, a goat anti-mouse HRP antibody 
and a goat anti-rabbit HRP antibody were used for myosin and β-tubulin 
antibody detection respectively.  
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SDS treatments, the ECM from the PLA2 method was chosen for further analysis. 
Immunohistochemistry showed loss of myosin (a crucial contractive protein in muscle) 
staining from the decellularized sections (Figure 3.8 A). Western blotting (section 2.3.6) 
was used to confirm the loss of cytoskeletal components and intracellular proteins from 
the decellularised matrix. Protein extracts from untreated and PLA2 decellularised 
muscles were solubilized in RIPA buffer and equal amounts of protein were separated 
on a 7.5% SDS PAGE, blotted and probed for myosin and β-tubulin. Western blots for 
myosin revealed two distinct bands at 220 kDa and 140 kDa in the control lane 
containing extracts of untreated muscle while no band can be seen in the lane containing 
extracts from the decellularised tissue, indicating that myosin had been removed from 
the decellularised muscle. Similar results were obtained when the blots were probed with 
an antibody recognising β-tubulin; no band was visible at the 50 kDa mark in the lane 
containing the decellularised extract whereas this band was evident in the control tissue 
lane (Figure 3.8 B). 
3.2.3.3 Retention of matrix proteins after decellularization  
Imunofluroescence experiments revealed the major structural proteins of the matrix, 
collagen type I and collagen type III, were well preserved in the endomysium around 
each muscle fibre with possibly an increase in the intensity of collagen type III staining 
in the interstitial connective tissue after decellularization (Figure 3.9 b, d). Positive 
staining for the basement membrane components, collagen type IV, collagen type VI, 
laminin α2 and fibronectin was also observed in the acellular ECM prepared using PLA2 
(Figure 3.9 f, h, j, l). The muscle cross-sections maintained their polyhedral tubular 
organization even after decellularization indicating that the overall structure of the ECM 
was preserved. Although the immunofluorescent staining of the proteoglycans decorin 
and perlecan was less strong than that of the collagens a similar level of signal was seen 
in the decellularized sections as in the untreated control sections indicating these 
molecules were preserved in the matrix (Figure 3.10 a-d). EV3C3 is mAb that 
recognises a GAG epitope on heparan sulphate chains and positive staining with this 
antibody revealed this epitope was also intact after decellularization with a signal 
comparable to that seen with control muscle matrix (Figure 3.10 e-f). In one or more of  
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Figure 3.9. Immunofluorescence labelling of untreated and PLA2 
decellularised quadriceps muscle sections of 3 month old C57 black mice. 
Sections were fixed and stained with antibodies against structural and basement 
membrane components of ECM: collagen I (a, b), collagen III (c, d), collagen IV 
(e, f) collagen VI (g, h), laminin α2 (i, j) and fibronectin (k, l). The antibodies 
recognising all the ECM components except the laminin chain were rabbit 
polyclonal antibodies. The anti-laminin-2 (4H8-2) was a rat monoclonal 
antibody. Secondary antibodies were: goat anti-rabbit FITC conjugated antibody 
(e, f, g, h, k and l); a goat anti-rabbit Alexa fluor 546 conjugated antibody (a, b, c, 
d), and a goat anti-rat-IgG FITC conjugated antibody (I, j). Nuclei are stained 
with DAPI (blue). Scale bars- 100μm 
 
Chapter 3 
100 
 
 
Figure 3.10. Immunofluorescence labelling of untreated (a, c, d) and PLA2 
decellularised (b ,d ,f) quadriceps muscle sections of 3 month old C57 
black mice. Sections were fixed and stained with antibodies against the 
proteoglycan perlecan (a, b), decorin (c, d) and a GAG epitope, EV3C3 (e, f). 
Perlecan and Decorin were rabbit and sheep polyclonal antibodies respectively 
and EV3C3 was a phage display mouse monoclonal antibody. Secondary 
antibodies used were: Dylight 549-conjugated donkey anti-sheep (c, d), and 
goat anti-rabbit TRITC (a, b). Rabbit Anti-VSV-G and goat anti-rabbit TRITC 
antibodies were used for EV3C3 (e, f). Nuclei are stained with DAPI (blue). 
Scale bars: 100 μm for a-d, 50 μm for e-f. 
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the other decellularization methods decorin, fibronectin and collagen VI stained less 
intensely than in the untreated control sections. This was not the case following the 
PLA2 decellularization procedure and for this reason this decellularization method was 
adopted for the rest of the study.  
3.2.4 Analyses of solubilised acellular muscle matrix 
The solubilisation of ECM is problematical as a majority of the proteins exist in cross-
linked or aggregated forms [244]. Accordingly, three different solubilisation buffers 
were tested: RIPA, Urea and 0.1M acetic acid (section 2.2.4). Initially, untreated muscle 
was solubilized in RIPA buffer either for 4h or O/N at 4ºC and the solubilized proteins 
(20 µg) were resolved on 7.5% SDS-PAGE (section 2.3.3) and stained with Coomassie 
Brilliant Blue (section 2.3.4). RIPA buffer solubilized the muscle proteins and a protein 
concentration of 6.0 mg/ml was obtained from 40 mgs of muscle tissue (wet weight). 
However the SDS-PAGE analysis revealed only a few clearly resolved bands and the 
majority of the proteins appeared as unresolved smears (Figure 3.11).  
Untreated muscle and decellularised muscle matrix were solubilized in Urea buffer in an 
attempt to obtain proteins that could be better resolved on SDS-PAGE. The tissue was 
placed in Urea buffer for either for 4h or O/N at 4ºC. Since urea interferes in the BCA 
assay, a non-interfering (NI) protein assay (section 2.3.2.2) was used to measure the 
concentration of the solubilized proteins. This assay indicated that UREA buffer was 
able to better solubilize the native muscle than the RIPA buffer with concentrations of 8-
9 mg/ml being regularly obtained. However, as occurred with the RIPA solubilized 
muscle samples when 20 µg of protein  from untreated muscle was run on 7.5 % SDS-
PAGE Coomassie Brilliant Blue staining revealed that most of the proteins were not 
resolved and appeared as smears and this was the case regardless as to whether the 
extraction time was 4h or overnight. In contrast, proteins (8.0 µg) extracted from PLA2 
decellularized muscle resolved as a small number of bands of around 260 kDa plus some 
faint bands of a higher molecular weight (Figure 3.11).  
Finally, muscle tissue from both untreated and PLA2 treated muscle was solubilized in 
0.1M acetic acid buffer containing 20mM EDTA for 7 days at 4ºC. The extraction time  
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Figure 3.11 Muscle proteins and decellularised ECM solubilisation using 
different buffers. Whole muscles and PLA2 decellularised ECM proteins were 
solubilised in RIPA, UREA and 0.1M acetic acid buffers and resolved on a 7.5 % 
SDS-PAGE and visualized by Coomassie Brilliant Blue staining. RIPA Lane1: 
Marker; Lane 2: untreated muscle solubilised for 4h; Lane 3: untreated muscle 
solubilised O/N. UREA Lane1: untreated muscle solubilised for 4h; Lane 2: 
untreated muscle solubilised for O/N; Lane 3: PLA2 decellularised matrix 
solubilised for O/N. Acetic acid Lane1: Marker; Lane 2: Collagen I standard; 
Lane 3: PLA2 decellularised matrix. Arrows show high molecular weight bands. 
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was determined by measuring the protein concentration after solubilizing the muscle 
tissue for 1, 3, 5 and 7 days in 0.1M acetic acid and measuring the protein concentration 
using a BCA assay (section 2.3.2.1) (Table 3.1). After 7 days of solubilisation in 0.1M 
acetic acid the protein concentration of muscle extracts reached a maximum of 0.7 
mg/ml for decellularized tissue and 4.0 mg/ml for intact tissue. The proteins solubilized 
from PLA2 decellularised ECM resolved on 7.5% SDS-PAGE as two bands at 
approximately 260 kDa, two bands at around 140 kDa and additional high molecular 
weight bands at >260 kDa). A comparison of the banding pattern of this extract with that 
of the same concentration of a collagen I standard, run on the same gel, revealed a very 
similar banding pattern, that is the collagen I standard also gave rise to bands around 260 
and 140 kDa (Figure 3.11). The absence of low molecular weight proteins showed that 
decellularised ECM extract has lost most of the cytoplasmic proteins.  
              Table 3.1. Solubilised muscle ECM protein yield at different time points 
  
 
3.2.5 Western blots for PLA2 method 
Extracts from untreated and PLA2 decellularized muscles solubilized using 0.1M acetic 
acid were analysed using Western blotting (section 2.3.6) to assess the extent of 
preservation of collagen I, collagen VI, laminin α2, perlecan and fibronectin. Two 
distinct bands were evident on the collagen I blot, one at ~140 kDa which is probably 
the α1 chain, and a possible trimer above 260kDa. Staining with the antibody  
No. of days in 
solubilisation 
buffer 
Absorbance at 560 nm Concentration 
(mg/ml) 
1 0.152 0.15 
3 0.184 0.24 
5 0.313 0.5 
7 0.456 0.7 
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Figure 3.12. Western blot analysis of PLA2 decellularised matrix. Untreated 
and PLA2 treated muscle extracts were prepared by solubilising the ECM 
proteins in 0.1M acetic acid. Protein (40 µg) was loaded in both (untreated and 
PLA2) lanes and resolved on 4-15% Mini-PROTEAN TGX gradient gels. 
Proteins were transferred to a PVDF membrane (Immobilon-P) and Western blot 
analysis was performed using antibodies recognising collagen I, collagen VI, 
fibronectin, laminin α2 and perlecan. The anti-collagen I, anti-collagen VI and 
anti-perlecan antibodies were rabbit polyclonal antibodies. Anti-laminin-2 (4H8-
2) and anti-fibronectin (EP5) were rat and mouse monoclonal antibodies 
respectively. Secondary antibodies used were goat anti-mouse HRP antibody 
for the fibronectin blot, goat anti-rabbit HRP antibody for collagen I, collagen VI 
and perlecan blots and rabbit anti-rat HRP antibody for the laminin α2 blot.    
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recognising collagen VI, indicated one band above 260kDa that was similar in intensity 
for extracts from both untreated and PLA2 decellularised muscle. Fibronectin was 
detected as a 200 kDa band, although with lower signal intensity in the decellularized 
extract compared to untreated muscle extract. A band staining with the Laminin α2 
antibody was at the top of the gel (~400kDa) with an increased amount in the extract 
from decellularised muscle compared to the untreated muscle extract. A novel finding is 
the preservation of some perlecan in the decellularised ECM extract. Multiple bands 
were revealed with the anti-Perlecan antibody in the untreated sample (>260kDa and at 
140 kDa), but a single high molecular weight band at the top of the gel appeared in the 
decellularised extract (Figure 3.12). 
3.2.6 Scanning electron microscopy (SEM) (section 2.6) 
Structural changes following the process of decellularisation were investigated using 
SEM, which was performed on both, untreated and decellularised muscles. Five samples 
each of untreated and decellularised mouse muscle sections (60 µm thick) and 
representative samples of whole rat quadriceps muscles were examined. Untreated 
muscle samples show a hexagonal, compact fibre arrangement while decellularised 
samples show hollow tubular structures, indicating the loss of cells (Figure 3.13).  
          Table 3.2   ECM proteins in Native Muscle and Acellular Muscle 
ECM protein Native muscle Method of decellularisation 
Trypsin         SDS             PLA2 
Col I + ++ ++ ++ 
Col III + NT NT ++ 
Col IV + ++ ++ ++ 
Col VI + + + ++ 
Fibronectin + - + + 
Perlecan + NT + + 
Biglycan + NT - NT 
Decorin + NT - + 
HS EV3C3 
epitope 
+ NT NT + 
+ present, - absent, ++ present with an increased intensity, NT not tested 
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Figure 3.13 Scanning electron micrographs of untreated (a) and PLA2 
decellularized (b, c) rat quadriceps muscles. SEM imaging was performed on 
full thickness chunks of muscle (a, b) (approximately 0.5 mm thick, cut using a 
sharp razor blade) and muscle sections (c) (60 µm thick, cut using a cryostat). 
Scale bars: 10μm (a, b) and 20μm (c).   
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3.3 Discussion 
This chapter describes the development of a method to obtain a skeletal muscle ECM 
scaffold with well-preserved matrix components including the proteoglycans. Of the 
three methods that were explored, a phospholipase based method provided the best 
balance between removal of cells and cellular components like DNA and the 
preservation of ECM components. 
The first method tested used a proteolytic enzyme, trypsin. This method was effective in 
decellularizing the muscle tissue (Fig 3.1) and by immunohistochemistry it appeared as 
if collagens type I, type IV and type VI were preserved, but immunohistochemistry also 
suggested that the matrix glycoprotein, fibronectin, was destroyed (Fig 3.2 and 3.3).  
Previously, trypsin was used as a decellularization agent due to its serine protease 
activity but it can also cleave the core proteins of proteoglycans and so release GAG 
chains [175]. Stern et al (2009) used trypsin and Triton X-100 to decellularize hamstring 
and quadriceps muscles of rats and showed that the levels of GAGs in the decellularized 
matrix were below the limits of detection [175]. Although Stern et al (2009) did not 
perform an immunohistochemical examination of the decellularised muscle ECM; they 
measured the collagen content as a percentage of total protein content and found it to be 
72% in the decellularised ECM. Although no intact cells were seen using this method 
strands of disrupted DNA and RNA were evident [245].  
Since, the main goal was to preserve most of the ECM components in the remaining 
matrix including fibronectin, a detergent based method was tried. A method using the 
anionic detergent SDS was used. This detergent assists in the decellularization process 
by solubilizing the cell membrane and disrupting DNA-protein or lipid-protein 
interactions. Others have found that although SDS removes cells from dense tissues 
more effectively than other chemical agents it can adversely affect the ultrastructure of 
the remaining ECM [168, 246] and may lead to the removal of growth factors [177]. In 
our study, DNA quantification results indicated that the SDS method did not efficiently 
remove all of the DNA from the muscle tissue (Fig 3.4), although by 
immunohistochemistry it was evident that most of the ECM components including all 
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the collagens and fibronectin were retained (Fig 3.5 and 3.6). Other workers have used a 
variety of methods to decellularize skeletal muscle and to analyse the decellularized 
matrix. DeQuach et al (2010) used Time-of-Flight Secondary Ion Mass Spectrometry 
(TOF-SIMS) to characterize the matrix remaining following decellularization of porcine 
intercostal muscle using 1% SDS. They showed the presence of collagens, fibronectin, 
laminin, fibrinogen, fibrillin-1 and fibrillin-5, proteoglycans such as decorin, lumican 
and HS GAGs in this matrix [174]. They assessed whether cellular material remained by 
sectioning the decellularised matrix and staining with hematoxylin and eosin. Although 
they reported loss of all cells, using this method it would be difficult to determine 
whether cell fragments or strands of DNA remained, as were evident in our study when 
we used SDS to decellularize quadriceps muscle, although we did use a lower 
concentration of SDS (0.2%). Interestingly, DeQuach et al (2010) also decellularized 
cardiac tissue using the same 1% SDS procedure and their analyses revealed tissue 
specific differences in the cardiac matrix and skeletal muscle matrix, and for both tissues 
significant quantities of GAGs were measured in the acellular matrices [174]. In an 
attempt to produce an acellular muscle matrix that retains both the biochemical and 
mechanical properties of intact tibialis anterior muscle Gillies et al. (2011) developed a 
procedure involving cell lysis by osmotic shock, latrunculin B treatment to disrupt actin, 
high ionic strength salt treatment to depolymerize myosin and finally DNase treatment 
[176]. In this case, although the proteins in decellularised muscle were greatly decreased 
from those in intact muscle some myosin fragments and a small amount of actin 
remained. The collagen content was consistent with that of intact muscle but the GAG 
content was reduced by approximately half [176], possibly because cell surface GAGs 
would have been included in the GAGs measured from intact muscle. 
The final method examined was a modification of the method used by Wang et al. 
(2011) and involved a combination of enzyme, detergent and nucleases [243]. This 
method, coined the “phospholipase method” consisted of sequential incubation of mouse 
Quadriceps muscle in phospholipase A2 and sodium deoxycholate; a high ionic strength 
solution and DNase I [243]. This method avoided the use of proteases or strong ionic 
detergents like SDS that could degrade the ECM. This method was originally used by 
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Wang et al. (2011) to prepare an acellular liver matrix using perfusion of the 
decellularisation reagents. In this case preservation of growth factors, cytokines and 
extracellular components of the matrix were reported [243]. This present study is the 
first to use a phospholipase in the decellularization reagents for skeletal muscle.  
PLA2 decellularisation successfully removed most of the cellular material, as shown by 
DNA and cellular protein analysis (Figs 3.7 and 3.8) and appeared to be a better method 
than the previous two methods. SEM images of decellularized muscles suggested that 
while the PLA2 method successfully removed the muscle fibres from the tissue, the 
overall architecture of the remaining matrix was well maintained (Fig 3.13). Similar to 
our observations with acellular quadriceps muscle, scanning electron microscopy of the 
acellular tibialis anterior muscle obtained by the method of Gillies et al (2011) revealed 
hollow tubular extracellular matrix structures, indicating retention of the tissue 
architecture [176]. Using the PLA2 method immunohistochemistry revealed all the 
collagens examined (type I, III, IV and VI) were present in the decellularised matrix (Fig 
3.9). Interestingly in some instances the staining intensity increased in the decellularised 
matrix, which may imply more antigenic sites were exposed following the loss of cells 
(Figure 3.9 and Table 3.2). The Western blotting data for collagens type I and VI in the 
solubilised ECM extracts indicated intact α1chains as well as high molecular weight 
collagen trimers (Figure 3.12).  
Collagens type I and III are the major structural proteins in skeletal muscle ECM and 
constitute major portions of endomysium and perimysium [68]. In addition to their 
structural biomechanical function, collagens also bind to different growth factors like 
transforming growth factor β (TGF-β) and insulin like growth factor (IGF 1 and 2), and 
affect diverse cell functions such as proliferation and differentiation through these 
interactions [69]. In vitro studies suggest a possible role for IGF-1 in satellite cell 
proliferation [33] whereas in vivo studies show that IGF-1 induces hypertrophy in 
muscle [247] and its direct injection in muscle improves the process of muscle 
regeneration [36]. TGF-β1 plays a role in determining the fibre type formation during 
muscle development [248, 249] and also induces the myogenic cells into myofibroblasts 
leading to the formation of scar tissue within the regenerating muscle [250]. Recently, 
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Urciulo et al (2013) showed that collagen VI plays an important role in regulating the 
self-renewal capacity of the satellite cells and it forms an essential component of the 
satellite cell niche [251]. Once activated, satellite cells proliferate, migrate to the 
damaged area of the muscle, differentiate and fuse to form new muscle fibres which 
leads to an increase in the cross sectional area of the muscle. Collagen VI also seems to 
be important for regulating the mechanical properties of muscle as studies using a Col6a 
1-/- mice model indicated an increase in elasticity and reduced stiffness of skeletal 
muscle [251]. The data indicates good collagen retention with the PLA2 method which 
has the added advantage that this enables preservation of collagen-binding molecules 
such as laminins, fibronectin, proteoglycans and GAGs, that in turn preserve cytokines 
and growth factors bound to them [243].  
Immunohistochemistry results also showed that the two major basement membrane 
glycoproteins, laminin-α2 and fibronectin were preserved in the decellularised matrix 
(Figure 3.9). A result that was confirmed by the western blotting data, although there 
appeared to be a decrease in the levels of fibronectin in the solubilised acellular ECM 
extracts (Figure 3.12). In skeletal muscle, laminins containing the α2 chain are a major 
component of the basement membrane, with laminin-2 (α2β1γ1) being the major form 
around the sarcolemma of mature myofibres, while laminin-4 (α2β2γ1) occurs at 
neuromuscular junctions and myotendinous junctions [76]. These laminins bind α7β1 
integrin, the major laminin receptor in skeletal muscle, to activate the 
phosphatidylinositol 3-kinase/Akt and the Ras/Raf/MEK/Erk signalling pathways. This 
has the effect of promoting myotube survival and stability by up regulating suppressors 
of apoptosis and down regulating the expression of pro-apoptotic molecules [252]. 
Laminins also bind to non-integrin cell surface receptors like α-dystroglycan and control 
the transmission of contractile force from the muscle fibre to the ECM [77]. Mice 
lacking the laminin 2 subunit have severely impaired muscle regeneration and 
muscular dystrophy, which can be rescued if the link between the basement membrane 
and dystroglycan is restored [253]. Fibronectin binds to collagen, laminin and other 
molecules of the ECM to play a key role in myoblast adhesion, migration and 
differentiation [74]. Like collagen VI, fibronectin is a key component of the satellite cell 
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niche and loss of fibronectin severely reduces the pool of satellite cells because 
fibronectin is involved in stimulating Wnt7a signaling which induces satellite cell 
expansion [254]. Fibronectin binds to the integrins-α5β1 and αvβ3 and controls the 
organization of cell-matrix adhesions and fibronectin fibrillogenesis [255]. These 
integrins are easily detected in myoblasts and are considered to play a crucial role during 
myogenic differentiation [256].   
It was particularly encouraging that using this phospholipase method to decellularize 
muscle resulted in the retention of the proteoglycans, perlecan and decorin, as well as a 
heparan sulfate epitope that was detected by the EV3C3 antibody [257]. Western blot 
data also showed preservation of perlecan in the solubilised muscle matrix (Figure 3.12). 
The proteoglycan perlecan is an integral component of the muscle basement membrane 
where it binds collagen IV through its core protein. Knockout mouse studies have 
suggested that perlecan is important for maintaining the muscle mass of fast fiber type 
muscle probably through its regulation of myostatin signalling and expression. Loss of 
perlecan also seemed to increase the sensitivity of muscles to mechanical stress [258]. In 
addition, perlecan is essential for the functioning of the neuromuscular junctions as it 
binds and localizes acetyl-cholinesterase to the neuromuscular junctions [102]. Another 
proteoglycan present in the acellular muscle matrix was decorin, the core protein of 
which contains binding sites for collagen I and fibronectin. The N-terminal domain of 
decorin’s core protein binds myostatin and suppresses myostatin signaling, thereby 
enhancing the proliferation and differentiation of myogenic cells [109].  Moreover, the 
intra-muscle injection of a peptide from this region of decorin induced muscle 
hypertrophy [259].  Recently, Li et al (2007) demonstrated that decorin activated the 
differentiation of C2C12 cells in vitro and enhanced muscle regeneration in two mouse 
models by upregulating the expression of p21, follistatin, peroxisome proliferator-
activated receptor gamma coactivator-1-alpha (PGC-1α) and down regulating myostatin 
expression [110]. Decorin also binds TGF-β through a core protein region and this 
interaction inhibited TGF-β activity triggered in response to muscle injury [260]. The 
GAG chains of perlecan and decorin and other matrix proteoglycans play important 
roles in myogenesis. Of particular importance are the HS chains because of their ability 
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to bind and sequester growth factors like FGF-2 and HGF. Both of these growth factors 
stimulate skeletal muscle cell proliferation and inhibit differentiation [84].  Collectively 
these studies outline roles played by collagens, laminin-α2, fibronectin, perlecan, 
decorin and HS chains in myoblast development and highlight the importance of 
preservation of these components if a fully functional decellularized ECM from muscle 
is the goal.  
Generally it is impossible to directly compare the efficacy of the various 
decellularization methods as different types of tissue were used and the analyses of the 
acellular matrices differed from study to study. However, when a direct comparison of 
different methods has been made it is clear that the decellularization method has a 
marked effect on the extracellular matrix components retained, on the removal of DNA 
and RNA remnants, and on the organization of the collagen fibres [176, 261]. Moreover, 
the quality of the acellular matrix produced was reflected in the morphology, 
proliferation and integrin expression levels of cells grown on these surfaces [176, 261]. 
Although PLA2 decellularisation method preserved most of the ECM components tested, 
including perlecan and a GAG epitope, accurate quantification of the GAG components 
and any growth factors remaining in the decellularised ECM was not done. It would be 
interesting to evaluate these two components of the matrix thoroughly as growth factors 
forms an integral part of ECM niche and their binding to PGs and GAGs is well known 
[87, 88, 115, 117]. 
3.4 Conclusion 
With the aim of obtaining a three dimensional decellularized muscle scaffold which 
could further be utilized to study cell behaviour and cell-matrix interaction in vitro, 
skeletal muscle tissue was decellularized using three different methods. In each case the 
ECM scaffold obtained had different matrix components preserved and different levels 
of cellular DNA remaining. Of the three methods tested, the phospholipase method 
provided the best balance between loss of cell components and preservation of ECM 
components.   
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3.5 Future Directions 
The contribution of ECM to muscle repair and regeneration is an area of increasing 
interest and more research is being undertaken to understand more about the cell-ECM-
growth factor interactions and their role in tissue repair [262]. However, less attention 
has been paid to the fact that the same tissue can vary in its ECM composition in 
different situations: for example, healthy versus diseased, young versus old or the same 
tissue type but in a different anatomical location for example, in case of muscle, a soleus 
muscle versus a tibialis anterior muscle, or a gastrocnemius versus a quadriceps muscle. 
Limited work has been published of a direct comparison of ECM obtained after 
decellularisation of muscle from different aged animals. It would be intriguing to 
investigate whether there are any significant differences in ECM obtained from mice of 
different ages and if so how these differences may affect myoblast proliferation and 
differentiation. 
In this study, immunohistochemistry technique was used to assess the preservation of 
ECM proteins in the decellularised matrix. However, using immunohistochemistry, it is 
difficult to quantify the amount of ECM proteins remained in the matrix due to the semi-
quantitative nature of this technique. In future, a thorough biochemical approach to 
quantify the amount of collagens (Sircoll assay kit, Biocolor assays) and GAGs (Blyscan 
Assay kit, Biocolor assays) must be used.  
Every technique that has been used to assess DNA removal (DAPI staining, Nanodrop 
and gel electrophoresis) has a certain threshold level. For example, if the DNA was 
detected in the decellularized matrix using Nanodrop (20ng/μl), it is possible that the 
same sample when electrophoresed on an agarose gel failed to detect any measurable 
levels of DNA as the amount of DNA was below the limits of detection under a UV 
transilluminator and secondly, there is a probability that the DNA was degraded. In 
future, better methods such as those available in the market (Quant-
iT PicoGreen dsDNA assay kit) may be used to quantify the DNA.     
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Chapter 4: 
Acellular skeletal muscle matrix supported serum free proliferation 
and differentiation of C2C12 murine myoblasts in in vitro 2D and 3D 
cultures
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4.1 Introduction 
Acellular ECM scaffolds obtained from muscle have been investigated by other workers 
to assess their effects on myoblasts both in tissue culture and in vivo in animal models. 
An understanding of the efficacy with which these ECM scaffolds become repopulated 
by host myogenic cells in vivo is crucial for determining whether they can be used in 
future translational applications in human muscle [174, 175]. In vitro testing of scaffolds 
can provide valuable insights into the cell-ECM interactions and a measure of the cyto-
compatibility of the scaffolds. The examination of myogenesis on scaffold materials in 
tissue culture have traditionally used foetal bovine and horse sera as a source of growth 
factors to stimulate myoblast proliferation, fusion and differentiation. However, these 
sera contain a diversity of ill-defined components, making it difficult to assess the 
contribution of different growth factors and ECM molecules at the various stages of 
myogenesis. Furthermore, cells cultured in animal sera are increasingly being viewed 
unsuitable for human transplantation applications [263] [264]. The use of alternative 
artificial serum-free media to promote myogenesis is desirable as a way of avoiding both 
the undefined nature of sera and possible batch to batch variability, as well as potential 
regulatory issues associated with the use of animal materials to culture cells to be used 
for transplantation. Serum-free media formulations have been tested for myoblast 
proliferation and differentiation previously [220, 265-267]. Fujita et al (2010) evaluated 
protein expression, glucose metabolism, sarcomere formation and generation of active 
tension during different stages of muscle differentiation in several serum free media: 
DMEM containing either Ham’s F-12, AIM-V, 0.2 % Ultroser G, 0.1 % sericin or AIM-
V/0.1% Ultroser G  [268, 269]. All the media except DMEM/F-12 were able to induce 
sarcomere formation in differentiated myotubes, but there was more active tension 
generation in AIM-V media as compared to the media containing horse serum [268]. 
The authors suggested that serum free media was better in promoting the differentiation 
of C2C12 myoblasts than the serum-containing media. The above study suggests that the 
serum free media tested so far have showed variable results and therein lies the 
opportunity for improvement in formulation of serum free media for muscle cell culture. 
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Traditional two-dimensional tissue culture is a useful model system to study cell-matrix 
interactions and the associated factors which modulate these interactions, for example 
how cells at different stages of differentiation respond to different types of matrix 
glycoproteins, and the physical and mechanical properties of a substrate. Studies of cell 
behaviour on substrates of a pure matrix glycoprotein, like fibronectin [270] [271], a 
laminin [271, 272] or a collagen [273] are relatively common, but studies of cell 
behaviour during differentiation on substrates comprising the mix of glycoproteins 
found in their natural tissue ECM are just beginning. In the case of myoblasts these 
studies have been conducted in the presence of serum [174, 175], which contains soluble 
matrix proteins that can adhere to the substrate proteins. This makes it difficult to 
determine the exact contribution of a matrix glycoprotein substrate on the differentiation 
process.  
Previous studies have indicated that cell behaviour on a 2-dimensional (2D) matrix 
glycoprotein substrate is not identical to that seen when the glycoprotein is in a three-
dimensional (3D) scaffold. For example, cell-adhesion complexes in “3D matrices” 
differ markedly from their counterparts on 2D substrates in their structure and function, 
and cell-signalling events can also differ between 3D matrices and 2D flat substrates 
[231]. For these reasons there is a need to improve our understanding of cell-matrix 
interactions by designing 3D culture systems which closely mimic the in-vivo cell 
microenvironment.  
This chapter describes the functional characterisation of the decellularized skeletal 
muscle matrix, prepared in the previous chapter. To avoid the confounding effects of 
serum, a serum-free medium (developed in our lab) that supports myoblast 
differentiation in tissue culture, when these cells are provided with a matrix glycoprotein 
substrate, was used. We hypothesized firstly, that a substrate of solubilised muscle 
matrix would regulate myoblast differentiation differently than a substrate of a pure 
matrix glycoprotein, and secondly, that the correct 3D arrangement of ECM components 
from a muscle matrix would affect cell behaviour differently from a solubilized ECM 
under in vitro conditions. Hence, this study used the serum-free medium, to investigate 
the formation of differentiated myotubes from mouse and human myoblasts either on 
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surfaces coated with solubilised skeletal muscle ECM, or on intact acellular skeletal 
muscle matrices.   
4.2 Results  
4.2.1 Proliferation of C2C12 cells on different matrices 
To compare the ability of substrates of various ECM proteins to support cell adhesion 
and growth the murine myoblast cells, C2C12, were cultured on collagen I, fibronectin 
or solubilised rat muscle matrix coated plastic dishes in our serum free medium (section 
2.7.5.3). Solubilized rat quadriceps muscle matrix (sections 2.2.3 and 2.3.4) was used for 
these coating experiments as it was not possible to obtain sufficient matrix material from 
the smaller mouse muscles. It was found C2C12 myoblasts adhered to, spread and 
proliferated on all matrices (Fig 4.1 a–i). By day 3 the cells were almost 70% confluent, 
and by day 4 the cells became confluent on all 3 substrates. In contrast, on uncoated 
tissue culture plastic C2C12 cells in the serum-free medium did not adhere to the 
substrate; they had a rounded morphology and aggregated together adhering to each 
other rather than the substrate (Fig 4.1. j-k). Without a matrix protein substrate, 
proliferation was poor, the aggregates failed to thrive, and after 4 days many of the cells 
had died. Cell proliferation was quantified by culturing C2C12 cells in serum free 
proliferation medium for 7 days on collagen I, fibronectin and solubilised muscle matrix 
substrates in a 24-well plate, with the cells being harvested and counted each day using a 
Z™ Series Beckmann coulter counter (section 2.7.7) (Fig 4.2). Interestingly, C2C12 
myoblasts proliferated at a similar rate on collagen I and fibronectin coated surfaces with 
cells reaching approximately 2.5 x 10
5
 million at day 3 in the wells of a 24-welled plate 
from an initial seeding number of 7.0 x 10
3 
cells/well. On muscle matrix coated surfaces, 
the cells proliferated at a slower rate and reached to 2 x 10
5
 cells by day 4 and plateaued 
thereafter. C2C12 myoblasts began to differentiate on day 4 which may explain the 
plateau in cell numbers seen on muscle matrix, and to a lesser extent on fibronectin and 
collagen.  
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Figure 4.1. Phase contrast images of proliferating C2C12 cells cultured on 
collagen I (a, d, g), fibronectin (b, e, h) solubilised muscle matrix (c, f, i) 
and uncoated plastic (j, k) for 1, 3 and 4 days in serum free proliferation 
medium. C2C12 cells (3.5 x 103 cells/cm2) were seeded in wells of a 24-well plate 
coated with either collagen I (10 µg/cm2), fibronectin (10 µg/cm2), solubilised 
muscle matrix (10 µg/cm2) or uncoated plastic and cultured for 4 days in serum 
free medium. Images were captured at day 1, 3 and 4 after seeding, with a Zeiss 
Axiovert bright field microscope at an overall magnification of 120x using Spot 
Advanced software. Scale bars - 100 μm for a-k.  
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Figure 4.2. Proliferation of C2C12 cells in serum free proliferation medium 
was assessed on collagen I, fibronectin and solubilised muscle matrix. 
C2C12 cells (3.5 x 103 cells/cm2) were seeded in wells of a 24-well plate coated 
with either collagen I (10 µg/cm2), fibronectin (10 µg/cm2) or solubilised muscle 
matrix (10 µg/cm2), and cultured for 7 days in serum free medium. After every 24 
h, cells were removed from the plastic using 0.05% trypsin/EDTA and counted 
using the Z™ Series COULTER COUNTER®  
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4.2.2 Differentiation of myoblasts into myotubes 
To examine the effect of muscle matrix on the differentiation of C2C12 myoblasts, cells 
were cultured on muscle matrix, fibronectin and collagen I coated surfaces for 12 days. 
They were cultured in serum free proliferation medium until almost confluent (90%-
100% confluency) (proliferation day 4), and then switched into serum-free 
differentiation medium for the remaining 8 days (differentiation day 8). Phase contrast 
microscopy of the cells after 4 days in differentiation medium clearly showed fusion of 
myoblasts into myotubes with a similar capacity on collagen I (Figure 4.3. a, d) and 
fibronectin (Figure 4.3. b, e). However on muscle matrix coated surfaces myotubes 
appeared much thicker than on the other substrates (Figure 4.3. c, f). Immunostaining 
with a mAb to myosin heavy chain 7 (MyHCB) (section 2.7.12) revealed that the 
myoblasts differentiated and fused to form myotubes on all the ECM substrates with 
similar capacity (Figure 4.4). By day 6 in differentiation media, striations appeared on 
the myotubes, which are indicative of assembly into sarcomeres.  
Myotube width was also measured at days 4 and 6 in differentiation medium using 
image J analysis software (section 2.7.13) (Figure 4.5). This analysis revealed that 
myotube width increased from day 4 to day 6 and this increase was similar on both 
collagen type I and muscle matrices, but no visible difference in myotube width was 
found in myotubes formed on fibronectin.   
4.2.3 qPCR Experimental workup:   
(a) RNA concentration and quality 
RNA was isolated from C2C12 myoblasts cultured for 3 days in proliferation media or 
for 1, 4 or 8 days in differentiation media on wells coated with collagen I (10 µg/cm
2
), 
fibronectin (10 µg/cm
2
) or solubilized matrix (10 µg/cm
2
) using the ISOLATE RNA 
KIT (section 2.8.1). Since the RNA was to be used for qPCR experiments, RNA 
concentration and purity was assessed by measuring the absorbance 
spectrophotometrically (section 2.8.2) and obtaining the ratio of A260/A280 nm. For all 
the RNA samples, A260/A280 values were between 1.9 and 2.1. As an additional quality 
control step the quality of RNA was also measured using LabChip® GX II and all 
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Figure 4.3. Phase contrast images of C2C12 cells cultured on collagen I (a, 
d), fibronectin (b, e) and solubilised muscle matrix (c, f) in serum free 
differentiation medium. C2C12 cells (3.5 x 103 cells/cm2) were seeded in wells 
of a 24-well plate coated with either collagen I (10 µg/cm2), fibronectin (10 
µg/cm2) or solubilised muscle matrix (10 µg/cm2), and cultured for 4 days in 
serum free proliferation medium. After 4 days, the medium was changed to a 
culture medium designed to stimulate differentiation and the cells were cultured 
for another 8 days. Images were captured at day 4 and 8 of differentiation with a 
Zeiss Axiovert bright field microscope at an overall magnification of 120x using 
Spot Advanced software. Scale bars - 100 μm for a-f.  
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Figure 4.4. Immunofluorescence images of C2C12 cells cultured on 
collagen I (a-c), fibronectin (d-f) and solubilised muscle matrix (g-i) at 4 
and 6 days in serum free differentiation medium. C2C12 cells (3.5 x 103 
cells/cm
2) were seeded in wells of a 24-well plate coated with either collagen I 
(10 µg/cm2), fibronectin (10 µg/cm2) or solubilised muscle matrix (10 µg/cm2), 
and cultured for 4 days in serum free proliferation medium. After 4 days, the 
medium was changed to a medium designed to stimulate differentiation and the 
cells were cultured for another 8 days. Post-differentiation, cells were fixed with 
4% paraformaldehyde and stained for myosin (green) and imaged using a Zeiss 
Axioskop fluorescent microscope at an overall magnification of 480x using Spot 
Advanced software.The antibody recognising myosin was a mouse monoclonal 
(NOQ7.5.4D) antibody. The secondary antibody used was a goat anti-mouse 
alexafluor 488 conjugated antibody. Scale bars - 50 μm for a-i.  
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Figure 4.5. Myotube width was measured using ImageJ software. C2C12 
cells (3.5 x 103 cells/cm2) were seeded in wells of a 24-well plate coated with 
either collagen I (10 µg/cm2), fibronectin (10 µg/cm2) or solubilised muscle 
matrix (10 µg/cm2), and cultured for 4 days in serum free proliferation medium. 
Then the medium was changed to a medium designed for differentiation and the 
cells were cultured for another 8 days. Myotube width of 25 myotubes was 
calculated using ImageJ software. Values are the mean±SD of 25 myotubes on 
days 4 and 6.   
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 samples were found to have a RNA quality score (RQS) of > 8.0. 
(b) Melt Curve Analysis (section 2.8.5 ) 
Melt curve analysis allows identification of the melting temperature of the amplified 
sequence within each sample. The appearance of a single sharp peak indicates that only 
a single sequence was amplified during the thermal cycling reaction. Primer-dimers 
usually appear as small peaks beside the sharp peak, as they usually have a lower 
melting temperature due to their short length. In my experiments as the amplified DNA 
within the sample became single stranded, a sharp decrease in the SYBR green 
fluorescence intensity was observed. As can be seen in figure 4.6 and figure 4.7, melt 
curve histograms for all four reference genes and seven genes of interest (Table 2.4) 
respectively from cDNA samples of C2C12 cells in days 1, 4 and 8 of differentiation, a 
prominent single peak was detected for each primer pair indicating gene specific 
annealing.  
(c) Primer efficiency calculations (section 2.8.6) 
Briefly, five-fold dilutions (1/5, 1/25, 1/125 and 1/625) of neat cDNA (from cultures day 
1 and day 4 of myotube differentiation) were prepared and were amplified for each 
primer pair (four reference genes and seven genes of interest) in a qPCR reaction. 
Efficiency of each primer was calculated using the equation E=10
(-1/slope)
 where a
 
value 
of 2.0 represents a perfect primer with product doubling after every cycle. The reaction 
efficiencies derived from these experiments are shown in Table 4.1 and the respective 
curves are shown in Figure 4.8-4.9. Primer efficiencies between 90% and 110 % are 
generally acceptable for gene quantification analysis.  
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Figure 4.6. Melt curve analysis of reference genes for C2C12 cells cultured 
on collagen I and muscle matrix. To assess the specificity of the primers, melt 
curve analysis was performed after every qRT-PCR run. Fluorescence (y-axis) 
is plotted versus temperature (x-axis). Melt curves show the temperature where 
two strands of DNA separate. 
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Figure 4.7. Melt curve analysis of genes of interest for C2C12 cells 
cultured on collagen I. To assess the specificity of the primers, melt curve 
analysis was performed after every qRT-PCR run. Fluorescence (y-axis) is 
plotted versus temperature (x-axis). Melt curves show the temperature where 
two strands of DNA separate. 
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Figure 4.8. Primer efficiency calculation of four reference genes for C2C12 
cells cultured on collagen I. To assess the efficiency of the primers, five-fold 
dilutions of cDNA (day 1 differentiation) was done and qPCR was performed. Ct 
values were plotted (y-axis) versus dilution series (x-axis) to determine the 
primer efficiency.  
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Figure 4.9. Primer efficiency calculation of four differentiation genes for 
C2C12 cells cultured on collagen I. To assess the efficiency of the primers, 
five-fold dilutions of cDNA (day 1 differentiation) was done and qPCR was 
performed. Ct values were plotted (y-axis) versus dilution series (x-axis) to 
determine the primer efficiency.  
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      Table 4.1 Primer efficiencies of reference genes and genes of interest 
Gene symbol Amplification 
efficiency (%) 
SDHA 102 
ACTAB 97 
TBP 100 
HPRT 114 
MYOG 90 
MYF5 110 
MYH 1 93 
MYH 3 138 
MYH 7 105 
ACTA 1 122 
ACTC 1 105 
(d) Validation of reference genes (section 2.8.7) 
In gene expression analysis using real time qPCR, reference genes (RGs), or 
housekeeping genes are included as internal controls, and it is assumed that expression 
of RGs should not change under the conditions of the experiment. However, expression 
of RGs may vary under different experimental conditions and if unrecognized this could 
result in an over- or under-estimation of gene expression. Thus, all RGs need to be 
validated for each experimental setting before performing the baseline correction for 
gene expression. Four reference genes (SDHA, TBP, HPRT, and ACTAB) were tested 
and analyzed using NormFinder [236] and BestKeeper [237] software.  
(e) NormFinder 
qRT-PCR was performed on cDNA obtained from cells cultured on collagen I, 
fibronectin and solubilized muscle matrix in serum free media at day 3 of proliferation 
and day 1 of differentiation. CT values obtained after performing the qRT-PCR were 
placed in the NormFinder software and analysed. Table 4.2 shows the list of 4 candidate 
reference genes and their ranks, using the NormFinder programme to calculate 
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expression stability. The gene with the lowest expression stability is considered to be 
expressed with the greatest consistency. SDHA was found to have the most constant 
expression across all conditions with an expression stability value of 0.004 and was 
therefore used as the reference gene for normalization of data. The analysis for a 
combination of two genes yielded SDHA and ACTAB as the best combination with the 
stability value for best combination of two genes as 0.359.  
Table 4.2 Stability values of 4 reference genes using the software Normfinder 
Gene  
name 
Stability 
value 
TBP 0.088 
SDHA 0.004 
ACTAB 0.071 
HPRT 0.025 
 
(f) Bestkeeper 
qRT-PCR was performed on cDNA obtained from cells cultured on collagen I, 
fibronectin and solubilized muscle matrix in serum free media at day 3 of proliferation 
and day 1 of differentiation. CT values obtained after performing the qRT-PCR were 
placed in the Bestkeeper software and analysed. The reference gene with the lowest 
coefficient of variance ± standard deviation (CV±SD) is considered to be the most 
stable. Under serum-free culture conditions, SDHA and ACTAB were found to be the 
most stable reference genes with CV±SD values of 3.38±0.82 and 4.35±0.97. Although, 
HPRT and TBP also showed low CV±SD values of 4.59±1.22 and 3.68±1.06 
respectively, the standard deviation was higher than 1 (starting template variation by a 
factor 2) in both cases making them unacceptable for normalization [237].  
4.2.4 Gene expression of myogenic markers in C2C12 cells on different 
matrices 
qRT-PCR was then used to examine the expression of seven genes that play important 
roles in different stages of myoblast differentiation (section 2.8.8). These were: 
myogenic factor 5 (Myf5) and myogenin (MYOG), both transcription factors belonging 
to the myogenic regulatory factor (MRF) family of proteins; three isoforms of myosin 
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heavy chain (MYH1, MYH3 and MYH7); and two muscle actin isoforms (ACTA1 and 
ACTAC1). Gene expression on days 1 (in differentiation medium), 4 (in differentiation 
medium) and 8 (in differentiation medium - myotubes) was assessed when C2C12 cells 
were cultured on collagen (Figure 4.10), fibronectin (Figure 4.11) and muscle-matrix 
(Figure 4.12).  
Myf5 showed similar low levels of expression at days 1, 4 and 8 on collagen I (Fig 4.10).  
On fibronectin and muscle matrix coated surfaces, Myf5 levels at day 8 were 
significantly lower than levels at day 1 (Figs 4.11 and 4.12). MYOG mRNA increased on 
muscle matrix coated surfaces to be at day 8 approximately 4-fold higher than at day 1 
(Fig 4.12). In contrast, on collagen I and fibronectin coated surfaces, myogenin levels 
peaked at day 4 before declining at day 8 (Figs 4.10 and 4.11). A large increase was 
observed in the MYH1, MYH7 and ACTA1 expression from differentiation day 1 to 
differentiation day 4 and this was maintained at day 8 on all three matrices, suggesting 
strong differentiation. MYH3 and ACTC1 (which are expressed in immature muscle) also 
increased from differentiation day 1 to day 4, before decreasing at day 8 with the trend 
being similar on all 3 matrices (Fig 4.10-4.12). However, there was virtually no decrease 
in MYH3 expression at day 8 on collagen I, whereas on fibronectin expression decreased 
to be the same as that on day 1 and on muscle matrix although the decrease was marked 
expression remained higher than that at day 1. These data, plus the fact that on muscle 
matrix MYH1 did not increase from day 4 to day 8, tend to suggest that on muscle matrix 
differentiation is occurring earlier than on collagen I, but at about the same time as on 
fibronectin. 
4.2.5 C2C12 cell adhesion and proliferation on three-dimensional matrix 
scaffolds 
Decellularized 3D rat muscle scaffolds were used as a substrate to evaluate whether they 
supported proliferation and movement of C2C12 myoblasts in serum free culture 
(section 2.7.9). Cell proliferation was assessed by using the Click-iT EdU assay (section 
2.7.11), which labels the recently synthesized DNA (proliferating cells) with the 
coloured thymidine analogue EdU [274]. This assay indicated many cells were  
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Figure 4.10. Quantitative real-time PCR was used to determine the 
expression of seven differentiation markers in differentiating C2C12 cells 
grown on collagen I at days 1, 4 and 8 of differentiation. C2C12 cells (3.5 x 
10
3
 cells/cm
2) were seeded in wells of a 24-well plate coated with collagen I (10 
µg/cm2) and cultured for 4 days in serum-free proliferation medium and for a 
further 8 days in differentiation medium. RNA was isolated from cells at day 1, 
day 4 and day 8 of differentiation. Relative expression levels for MYF5, MYOG, 
MYH1, MYH3, MYH7, ACTA1, ACTC1 were normalized to the Ct value of the 
reference gene (SDHA) and fold change was determined using 2-delta delta Ct 
method. Day 4 and Day 8 expression levels were normalized to Day 1 and log10 
transformed. Mean  SE of 4 biological replicates are shown. Wilcoxon’s T-test 
was performed and significance (p) values shown at each time point. *p<0.05.  
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Figure 4.11. Quantitative real-time PCR was used to determine the 
expression of seven differentiation markers in differentiating C2C12 cells 
grown on fibronectin at days 1, 4 and 8 of differentiation. C2C12 cells (3.5 x 
10
3
 cells/cm
2) were seeded in wells of a 24-well plate coated with fibronectin (10 
µg/cm2) and cultured for 4 days in serum-free proliferation medium and for a 
further 8 days in differentiation medium. RNA was isolated from cells at day 1, 
day 4 and day 8 of differentiation. Relative expression levels for MYF5, MYOG, 
MYH1, MYH3, MYH7, ACTA1, ACTC1 were normalized to the Ct value of the 
reference gene (SDHA) and fold change was determined using 2-delta delta Ct 
method. Day 4 and Day 8 expression levels were normalized to Day 1 and log10 
transformed. Mean  SE of 4 biological replicates are shown. Wilcoxon’s T-test 
was performed and significance (p) values shown at each time point. *p<0.05.  
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Figure 4.12. Quantitative real-time PCR was used to determine the 
expression of seven differentiation markers in differentiating C2C12 cells 
grown on solubilised muscle matrix at days 1, 4 and 8 of differentiation. 
C2C12 cells (3.5 x 103 cells/cm2) were added in wells of a 24-well plate coated 
with solubilised muscle matrix (10 µg/cm2) and cultured for 4 days in serum-free 
proliferation medium and for a further 8 days in differentiation medium. RNA was 
isolated from cells at day 1, day 4 and day 8 of differentiation. Relative 
expression levels for MYF5, MYOG, MYH1, MYH3, MYH7, ACTA1, ACTC1 
were normalized to the Ct value of the reference gene (SDHA) and fold change 
was determined using 2-delta delta Ct method. Day 4 and Day 8 expression levels 
were normalized to Day 1 and log10 transformed. Mean  SE of 4 biological 
replicates are shown. Wilcoxon’s T-test was performed and significance (p) 
values shown at each time point. *p<0.05.  
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proliferating at day 3 after seeding on the intact acellular muscle matrix, in serum free 
proliferation medium (Fig 4.13. a). The three-dimensional colour coded image of the 
muscle scaffold provided evidence that the cells were distributed up to a depth of 138 
μm into the muscle scaffold (Fig 4.13 b). Six days after switching to differentiation 
medium (i.e day ten of culture) the EdU assay was repeated and in contrast to 
proliferation day 3, the nuclei were elongated and there were no proliferating (EdU 
staining) cells present, which suggests that the cells ceased proliferation and were 
differentiating (Fig 4.13 c).  
The Kwik Diff dye system (section 2.7.10), which stains both cell nuclei and cytoplasm, 
was used to stain C2C12 cells cultured on intact acellular muscle matrices for 7 -14 days 
in serum free proliferation medium. This revealed that the myoblasts became organised 
on the 3D matrix scaffolds lining up longitudinally, presumably along tracts of ECM 
material (Fig 4.14. a-b). C2C12 myoblasts organized in a circular pattern where the 
EMC had been cut in transverse section (Fig 4.14 c).  
4.2.6 Human skeletal muscle myoblast (HSMM) behaviour on solubilised 
muscle matrix and collagen I (section 2.7.5.2) 
The ability of a solubilized muscle matrix substrate to support the adhesion and growth 
of HSMMs was compared to a collagen I substrate.  The HSMMs adhered to the muscle 
matrix, spread and expressed desmin after only a day in culture. In contrast, on collagen 
I the HSMMs did not express desmin at this time although a little desmin expression is 
evident at day 4 (Fig 4.15. a, b & c). In addition, the EdU assay indicated that more cells 
were proliferating on the muscle matrix substrate than on collagen I and desmin staining 
was more pronounced in those cells on the muscle matrix than on collagen I (Fig 4.15 b, 
d).  
To determine whether cell density plays a key role in determining the differentiation 
pattern, HSMM cells were cultured at two different cell densities: 6x10
3
 cells/cm
2 
and 
15x10
3
 cells/cm
2
 on collagen I and solubilized muscle matrix coated surfaces for 4 days 
in SkGM-2 proliferation medium and then for further 6 days in differentiation medium. 
Six days after switching to differentiation conditions at the lower seeding density only a  
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Figure 4.13. Proliferation and migration of C2C12 cells on decellularised 
whole muscle ECM. The click-iT EdU assay was performed on C2C12 
myoblasts (5x104 cells/scaffold) cultured for 3 days in serum free proliferation 
medium (a) 3D image of proliferating C2C12 myoblasts; (b) The colour coded 
image shows the distribution and migration of cells into the scaffold after 3 days; 
(c) The EdU assay was performed on cells cultured for 3 days in proliferation 
medium and then followed by 6 days in differentiation medium. scale bar-100 
μm, Nuclei are stained with DAPI (blue) (proliferating cells – green, all cells – 
blue).   
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Figure 4.14. Three-dimensional culture of C2C12 cells on whole muscle 
scaffolds. C2C12 myoblasts (5x104 cells/scaffold) were grown for 14 days on 
decellularised whole muscle scaffolds (1mm2) in serum free proliferation 
medium, stained with either Kwik-Diff or DAPI and imaged using bright field 
microscope (Zeiss-Axiovert). Scale bars 100 μm for (a-c) and 50 μm for (d-e). 
Cells appear purple in colour (a-e). 
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Figure 4.15. Human skeletal muscle myoblasts (HSMM) cell adhesion and 
proliferation on collagen I and muscle matrix.  HSMMs (5x104) were cultured 
for 1 and 4 days in SkGM-2 medium on collagen I (10 µg/cm2) (a-b) and matrix 
(10 µg/cm2) (c-d) respectively, stained for desmin (green) (a, c) and desmin 
(red) + EdU (green) (b, d) and imaged using Zeiss Axioskop fluorescent (a, c) 
and Nikon A1 confocal microscope (b, d). Nuclei are stained with DAPI (blue). 
The antibody recognising desmin was a mouse monoclonal (DE-U-10) antibody. 
The secondary antibody used was a goat anti-mouse alexafluor 488 and 546 
conjugated for (a, c) and (b, d) respectively. Scale bar- 50 μm for a, c and 100 
μm for (b, d). (Proliferating cells – green, white and yellow, all cells – blue, 
desmin-green for a, c and red for b, d).  
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few myotubes expressed myosin on the matrix coated substrate, however, no myosin 
expressing myotubes were visible on collagen I coated surfaces (Fig 4.16 a, c). On the 
contrary, at the higher seeding density several multinucleated parallel myosin expressing 
myotubes were visible on both collagen I and muscle matrix coated surfaces (Fig 4.16. 
b, d). 
4.2.7 HSMM cell adhesion on three dimensional muscle matrix scaffolds 
Decellularized 3D rat matrix scaffolds were also used as substrate to test adhesion, 
spreading and viability of HSMM cells (section 2.7.9). It was found that HSMM cells 
cultured for 2 weeks on decellularised (3D) matrix scaffolds grew along tracts of ECM 
(Fig 4.17 a-b) and Phalloidin staining after 3 days in culture indicated they were well 
spread with elongated F-actin fibres (Fig 4.17 c). Six days after switching to 
differentiation medium, nuclei became elongated and uniformly oriented suggesting 
cells were committed towards a differentiation lineage (Fig 4.17 d).  
4.2.8 Immunostaining for secreted ECM proteins under serum free culture 
(section 2.11.2) 
To determine whether C2C12 cells synthesize and secrete ECM proteins under serum 
free culture conditions, C2C12 cells were grown on etched glass coverslips for 3 days in 
proliferation medium and 6 days in differentiation medium and immunostained using 
antibodies against collagen type I, collagen type IV, fibronectin and perlecan (Fig 4.18). 
Undifferentiated cells secreted large amounts of all four matrix proteins and the staining 
pattern was similar for all four matrix protein antibodies. However, the arrangement of 
the matrix proteins was different in the differentiated myotubes when compared to the 
undifferentiated cell population (Fig 4.18). Collagen type I and IV were found 
distributed around the length of the myotubes while fibronectin appeared in a 
filamentous web-like pattern along the surface of the myotubes. Perlecan was distributed 
along the edges of the myotubes; on some myotubes the staining was quite intense but 
on others the staining appeared weak.      
4.2.9 Immunostaining for Matrix deposition after cell removal (section 
2.11.2) 
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Figure 4.16. Immunostaining for myosin on differentiated HSMMs on 
collagen I and muscle matrix coated surfaces. HSMMs were seeded at two 
different densities, 6x103 cells/cm2 for (a, c) and 15x103 cells/cm2 for (b, d) on 
collagen type I and solubilized muscle matrix and cultured for 4 days in SkGM-2 
proliferation medium. Then the medium was changed to a differentiation medium 
containing 2% HS and cells were cultured for another 6 days. Post-
differentiation, cells were fixed with 4% paraformaldehyde and stained with 
myosin (green) and imaged using Nikon A1 confocal (a, c) and a Zeiss Axioskop 
fluorescent (b, d) microscope. The antibody recognising myosin was a mouse 
monoclonal (NOQ7.5.4D) antibody. The secondary antibody used was a goat 
anti-mouse alexafluor 488 conjugated antibody. Nuclei are stained with DAPI 
(blue). Scale bar- 100 μm for a-d.  
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Figure 4.17. Three-dimensional culture of human skeletal muscle 
myoblasts (HSMMs) on whole muscle scaffolds. HSMMs (5x104 
cells/scaffold) were cultured for 14 days on decellularised whole muscle 
scaffolds in SkGM-2 medium, stained with Kwik Diff and imaged using bright 
field microscopy (a, b). HSMMs were cultured for 3 days in SkGM-2 medium, 
stained with rhodamine phalloidin for F-actin (red) and DAPI (blue), and imaged 
using Nikon A1 confocal microscope (c-d). Scale bar 100 µm a, b and d, 50 µm 
for c.  
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Figure 4. 18. Secretion and orientation of matrix proteins by C2C12 cells 
under serum free conditions on etched glass. C2C12 cells (3.5x103 
cells/cm2) were seeded on etched glass coverslips (13mm2) in the wells of a 12-
well plate and cultured for 3 days in serum free proliferation medium. After 3 
days, the media was changed to a serum free differentiation medium and cells 
were cultured for another 6 days. Coverslips were fixed and stained with 
antibodies recognising Collagen I, Fibronectin, Collagen IV and Perlecan which 
were all rabbit polyclonal antibodies. Secondary antibody was a goat anti-rabbit 
alexafluor 488 conjugated for all primary antibody. Nuclei are stained with DAPI 
(blue). Scale bar-50μm.  
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To determine the pattern of matrix protein deposition on glass surface, C2C12 cells were 
cultured on etched glass coverslips for 3 days in proliferation media and then the cells 
were removed using 20mM NH4OH/0.5% TX-100 in PBS (section 2.11.2) (Figure 4.19). 
No DNA remnants were found on the coverslips as evidenced by the absence of DAPI 
staining. Immunostaining was then performed for the ECM proteins collagen type I, 
collagen type IV, fibronectin and perlecan. Clear staining was observed for all four 
matrix protein antibodies, although the staining intensity was lower when compared to 
that seen when the cells were on the coverslips (compare Fig 4.18 and 4.19). Collagen I 
staining was patchy and it appeared that collagen I was deposited in a straight line 
pattern. Collagen IV, perlecan and fibronection staining patterns were similar with an 
interconnected net like pattern on the surface of the glass (Fig 4.19). 
4.2.10 Immunostaining for secreted ECM proteins on collagen type I and 
solubilised muscle matrix coated etched glass substrates (section 2.11.2) 
To determine whether C2C12 cells synthesize and secrete different amounts of ECM 
proteins on collagen type I and solubilised muscle matrix under serum free culture 
conditions, C2C12 cells were grown on etched glass coverslips for 3 days in 
proliferation medium and immunostained using antibodies against collagen type IV  and  
fibronectin (Fig 4.20). Immunostaining revealed patchy staining for fibronectin and 
collagen type IV on solubilised muscle matrix coated coverslips suggesting presence of 
both these matrix molecules in the matrix extract (Fig 4.20 a, d). C2C12 cells secreted 
similar amounts of fibronectin on both collagen type I and solubilised musscle matrix 
coated substrates as the fibronectin staining intensity appeared similar on both substrates 
(Fig 5.20. b, c). However, collagen type IV staining was stronger when the cells were 
cultured on muscle matrix coated substrates when compared to that seen when the cells 
were cultured on collagen I substrate (Fig 5.20. e, f).  
4.3 Discussion 
This chapter provides a first report where a serum free culture system has been used to 
promote myoblast proliferation and differentiation on solubilized and three-dimensional  
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Figure 4.19. Secretion and deposition of matrix proteins by C2C12 cells 
under serum free conditions on etched glass. C2C12 cells (3.5x103 
cells/cm2) were seeded on etched glass coverslips (13mm2) placed in the wells 
of a 12-well plate and cultured for 3 days in serum free medium. After 3 days, 
the cells were stripped using NH4OH/TX-100 and coverslips were fixed and 
stained with antibodies recognising Collagen I, Fibronectin, Collagen IV and 
Perlecan which were all rabbit polyclonal antibodies. Secondary antibody was a 
goat anti-rabbit alexafluor 488 conjugated antibody. Nuclei are stained with 
DAPI (blue). Scale bar-50μm.  
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Figure 4.20. Secretion of matrix proteins under serum free conditions on 
collagen I and solubilized muscle matrix on etched glass. C2C12 cells 
(3.5x103 cells/cm2) were seeded on etched glass coverslips placed in wells of a 
24-well plate coated with either collagen I (b, e) (10 µg/cm2) or solubilised 
muscle matrix (c, f) (10 µg/cm2), and cultured for 3 days in serum free medium. 
Coverslips were fixed with 4% paraformaldehyde and stained with the antibodies 
against fibronectin (a-c) and Collagen type IV (d-f), both rabbit polyclonal 
antibodies. Secondary antibody used was goat anti-rabbit alexafluor 488 
conjugated for both primary antibodies. Nuclei are stained with DAPI (blue). 
Scale bar-50 μm. Coverslips without cells (a, d), coated with solubilised muscle 
matrix and stained for Collagen type IV and fibronectin were used as positive 
controls.  
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skeletal muscle matrices. In the serum free system C2C12 mouse myoblasts proliferated 
on a muscle matrix substrate prepared from solubilized acellular muscle, but seemed to 
progress towards differentiation at a lower confluency when compared to C2C12 cells 
cultured on collagen I and fibronectin coated surfaces. Gene expression data of a 
selection of genes covering different aspects of the differentiation pathway suggest a 
similar differentiation pattern on muscle matrix and fibronectin and visually the 
alignment of myosin expressing myotubes on muscle matrix and fibronectin are 
comparable. Furthermore, three-dimensional acellular muscle matrix supported cell 
growth and migration and also provided physical and chemical signals for cell 
alignment/orientation, suggesting that in vivo it is the muscle ECM that directs cell 
positioning. The serum free system used here has removed any possibility that soluble 
ECM molecules in the culture medium have affected cell behaviour, or have modulated 
the contribution of the matrix protein substrates to myoblast differentiation.  
A number of transformed cell lines such as mouse C2C12 and rat L6 have been routinely 
used to investigate underlying molecular mechanisms of myoblast fusion and myotube 
formation [275-277]. Furthermore, these cell types have also been useful to screen drugs 
against metabolic syndromes [278] and inflammatory muscle diseases [279]. The 
advantages of using these cell lines over primary muscle myoblasts are their easy 
availability, and ability to grow indefinitely for a longer period of time. In recent years 
two groups have reported the growth and differentiation of C2C12 myoblasts on 
solubilized skeletal muscle ECM [174] [175]. DeQuach et al (2010) used SDS to 
decellularise porcine muscle and demonstrated retention of collagens, fibrinogen, 
fibrillin-1 and -5, the proteoglycans decorin, and HS GAGs [174]. Stern et al (2009) 
used trypsin and Triton X-100 to decellularise quadriceps and hamstring muscle [175]. 
Both studies reported better differentiation as measured by increased myotube size and 
more nuclei per myofibre in cells cultured on substrates of decellularised muscle matrix 
compared to collagen I substrates. However, care must be taken in interpreting these 
studies as both used media supplemented with foetal bovine serum (FBS) for 
proliferation and horse serum (HS) for differentiation. These sera add an ill-defined 
mixture of growth factors and ECM proteins to the medium, therefore assessing the 
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ability of acellular muscle ECM to support myoblast proliferation and differentiation in 
the presence of serum introduces confounding factors.  
In this study, the ability of a skeletal muscle derived ECM to support myoblast growth 
and differentiation was assessed using defined serum free medium in two-dimensional 
and three-dimensional cultures. This enabled the muscle matrix to be compared to 
purified collagen I and fibronectin in the absence of confounding variables. We found 
under our serum free conditions C2C12 myoblasts adhered to, and maintained their 
characteristic stellate shape, on substrates of fibronectin, collagen I and solubilised 
muscle matrix (Fig 4.1). However, C2C12 myoblast proliferation was slower on muscle 
matrix, and plateaued at day 4; whereas proliferation on collagen I and fibronectin 
continued until day 6, such that the number of cells on the pure matrix protein substrates 
was approximately 1.5 times that on muscle matrix (Fig 4.2). It is possible the slower 
growth and earlier plateau in cell number on the muscle matrix substrate was due to 
adult muscle-specific factors in the matrix substrate that directed the cells to 
differentiate, even though the growth factors in the medium were designed to stimulate 
proliferation. Slow proliferation is not necessarily a disadvantage, as it may allow time 
for the cells to become organised and aligned prior to differentiation. The work of 
Ricotti et al (2012) [280] supports this suggestion. They evaluated the proliferation and 
differentiation of two myoblast cell lines on synthetic substrates comprising electrospun 
poly (hydroxybutyrate) (PHB) sub-micron fibers either highly oriented or randomly 
aligned, or films of PHB. They demonstrated that myoblasts proliferated more slowly 
but differentiated to form longer myotubes expressing higher levels of the genes 
characteristic of a differentiated phenotype when grown on PHB aligned nanofibres 
compared to randomly aligned nanofibres or PHB films [280]. 
In our study immunofluorescent analyses revealed MyHCB was expressed in C2C12 
myotubes in serum free media on days 4 and 6, with striations apparent by day 6, 
indicating the formation of sarcomeres (Fig 4.4). Myotubes appeared to thicken from 
day 4 to day 6 on substrates of collagen and muscle-matrix but this was not statistically 
significant (Fig 4.5). Myotubes on collagen I substrate were randomly oriented, whereas 
myotubes at day 6 of differentiation were better aligned with less branching on 
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fibronectin and matrix coated surfaces. The alignment of myotubes is an important pre-
requisite to form a functional muscle. Parallel alignment of myotubes could potentially 
enhance myotube striations and promote better differentiation [281]. Others have 
described C2C12 cells cultured on fibronectin substrates as elongating, aligning and 
fusing earlier than cells cultured on laminin and gelatin (denatured collagen) coated 
substrates [282]. Vaz et al (2012) performed the time-lapse imaging of C2C12 cells 
cultured on fibronectin and gelatin coated surfaces and found that C2C12 cells on 
fibronectin coated surfaces migrated further and with ‘directionality’, whereas cells on 
gelatin moved randomly [282]. It is expected that directional migration will assist cell 
alignment and hence myotube formation.  
Our results were in agreement to the previous studies where C2C12 cells have been 
cultured on muscle matrix coated surfaces [174, 175]. Both studies reported increased 
myotube size and more nuclei per myofibre in cells cultured on decellularised muscle 
matrix compared to collagen I although De Quach et al (2010) reported no difference in 
the number of myotubes on both surfaces [174] while Stern et al (2009) reported fewer 
myotubes on muscle matrix coated surfaces [175]. To form a functional muscle, 
contractility of the myotubes is an essential phenomenon as this is a key function of 
muscle cells in vivo. In our studies, although the myotubes were not electrically 
stimulated to generate active contractile force, they were able to generate unidirectional 
spontaneous contractions, clearly suggesting the functionality of myotubes under serum 
free culture conditions (data not shown). It was difficult to maintain myotubes in culture 
beyond 8 days as myotubes cultured on rigid glass substrates have a greater tendency to 
detach from the surface due to sustained actinomyosin contractions [283].  
A number of genes are involved at different stages of muscle differentiation and we 
chose to investigate a selection of genes that spanned differentiation from myoblasts 
through to myotubes. Myogenic regulatory factors (MRFs) are transcription regulators 
that control the process of muscle differentiation. Myf5 is the first regulatory factor to be 
expressed during mouse embryogenesis and is a marker of committed satellite cells and 
myoblasts, whereas myogenin is more directly involved in the differentiation process 
and triggers the expression of myotube specific genes [197].  Myosin, the muscle 
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contractile protein, consists of four light chains and two heavy chains. Myosin heavy 
chain exists in different isoforms: MYH3 is an embryonic form whereas MYH1 and 
MYH7 are adult isoforms, MYH1 being present in fast-twitch fibres and MYH7 is in 
slow-twitch muscle fibres [284, 285]. Cardiac actin (ACTC1) is expressed during early 
differentiation of skeletal muscle and is then down regulated as skeletal muscle alpha 
actin (ACTA1) is expressed [286]. Muscle alpha actin is the major actin isoform in 
muscle and is classified as a late differentiation marker [284]. 
The myoblast marker, Myf5, was expressed when the gene expression profile of the 
differentiation markers was first assessed at differentiation day 1, as expected (Fig 4.10-
4.12), and showed no change over time in C2C12 myoblasts cultured on collagen I, but 
decreased by day 8 in myoblasts cultured on muscle-matrix and fibronectin. This is 
consistent with Brown et al (2012) who found that Myf5 decreased in C2C12 cells as 
differentiation proceeded [287]. These authors also found MYOG levels increased when 
C2C12 cells were placed in differentiating conditions, but decreased as the cells became 
well differentiated, which is similar to our findings of MYOG expression levels in 
C2C12 cells on collagen and fibronectin (Fig 4.10 and 4.11). Wilschut et al (2010) 
measured the mRNA levels of Myf5 and MYOG genes of primary porcine muscle stem 
cells cultured on different ECM substrates: collagen I, laminin, fibronectin, gelatin and 
Matrigel [288]. They found the expression of Myf5 decreased with cell differentiation 
regardless of substrate; in contrast the pattern of MYOG expression in cells on Matrigel 
differed markedly. On Matrigel, MYOG expression increased in a time dependent 
manner being significantly higher than that measured from cells cultured on the other 
substrates at day 5 of differentiation [288]. It is not possible to equate C2C12 cells with 
primary porcine muscle stem cells in terms of their differentiation, but notably on 
muscle matrix substrates we similarly found MYOG expression levels to be increasing as 
differentiation progressed (Fig 4.12). Like our solubilised acellular muscle matrix, 
Matrigel is a complex mixture of ECM proteins obtained from basement membrane 
extracts of the murine EHS tumor [289]. Stern et al (2009) measured the expression 
levels of myogenin protein and found the protein levels to be higher in C2C12 cells 
cultured on skeletal muscle matrix coated surfaces than on uncoated surfaces and this 
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increased from day 1 to day 3 of differentiation [175]. It is interesting that MYOG null 
(MYOG
-/-
) myoblasts that cannot differentiate in vivo form myotubes as efficiently as 
wild-type myoblasts when in tissue culture on a gelatin substrate [290]. These data 
suggest in vitro the requirements for myogenin are not as stringent as they are in vivo, 
and possibly factors in complex matrices act to maintain expression of this protein 
further into the differentiation pathway than is usually seen in vitro.  
The mRNA levels for other early differentiation markers, MYH3 and ACTC1, was found 
to have increased at day 4 of differentiation on all three surfaces, but decreased by day 8 
and the drop in expression was more pronounced on muscle matrix and fibronectin 
substrates than on collagen I substrates (Fig 4.10-4.12). It is thought that Myf5 initiates 
the expression of MYH3 and MyoD enhances MYH3 expression. MyoD is expressed 
slightly later than Myf5, appearing in myoblasts and myocytes but decreasing markedly 
in myotubes [197]. It therefore might be expected that the decrease in Myf5 expression is 
followed a day or two later by a corresponding decrease in MYH3 expression and this is 
what was observed by Brown et al. (2012) in their study with C2C12 cells [287]. The 
time points of our study do not allow such a detailed interpretation, but our data with 
cells grown on fibronectin and muscle matrix are consistent with that earlier report 
[287]. Interestingly, an early peak in MYH3 expression followed by only a slight decline 
was also observed in human muscle myoblasts cultured on gelatin substrates [284], 
which is consistent with our data for cells on collagen I. The decrease in ACTC1 
expression levels by day 8 on all three surfaces is probably associated with an increased 
expression of other actin isoforms, a conclusion that is supported by the expression 
pattern observed for ACTA1 on all substrates (Fig 4.10-4.12).  
Expression of myosin (MYH1) and (MYH7) and skeletal muscle actin (ACTA1) increased 
in a time dependent manner suggesting the maturation of myotubes, but the increase in 
MYH1 expression at day 4 was higher on muscle matrix than on collagen I or fibronectin 
which suggests that myotubes on muscle matrix are transiting faster towards a more 
differentiated phenotype. Thus, like Brown et al (2012) concluded from their study of 
the expression patterns of 6 myosin heavy chain isoforms during C2C12 cell 
differentiation [287]; our data also shows a temporal pattern of expression. The 
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expression levels of MYH3 and ACTC1 peak early and then decline whereas MYH1, 
MYH7 and ACTA1 are expressed either at increasing levels at day 8 or at the same level 
as day 4. A difference between our data and their study was in the expression levels of 
MYH7; they observed similar declines in MYH7 and MYH3 expression over the same 
time frame, and hence grouped MYH7 with the “early” expressing isoforms [287]. From 
our data grouping MYH7 with adult isoforms is appropriate and this is a better fit with 
the known in vivo expression patterns of these myosin heavy chain genes. It is possible 
that culturing C2C12 cells on matrix proteins directs gene expression to fit more closely 
with what occurs in vivo.  
Solubilization of an ECM destroys the positional information provided to cells by the 
location of molecules in an intact matrix, and may also disrupt protein-protein 
interactions which influence protein conformation. To examine how an intact muscle 
matrix affects C2C12 and HSMM cell proliferation and differentiation, we seeded 
acellular matrices with well-preserved 3D structure with C2C12 cells and HSMMs in 
serum-free medium (Fig 4.13-4.14 and 4.17). Interestingly, the C2C12 myoblasts lined 
up longitudinally, or organised into circular patterns, depending on the alignment of the 
endomysial matrix “tubes” that in vivo surround the muscle fibres. Thus, particular 
matrix proteins were providing cues to direct myoblast adhesion and spreading in 
specific locations on the acellular matrices (Fig 4.14). Similarly, HSMMs were also well 
spread with elongated actin fibres (Fig 4.17). A recent study described the lack of full 
functional recovery of volumetric muscle injuries in rats treated with muscle autografts 
and it was suggested this may have been because no attention was paid to the alignment 
of the grafts in accordance with the muscle fibres in the injury bed [291]. Our data 
indicates that myoblasts are directed by matrix signals to align in certain ways and if 
autografts are incorrectly orientated then cell positioning on these grafts will also be 
incorrect for the regeneration of a contracting muscle. Others have used acellular muscle 
matrix as grafts and describe the population of these matrices by host cells that are 
induced to differentiate into multinucleated myofibres [292]. In a similar study both 
blood vessels and myofibres were seen to penetrate further into the acellular scaffold as 
time progressed, but full function was not achieved 42 days post grafting [25]. We also 
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saw myoblast migration into the acellular matrices in our ex vivo cultures as well as 
evidence of differentiation. All these studies illustrate the importance of the ECM in 
directing myogenesis.   
The significance of cell-matrix interactions in the formation of functional muscle tissue 
is also illustrated by the work of Hinds and colleagues (2011) [218]. Engineered muscle 
bundles were cultured on Matrigel substrates of varying concentrations of matrigel 
(10%, 20%, 30% and 40%) and two matrix proteins: collagen I and fibrinogen. They 
studied several parameters for muscle contractility including contractile force 
measurements and kinetics. Results showed a maximum force generation using 
fibrinogen and 40% matrigel combination. Further, they also measured the tetanic force 
of the engineered muscle bundles cultured on: (a) standard Matrigel and (b) growth 
factor reduced (GFR) Matrigel containing reduced levels of IGF-1, PDGF and TGF-β 
and found that there were no significant differences in the tetanic force kinetics. The 
authors proposed that enhanced force generation was a result of myotube-matrix 
interactions, possibly by the myotubes binding to laminin (a major component of 
Matrigel) via α7 integrin [218]. Although measurement of the mechanical properties of 
the acellular matrix was beyond the scope of our study but considering that laminin α2 
chain was preserved in the matrix and cells adhered and proliferated on the 3D matrix, it 
is possible that the decellularised muscle tissue prepared by our method would assist in 
the formation of functional muscle if tested in vivo.  
Due to the inherited genetic anomalies in transformed cell types like C2C12, it is 
important to use primary muscle cells to provide a more relevant system. Although, 
primary cells grow more slowly than a cell line and can be maintained in culture for a 
limited number of passages, they are very relevant for translating basic research to a 
clinical setting. Hence, HSMMs were also used for functional characterisation of the 
matrix. Interestingly, HSMMs showed a slight increase in proliferation when cultured on 
muscle matrix coated surfaces (Fig 4.15). These cells more readily formed myotubes 
when they were seeded at high density (Fig 4.16). At low cell density (6x10
3
 cells/cm
2
) 
myotubes were only formed on muscle matrix coated surfaces, however  at higher cell 
densities (15x10
3
 cells/cm
2
) similar no of myotubes were formed on both surfaces. Cell 
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density plays a key role in regulating skeletal muscle myogenesis as has been reported 
by previous studies [293, 294]. Kaspar et al (2005) showed that C2C12 cells when 
seeded at a density of 2.5 x 10
4
 cells/cm
2
, expressed myogenin and α-skeletal actin at 
significantly higher levels than cells seeded at 0.3 x 10
4
 cells/cm
2 
[293]. Lindon et al 
(2001) investigated the induction of myogenin gene expression at high (4 x 10
4
 
cells/cm
2
) and low cell densities (0.4 x 10
4
 cells/cm
2
) and demonstrated that induction of 
myogenin was inhibited by Myf5 at a lower cell density [294].  
Our serum free medium supported excellent C2C12 cell growth and C2C12 cells were 
found to secrete major ECM proteins (Fig 4.18-4.19). Secreted ECM proteins play an 
important role in muscle differentiation as shown by Chan et al (2007) [295]. They 
conducted a proteomic study on C2C12 cells cultured in a serum free medium to 
elucidate the proteins secreted during myogenic differentiation. In total, 80 non-
redundant proteins were identified, out of which 27 were secreted proteins. The majority 
of the secreted proteins were ECM proteins and proteoglycans including fibronectin, 
pro-collagen isoforms, biglycan, heparan sulphate and various matrix metalloproteinases 
(MMPs) [295]. We obtained similar results: immunocytochemical analyses revealed the 
secretion of collagen type I, collagen type IV, fibronectin and perlecan after three days 
in serum free medium. A decrease in immunostaining was observed for all the ECM 
proteins tested including collagens type I and IV, as the myoblasts differentiated. This 
observation is in agreement with a previous study by Kuhl et al (1982) which showed 
that myoblasts have a tendency to produce more collagen than myotubes [296]. The 
downregulation of perlecan during muscle differentiation has also been reported [297]. 
Immunostaining showed that C2C12 cells cultured on solubilized muscle matrix and 
collagen I coated substrates secreted two major basement membrane proteins: collagen 
type IV and fibronectin (Fig 4.20). An increase in collagen type IV staining intensity 
was observed when cells were cultured on solubilized muscle matrix coated substrates, 
compared to those on collagen I, suggesting more deposition of this protein on matrix 
coated substrates.  
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4.4 Conclusion  
In summary, our results demonstrated the acellular skeletal muscle matrix (prepared in 
chapter 3) supported proliferation and differentiation of C2C12 murine myoblasts in a 
serum free culture system both in 2D and 3D in vitro cultures.  
4.5 Future directions 
The primary function of a muscle is to generate active force and thus it would be useful 
to investigate the active tension generating ability of myotubes formed in this study. 
Another useful experiment to perform would be to measure the glucose and lactate 
concentrations in the media to assess the metabolic activity of the cells under serum-free 
culture conditions.  
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Chapter 5:  
Silk fibroin as a potential biomaterial for human skeletal muscle 
myoblast differentiation
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5.1 Introduction  
Artificial ECMs or scaffolds used in tissue engineering frequently contain structural 
ECM proteins like collagen, fibronectin, elastin, fibrin, and laminin [124] and some 
scaffolds are comprised entirely of one or more of these ECM proteins. These natural 
scaffolds have advantages over their synthetic counterparts in that their physiological 
activities, mechanical properties and biodegradability are similar to natural tissues. 
However, sourcing these proteins from animal tissues is a major disadvantage if the 
scaffold is to be used clinically. Silk, a natural biopolymer has emerged as an alternative 
biomaterial.  
In recent years silk, usually obtained from the larvae of various Lepidoptera species, has 
been used as a potential biomaterial for myoblast growth and differentiation in vitro. In 
one study, silk fibroin was combined with tropoelastin to provide an insoluble 
biocomposite material with tunable elastic and mechanical properties [298]. The 
researchers tested the ability of these hybrid materials to support cell growth and 
differentiation by C2C12 and human mesenchymal stem cell cultures on different silk-
tropoelastin composites varying in their protein content. Their findings showed that 
C2C12 cells proliferated and differentiated much better on substrates having high 
stiffness and low surface roughness [298]. On the other hand, human mesenchymal stem 
cells preferred substrates having high surface roughness, high tropoelastin content and 
more pronounced nano-topographical features [298]. In another study, silk fibroin was 
blended with polyurethane (PU) in different ratios to make composite films of different 
tensile strength and mechanical properties. Biocompatibility of the silk fibroin/PU films 
was tested by C2C12 cell culture and cell adhesion, proliferation and differentiation was 
examined on these films [299]. As the silk fibroin content increased, the stiffness of the 
films also increased. The films with the highest silk fibroin content supported better 
adhesion and myogenic differentiation, which was marked by upregulation of the muscle 
marker genes: sarcomeric actin and α-actin. Micropatterned spider-silk derived films 
have also been found to support myoblast adhesion and orientation on structured films 
[300]. Shen et al (2013) prepared PU scaffold with microchannel patterns and coated it 
with either silk fibroin or gelatin to give PU/silk fibroin or PU/Gel microchannel films 
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[281]. Silk fibroin or gelatin coating improved the hydrophilicity of the PU films. 
Myoblasts seeded on PU/Silk fibroin proliferated at a higher rate and showed better 
differentiation when compared to myoblasts on the PU/Gel films [281]. When 0.1% 
sericin, the protein coating the silk fibroin was used as a supplement in a serum free 
medium to assess muscle cell differentiation, sericin supported less myotube 
differentiation than cultures in foetal bovine serum with sparsely distributed sarcomeric 
structures within the myotubes [268]. Silk sutures have also been utilized as support 
structures on laminin coated polydimethylsiloxane substrates to obtain cylindrical 
muscle-like constructs called “myooids”. These myooids expressed muscle specific 
proteins, generated active tension upon electric pulse stimulation and possessed a 
sarcomeric structure [269].  
Most of the studies conducted to date evaluating silk biomaterials for their ability to 
support myogenesis have been done on silk fibroin obtained from Bombyx mori. Not 
much research has been carried out on silk scaffolds obtained from Antherea mylitta 
Samia ricini and Antherea assamensis, other species of silkworm. It is only recently that 
silk fibroin scaffolds derived from other families of silkworm, for example the 
Saturniidae family (which includes A. mylitta, S. ricini and A. assamensis) are gaining 
attention as an alternative silk biomaterial [138]. Pal et al (2013) prepared silk fibroin 
2D films and 3D scaffolds from S. ricini [138]. They investigated the molecular 
composition of the fibroin, its thermal properties and did biochemical characterizations 
of the scaffolds. SDS-PAGE analysis revealed that silk fibroin from S. ricini is a 
heterodimer of 245 kDa and 205 kDa subunits. The scaffolds showed good thermal 
stability, “swellability” and were found to be compatible when fibroblasts and human 
osteoblast like cells were cultured on these scaffolds [138]. Kar et al (2013) solubilised 
silk fibroin from the gland of A. assamensis and evaluated its biochemical and 
biophysical characteristics [140]. Their results showed that fibroin protein from A. 
assamensis consisted of two polypeptides of 250kDa each linked by disulphide bond. 
The dissolved fibroin solution attained a random coil structure as revealed by the fourier 
transform infrared spectroscopy and X-ray diffraction studies [140]. They also tested the 
cytocompatibility of the 2D matrices by growing MG-63 human osteoblast like cells on 
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these matrices and obtained favourable outcomes [140]. 
 
Figure 5.1. Schematic representation of silk protein fibroin isolation from 
mulberry and different non-mulberry species and preparation of 3D fibroin 
scaffolds.  
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Fibroin cryogels from A. assamensis have also been tested as a potential biomaterial for 
liver tissue engineering [147]. Patra et al (2012) investigated the potential of fibroin silk 
scaffold obtained from A. mylitta for preparation of a cardiac patch in vitro using 
neonatal rat cardiomyocytes [141]. Their results indicated that cardiomyocytes attach 
and spread much faster on A. mylitta silk than B. mori silk. Furthermore, cells cultured 
on 3D A. mylitta scaffolds expressed connexin 43, exhibited well-organized and aligned 
sarcomeres and were able to induce spontaneous contractions which lasted for about 20 
days in culture [141].  
These examples illustrate the usefulness of silk for supporting myoblast growth and 
differentiation, but no comparative study has been conducted of silk fibroin scaffolds, 
where the silk has been derived from different insect species (Figure 5.1). This chapter 
describes the use of four different scaffolds of silk fibroin from the mulberry, Bombyx 
mori, and non-mulberry varieties Antheraea mylitta, Antheraea assamensis/assama and 
Philosamia/Samia ricini to investigate the attachment, growth, proliferation and 
differentiation of muscle cells (from both mouse and human) in 2D and 3D cultures.  
5.2 Results 
5.2.1 Solubilisation of silk fibroin (section 2.9.2) 
Briefly, silk fibroin scaffolds were solubilised in PBS for 30 min at 42ºC to give a 
fibroin solution, which was clarified by centrifugation and the protein concentration of 
supernatants was measured using a BCA assay (section 2.3.2.1). The scaffolds used for 
solubilisation were 6 mm in diameter and 3 mm in height. Table 5.1 shows the amount 
of protein solubilised and the % recovery of solubilised silk fibroin protein/scaffold for 
each type of silk.  
A. assamensis silk gave the maximum amount of solubilised silk fibroin protein with a 
yield of 2.83 mg which equated to a 72.56 % recovery of the protein in solution. B. mori 
silk was also found to be readily soluble in PBS giving a % recovery of 64.42. A. mylitta 
and S. ricini silk scaffolds were found to be the least soluble with % recoveries of 26.9 
and 7.5 respectively. All the solubilised proteins were stored at 4ºC until further use.  
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Interestingly, after 4 days of storage at 4 ºC, B. mori silk fibroin at 6 mg/ml formed a 
gel.      
              Table 5.1 Solubilised silk fibroin yield from all four silk scaffolds 
 
 
 
 
 
 
5.2.2 Cyto-compatibility of different silk fibroins in serum-free culture 
conditions 
To assess the ability of solubilised silk proteins to support cell adhesion and cell growth 
in serum free culture, the murine myoblast cells, C2C12 were cultured on silk fibroin 
coated plastic dishes in serum free medium for 4 days (Fig. 5.2). Cells maintained their 
spindle-shaped morphology, adhered to and proliferated well on all 4 silk substrates and 
by day 4 the cells became confluent on B. mori, A. mylitta and S. ricini, however on A. 
assamensis the cells did not achieve confluency (Fig 5.2). The staining of these cultures 
with rhodamine phalloidin indicated that F-actin containing stress fibres were oriented in 
parallel suggesting aligned, elongated cells. This was particularly the case for cells on B. 
mori and A. mylitta substrates but less so for cells on A. assamensis substrates. On 
uncoated plastic dishes cells appear rounded in morphology and clustered together 
(chapter 4, Fig 4.1). The relative number of metabolically active C2C12 cells on these 
silk protein substrates over a 3-day period was determined by an alamar blue assay 
(section 2.10.2) (Fig 5.3). At day 1 and 2 after seeding, there was no significant 
difference in the cell numbers on the different silk substrates or on substrates of the two  
Type of silk and starting 
dry weight/ scaffold  
before solubilisation (mg) 
Absorbance 
at 560 nm 
Concentration 
(mg/ml) 
Total yield of 
solubilised fibroin 
protein/scaffold 
(mg) 
% 
recovery 
Bm (5.2) 0.533 6.7 3.35 64.42 
Am (2.7) 0.117 1.45 0.725 26.85 
Aa (3.9) 0.452 5.76 2.83 72.56 
Sr (2.3) 0.030 0.35 0.175 7.6  
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Figure 5.2. Solubilised silk fibroin as a substrate supported C2C12 
proliferation under serum free conditions. C2C12 cells (3.5x103 cells/cm2) 
were seeded in wells of a 24-well plate coated with silk fibroin (10 µg/cm2) and 
cultured for 4 days in serum free medium. Phase contrast images of proliferating 
C2C12 cells cultured on Bm (a-b), Am (d-e), Aa (g-h) and Sr (j-k) were captured 
at day 2 and 4 after seeding with a Zeiss Axiovert bright field microscope at a 
magnification of 120x using Spot Advanced software. F-actin at day 4 was 
visualized using rhodamine phalloidin. Images were taken using a Zeiss 
Axioskop fluorescent microscope. Nuclei are stained with DAPI (blue). Scale 
bars - 100 μm for a-l. Am: A. mylitta; Bm: B.mori; Aa: A.assamensis; Sr: S.ricini 
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Figure 5.3. Solubilised silk fibroin as a substrate supported C2C12 
proliferation under serum free conditions. C2C12 cells (3.5x103 cells/cm2) 
were seeded in wells of a 24-well plate coated with silk fibroin (10 µg/cm2) and 
cultured for 3 days in serum free medium. The cell metabolic activities of C2C12 
cells on four different silk fibroins, two ECM proteins and tissue culture plastic in 
SkGM-2 medium are assessed using the Alamar Blue assay. At the indicated 
times Alamar Blue dye is added and absorbance measured. The relative 
fluorescence units are plotted as a measure of cell metabolic activity. The data 
are mean ± SD (n=4). * p≤0.05.Am: A. mylitta; Bm: B. mori; Aa: A. assamensis; 
Sr: S. ricini; Col I: collagen I; Fibro: Fibronectin 
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ECM proteins: collagen I and fibronectin, compared to the cell numbers on uncoated 
plastic. However, at day 3 the number of metabolically active cells was significantly 
higher on all substrates except on A. assamensis substrates, when compared to that on 
uncoated plastic. No significant differences in relative cell numbers were found among 
the 4 silk substrates, but there was a difference in the number of cells on collagen I 
where relative cell number was significantly higher than A. assamensis (Fig 5.3).  
5.2.3 C2C12 myoblasts fuse to form multinucleated myotubes on all 4 silk 
substrates  
To examine the effect of solubilised silk fibroin on the differentiation of C2C12 
myoblasts, cells were cultured on B. mori, A. mylitta, A. assamensis and S. ricini silk 
fibroin coated etched glass surfaces for 12 days. They were cultured in serum free 
proliferation medium (section 2.7.5.3) until almost confluent (90% confluency) 
(proliferation day 4), and then switched into serum-free differentiation medium (section 
2.7.3) for the remaining 8 days (differentiation day 8). Phase contrast microscopy of the 
cells after 4 days in differentiation medium clearly showed fusion of myoblasts into 
myotubes with a similar capacity on all four silk substrates (Figure 5.4. a-h). 
Immunostaining with a mAb to myosin heavy chain 7 (MyHCB) (section 2.7.12) 
revealed that the myoblasts differentiated and fused to form myotubes on all the silk 
fibroin substrates with similar capacity (Figure 5.5). Immunostaining with an antibody 
against fibronectin, revealed deposition of fibronectin on the glass surface and on the 
edges of, and around, some myotubes. DAPI staining indicated the majority of the nuclei 
were inside the myosin expressing myotubes, but a small proportion of nuclei were not 
within the myotubes indicating some cells remained unfused. To determine the number 
of cells proliferating 4 days after switching the medium to a differentiation medium, an 
EdU assay (section 2.7.11) was performed. The EdU staining nuclei, which indicated 
these cells were proliferating were ≤ 5.0% of the total number of cells on all 4 
solubilised silk proteins suggesting the majority of cells were committed to 
differentiation (Table 5.2). The EdU experiment was performed twice and the results 
shown in Table 5.2 are from one of those experiments.   
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Figure 5.4 Phase contrast images of C2C12 cells cultured on silk fibroins 
in serum free differentiation medium. C2C12 cells (3.5x103 cells/cm2) were 
seeded in wells of a 24-well plate coated with the indicated silk fibroins (10 
µg/cm2) and cultured for 4 days in serum free proliferation medium. After 4 days, 
the medium was changed to a differentiation medium and the cells were cultured 
for another 7 days. Images were captured at day 4 and 7 of differentiation with a 
Zeiss Axiovert bright field microscope at a magnification of 120x using Spot 
Advanced software. Scale bars - 100 μm. Am: A. mylitta; Bm: B.mori; Aa: 
A.assamensis; Sr: S.ricini 
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Figure 5.5. Immunofluorescence images showed differentiation of C2C12 cells 
cultured on silk fibroin substrates in serum free differentiation medium. C2C12 cells 
(3.5x10
3 
cells/cm
2
) were seeded in wells of a 24-well plate coated with indicated silk fibroins 
(10 µg/cm
2
) and cultured for 4 days in serum free proliferation medium. After 4 days, the 
medium was changed to a differentiation medium and the cells were cultured for another 7 
days. Post-differentiation, cells were fixed with 4% paraformaldehyde and stained with 
myosin (green) and fibronectin (red) imaged using a Zeiss Axioskop fluorescent microscope 
at a magnification of 480x using Spot Advanced software.The antibody recognising myosin 
and fibronectin were respectively mouse mAB (NOQ7.5.4D) and rabbit polyclonal antibody. 
The secondary antibodies used were a goat anti-mouse alexafluor 488 conjugated antibody 
and a goat anti-rabbit alexafluor 546 conjugated antibody. Scale bars - 50 μm for a-h. Am: 
A. mylitta; Bm: B.mori; Aa: A.assamensis; Sr: S.ricini 
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Table 5.2 EdU assay to assess the number of proliferating cells in C2C12 cell 
Type of silk B. 
mori 
A. 
mylitta 
A. 
assamensis 
S. 
ricini 
% of proliferating cells 3.0  3.2 3.3 5.0 
 
5.2.4 Secretion of matrix proteins in 2D serum free cultures (section 2.11.2) 
To determine whether C2C12 cells synthesize and secrete ECM proteins under serum 
free culture conditions, C2C12 cells were grown on etched glass coverslips coated with 
solubilised silk fibroin from B. mori, A. mylitta, A. assamensis or S. ricini for 3 days in 
proliferation medium. Immunostaining was performed using antibodies against 
collagens type I, type IV, type VI, fibronectin and perlecan (Fig 5.6-5.9). Although 
immunostaining revealed all of these molecules were expressed, the different silk 
fibroins appeared to trigger different levels of expression of these ECM molecules. A 
stronger staining was observed for collagen type I on B. mori and A. mylitta silk fibroin 
when compared to A. assamensis and S. ricini. A similar staining intensity was observed 
for the collagen type IV antibody on all 4 silk fibroin substrates. Collagen type VI 
staining intensity appeared to be the strongest on B. mori silk fibroin, followed by S. 
ricini and similar staining intensities were observed on A. mylitta and A. assamensis silk 
fibroin. The matrix glycoprotein, fibronectin was almost equally expressed on B. mori, 
A. mylitta and S. ricini silk fibroin substrates with similar staining intensities, while on 
A. assamensis there were low levels of staining with the anti-fibronectin antibody. 
Perlecan staining intensity was the strongest of all five matrix proteins on A. assamensis 
and B. mori silk fibroin substrates where it appeared to be staining a filamentous web 
like lattice. Although the staining pattern was similar on A. mylitta and S. ricini silk 
fibroins, the intensity of staining was lower on these two substrates (Fig 5.6-5.9).   
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Figure 5.6. Immunofluorescence revealed secretion of ECM proteins by 
C2C12 cells on B. mori silk fibroin in serum free medium. C2C12 cells 
(3.5x103/cm2) were seeded in wells of a 24-well plate coated with B. mori silk 
fibroin (10µg/cm2) and cultured for 3 days in serum free medium. Cells were 
fixed using 4% paraformaldehyde and stained for antibodies recognising 
collagens type I, type IV, type VI, perlecan and fibronectin (all rabbit polyclonal 
antibodies) and imaged using Nikon A1 confocal microscope. The secondary 
antibody used was a goat anti-rabbit alexafluor 488 conjugated antibody. Nuclei 
are stained with DAPI (blue). Scale bars- 50 μm.      
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Figure 5.7. Immunofluorescence revealed secretion of ECM proteins by 
C2C12 cells on A. mylitta silk fibroin in serum free medium. C2C12 cells 
(3.5x103/cm2) were seeded in wells of a 24-well plate coated with A. mylitta silk 
fibroin (10µg/cm2) and cultured for 3 days in serum free medium. Cells were 
fixed using 4% paraformaldehyde and stained for antibodies recognising 
collagens type I, type IV, type VI, perlecan and fibronectin (all rabbit polyclonal 
antibodies) and imaged using Nikon A1 confocal microscope. The secondary 
antibody used was a goat anti-rabbit alexafluor 488 conjugated antibody. Nuclei 
are stained with DAPI (blue). Scale bars- 50 μm.      
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Figure 5.8. Immunofluorescence revealed secretion of ECM proteins by 
C2C12 cells on A. assamensis silk fibroin in serum free medium. C2C12 
cells (3.5x103/cm2) were seeded in wells of a 24-well plate coated with A. 
assamensis silk fibroin (10µg/cm2) and cultured for 3 days in serum free 
medium. Cells were fixed using 4% paraformaldehyde and stained for antibodies 
recognising collagens type I, type IV, type VI, perlecan and fibronectin (all rabbit 
polyclonal antibodies) and imaged using Nikon A1 confocal microscope. The 
secondary antibody used was a goat anti-rabbit alexafluor 488 conjugated 
antibody. Nuclei are stained with DAPI (blue). Scale bars- 50 μm.      
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Figure 5.9. Immunofluorescence revealed secretion of ECM proteins by 
C2C12 cells on S. ricini silk fibroin in serum free medium. C2C12 cells 
(3.5x103/cm2) were seeded in wells of a 24-well plate coated with S. ricini silk 
fibroin (10µg/cm2) and cultured for 3 days in serum free medium. Cells were 
fixed using 4% paraformaldehyde and stained for antibodies recognising 
collagens type I, type IV, type VI, perlecan and fibronectin (all rabbit polyclonal 
antibodies) and imaged using Nikon A1 confocal microscope. The secondary 
antibody used was a goat anti-rabbit alexafluor 488 conjugated antibody. Nuclei 
are stained with DAPI (blue). Scale bars- 50 μm.      
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5.2.5 Proliferation of Human skeletal muscle myoblasts (HSMMs) on 2D silk 
fibroin substrates (section 2.7.5.2) 
As a first step in assessing which, if any, of these silk fibroin substrates could be useful 
for human muscle repair their compatibility with primary human myoblasts was 
examined. To assess the ability of solubilised silk proteins to support cell adhesion and 
growth of HSMMs, cells were cultured for 11 days in SkGM-2 proliferation medium on 
each of the four silk substrates or on either of two ECM coating proteins, collagen I and 
fibronectin, or on tissue culture plastic (TCP) and relative cell number was measured 
using the alamarBlue assay (section 2.10.2) (Fig 5.10). HSMMs cultures on all silk 
fibroin and matrix protein substrates exhibited similar metabolic activity at all 
investigated time points up to 8 days of culture, hence no significant differences were 
observed in the relative cell numbers on all substrates when compared to TCP. However, 
at day 11 in culture the metabolic activity of HSMMs cultured on A. mylitta silk fibroin 
was significantly higher than that of all other substrates. 
5.2.6 Differentiation of HSMMs on 2D silk fibroin substrates  
To examine the effects of silk proteins on differentiation of HSMMs, cells were cultured 
at a higher cell number (15x10
3
 cells/cm
2
) on each of the four silk substrates coated onto 
etched glass, or either: collagen I or fibronectin. They were cultured in SkGM-2 
proliferation medium until proliferation day 3 when they were almost confluent (90%-
100% confluency), and then switched into differentiation medium containing 
DMEM/F12/2% HS for the remaining 10 days (differentiation day 10). Immunostaining 
with a mAb to myosin heavy chain 7 (MyHCB) (section 2.7.12) revealed that myotubes 
were organized and parallel to each other on all substrates at day 7 of differentiation. 
The data for the silk substrates are shown in Fig 5.11. DAPI staining showed the 
clustering of nuclei within the myotubes (>2 nuclei close to each other) and nuclei were 
elongated. Striations were first visible in the myotubes by day 7 and by day 10 striations 
were evident in myotubes on all silk substrates. Antibody staining patterns of GLUT 4 (a 
marker for functional myotubes) revealed that GLUT 4 was present along the entire  
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Figure 5.10. Proliferation of human skeletal muscle myoblasts (HSMMs) on 
four silk fibroins, two ECM protein substrates and tissue culture plastic in 
SkGM-2 medium assessed using alamar Blue dye assay over a 11 day 
period. HSMMs (103/cm2) were seeded to the wells of a 48-well plate coated 
with either Bm (10 µg/cm2), Am (10 µg/cm2), Aa (10 µg/cm2), Sr (10 µg/cm2), 
collagen I (10 µg/cm2), fibronectin (10 µg/cm2) or uncoated plastic and cultured 
for 11 days in SkGM-2 medium. After the respective time points alamar Blue dye 
was added to the wells and absorbance measured at 600nm. Relative 
fluorescence units were plotted as a measure of cell proliferation. Data 
represented as mean ± SD (n=4). One-way ANOVA was performed and 
significance (p) values shown at each time point. p*<0.05. Am: A. mylitta; Bm: 
B.mori; Aa: A.assamensis; Sr: S.ricini 
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Figure 5.11. Immunofluorescence images show differentiation of HSMMs 
cultured on silk fibroin substrates in DMEM/F12/2%HS differentiation 
medium. HSMMs (15x103/cm2) were seeded in wells of a 24 well plate coated 
with indicated silk fibroins (10 µg/cm2) and cultured for 4 days in SkGM-2 
proliferation medium. After 4 days, the medium was changed to a differentiation 
medium and the cells were cultured for another 10 days. Post-differentiation, 
cells were fixed with 4% paraformaldehyde and stained with anti-myosin (green) 
and anti-GLUT4 (red) antibodies and imaged using a Zeiss Axioskop fluorescent 
microscope. The antibodies recognising myosin and GLUT4 were respectively a 
mouse mAb (NOQ7.5.4D) and a rabbit polyclonal antibody. The secondary 
antibodies used were a goat anti-mouse alexafluor 488 conjugated antibody and 
a goat anti-rabbit alexafluor 546 conjugated antibody. Nuclei are stained with 
DAPI (blue). Scale bars-50 μm for a-d and 25 μm for e-h. Am: A. mylitta; Bm: 
B.mori; Aa: A.assamensis; Sr: S.ricini 
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length of the myotube although perinuclear accumulation was also noted on all silk 
substrates (Fig 5.11 e-h).  
To quantify the differentiation of myotubes, fusion indices were calculated from the 
immunofluorescent images of MyHCB positive myotubes by calculating the number of 
nuclei within the myotubes (only regions with ≥ 2 nuclei were considered) relative to the 
total number of nuclei within a field of view (Figure 5.12. A). The results show that the 
percentage of nuclei within myotubes was similar (ranging from 77%-81%) on collagen 
I, fibronectin, B. mori, A. mylitta, and S. ricini with no significant differences observed 
between them. However, on A. assamensis, the percentage of nuclei within myotubes 
was significantly lower than that of HSMMs on other substrates being around 57% of all 
nuclei. The number of myotubes formed per field of view was also counted and this was 
similar on collagen I, fibronectin, B. mori, A. mylitta, and S. ricini with no significant 
differences observed (Figure 5.12 B). On A. assamensis silk fibroin, the number of 
myotubes formed was significantly lower than all other substrates. 
5.2.7 HSMM cell adhesion and spreading on four silk 3D scaffolds (section 
2.13.1) 
Three dimensional, porous silk scaffolds were also tested; these scaffolds were 14 mm in 
diameter and 4 mm in height. To determine, HSMM cell spreading on 3D silk scaffolds, 
HSMMs at 7.5x10
4
 cells were cultured for 2 days on B. mori, A. mylitta, A. assamensis 
or S. ricini silk scaffolds in SkGM-2 proliferation medium and stained with Rhodamine 
phalloidin to detect F-actin (Fig 5.13). Confocal imaging was performed to visualize 
stress fibre arrangement.  
Cells appeared well spread on all four silk scaffolds with distinct actin fibres and a 
similar actin fibre arrangement on A. mylitta, A. assamensis and S. ricini scaffolds. Here 
the cells appeared to be oriented around the scaffold pores (Fig 5.13 d, f and h), but 
HSMMs on B. mori scaffolds showed a different F-actin arrangement with fibres 
oriented in parallel along the pores and in places crossing over the pores of the scaffold 
(Fig 5.13 b). The images in Figure 5.13 are merged from several z-stack images (5 µm 
each stack, 150-200 µm into the scaffold) and are representative of six fields of view  
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Figure 5. 12 Fusion index and myotube numbers for HSMMs on substrates 
of silk fibroin proteins or two ECM proteins at day 7 of differentiation. (A) 
Fusion index was calculated from MyHCB positive myotubes as the ratio of 
number of nuclei inside the myotubes versus total number of nuclei in 6 random 
fields of view. (B) Number of myotubes were determined in 6 random fields of 
view. Data represented as mean ± SD (n=6) from two independent experiments. 
* shows p≤0.05. Am: A. mylitta; Bm: B.mori; Aa: A.assamensis; Sr: S.ricini 
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Figure 5.13. HSMMs cell adhesion and spreading on 3D silk scaffolds. 
HSMMs (7.5x104) were cultured on 3D silk scaffolds: Bm (b), Am (d),  Sr (f) and 
Aa (h) for 2 days in SkGM-2 proliferation medium, fixed with 4% 
paraformaldehyde and stained with rhodamine phalloidin for F-actin staining and 
imaged using Nikon A1 confocal microscope. The images represented are 
merged images of several z-stack images (5 µm each stack, 150-200 µm deep 
into the scaffold). Blank scaffolds (a, c, e, g) stained with Rhodamine phalloidin 
(red) and DAPI (blue). Scale bars 50 µm. Shown is a representative image of six 
fields of view. Am: A. mylitta; Bm: B.mori; Aa: A.assamensis; Sr: S.ricini 
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taken across the scaffolds. Staining of blank scaffolds with DAPI and Rhodamine 
phalloidin revealed their porous nature (Fig 5.13 a, c, e and g).   
5.2.8 HSMM cell adhesion on solubilized muscle matrix coated B. mori silk 
scaffold 
To examine whether coating the silk scaffolds with solubilised skeletal muscle matrix 
(prepared in chapter 3) would affect cell behaviour, B. mori silk scaffolds were coated 
with solubilized muscle matrix (200 µg/scaffold) for 2 h at 37ºC and HSMMs were 
cultured for 5 days in SkGM-2 medium on either matrix coated B. mori scaffolds or B. 
mori scaffolds alone (section 2.13.1) (Fig 5.14).   
Morphological staining of the cytoskeletal F-actin fibres by Rhodamine phalloidin 
showed well distributed cells across the entire scaffold on B. mori silk and matrix coated 
B. mori silk scaffolds (Fig 5.14 a, c). Interestingly, the matrix coated scaffolds, appeared 
to support a higher cell density even though the same number of cells were seeded on 
both scaffold types. High magnification images of the respective scaffolds confirmed 
that cells were distributed in a more compact arrangement on matrix coated B. mori 
scaffolds, or may have grown at a faster rate compared to cells on uncoated B. mori 
scaffolds (Fig 5.14).   
5.2.9 Matrix deposition by HSMMs on four silk 3D scaffolds  
To determine if like the C2C12 cells, HSMMs deposited ECM proteins onto the 3D silk 
scaffolds, HSMMs were cultured for 2 days in SkGM-2 proliferation medium on 3D silk 
scaffolds and immunostaining was performed to detect the presence of the matrix 
proteins, fibronectin and perlecan. Immunofluorescence images revealed deposition of 
both fibronectin and perlecan on all four silk scaffolds with comparable signal intensities 
(Fig 5.15 a-h). Close examination of the images show that matrix proteins were forming 
a mesh or lattice across the entire scaffold with interconnections going into the scaffold.   
5.2.10 Scanning electron microscopy (SEM) of 3D silk scaffolds (section 
2.13.3) 
To observe the ultrastructure of the scaffolds and the arrangement of HSMMs on the 
scaffolds, SEM was performed on all four silk scaffolds with and without HSMM cells  
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Figure 5.14. HSMMs cell adhesion and spreading on muscle matrix coated 
B. mori (3D) silk scaffolds. HSMMs (7.5x104) were cultured on either B. mori 
silk scaffold (a-b) or B. mori scaffold coated with solubilised muscle matrix (c-d) 
(200 µg/scaffold) for 5 days in SkGM-2 proliferation medium, fixed with 4% 
paraformaldehyde and stained with Rhodamine phalloidin to visualize F-actin 
and imaged using a Nikon A1 confocal microscope. (b, d) are high magnification 
images of a selected area of the respective images (a, c). The images 
represented are merged images of several z-stack images (5 µm each stack, 
150-200 µm deep into the scaffold) taken across the scaffolds. Nuclei and 
scaffolds are stained with DAPI (a, c). Scale bars -100 µm 
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Figure 5.15. Immunofluorescence revealed secretion of ECM proteins by 
HSMMs on 3D silk scaffolds. HSMMs (7.5x104 cells/scaffold) were seeded 
onto the scaffolds and cultured for 2 days in SkGM-2 medium. Cells were 
fixed using 4% paraformaldehyde and stained with antibodies recognising 
fibronectin (a-d) and perlecan (e-h) and imaged using a Nikon A1 confocal 
microscope. The images represented in the figure are merged images of several 
z-stack images (5 µm each stack, 150-200 µm deep into the scaffold). The 
antibodies recognising fibronectin and perlecan were rabbit polyclonal 
antibodies. The secondary antibody used was a goat anti-rabbit alexafluor 488 
conjugated antibody. Nuclei are stained with DAPI (blue). Scale bars- 50 μm for 
a-h. Am: A. mylitta; Bm: B.mori; Aa: A.assamensis; Sr: S.ricini 
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Figure 5.16. Scanning electron micrographs of 3D silk scaffolds. Blank 
scaffolds (without cells) reveal the porous nature of the scaffolds: Bm, Am, Sr 
and Aa (a, c, e, g) respectively. At day 5 after seeding, HSMMs formed a cell 
sheet on all four scaffolds covering almost the entire scaffold suggesting that 
scaffolds supported cell adhesion and growth (b, d, f, h). Scale bar-100 µm for 
a-h. Am: A. mylitta; Bm: B.mori; Aa: A.assamensis; Sr: S.ricini 
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Figure 5.17. Scanning electron micrographs of 3D silk scaffolds. High 
magnification images of blank scaffolds, Am and Sr show the interconnected 
pores in silk scaffolds (a, d). At day 2 after seeding, HSMMs adhere to the silk 
scaffolds and spread on Am scaffold (b, arrow shows a well spread cell), matrix 
deposition (arrow) can be seen (c); cells formed a sheet on Sr scaffold (e); 
magnified image of the box show cell projections (arrow) attached to the scaffold 
(f). Scale bar-10 µm for (a-b, d-e) and 2 µm for c and f. Am: A. mylitta; Sr: 
S.ricini 
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at days 2 and 5 after seeding (Fig 5.16-5.17). All four scaffolds appeared porous with 
pores ranging in diameter from 50-120 µm on A. mylitta, 30-110 µm on B. mori, 30-90 
µm on S. ricini and A. assamensis scaffolds. SEM images of blank scaffolds revealed the 
interconnected porous nature of the scaffolds. HSMMs formed a cell sheet on all four 
scaffolds, covering almost the entire scaffold after 5 days of seeding (Fig 5.16). Upon 
closer examination of cells on an A. mylitta scaffold, the cell morphology can be seen: 
cells appeared well spread, flat and elongated with many focal contact points and 
deposition of matrix can be seen. On S. ricini scaffold, cells appeared to be growing like 
thick sheets covering the porous structure of the scaffolds (Fig 5.17). 
5.2.11 HSMMs differentiation on 3D silk scaffolds section (2.13.1) 
To assess the differentiation of HSMMs on 3D silk scaffolds, HSMMs were seeded at a 
higher cell number (5x10
5
 cells per 14 mm diameter scaffold) on B. mori, A. mylitta, A. 
assamensis or S. ricini silk scaffolds and maintained in SKGM-2 proliferation medium 
for 4 days, and for a further 4 days in differentiation medium comprising of 
DMEM/F12/2%HS (Fig 5.18). Slow muscle myosin (MyHCB) immunostaining 
revealed that HSMMs fused and formed multinucleated myotubes on all four scaffolds 
but there were far less MyHCB positive myotubes on S. ricini scaffolds compared to 
scaffolds from the other insect species. The confocal imaging of the myotubes indicated 
that they were not confined to the same focal plane and suggested that myotubes formed 
as a result of fusion with cells at different depths in the 3D scaffolds (Fig 5.19). The 
parallel alignment of the MyHCB positive myotubes on B. mori, A. mylitta and A. 
assamensis was striking. Interestingly, on A. assamensis scaffolds there appeared to be 
two layers of myotubes, one at a 90º orientation to the other (Fig 5.18 and 5.19).  
5.2.12 Partially solubilised (or Unfixed) B. mori scaffold supported HSMM 
differentiation  (section 2.13.1) 
Interestingly, when the B. mori scaffolds were not fixed with ethanol, but were placed in 
medium for cell culture experiments without fixation the scaffolds started to partially 
solubilise. HSMMs were seeded on these scaffolds at (1x10
5
 cells/scaffold) and cultured 
for 11 days in proliferation medium and 7 days in differentiation medium. Visualization  
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Figure 5.18. Immuonostained images revealed HSMMs differentiation on 
3D silk scaffolds. HSMMs (5x105) were cultured for 4 days in SkGM-2 
proliferation medium on ethanol fixed and sterilized Bm, Am, Aa and Sr silk 
scaffolds, and then the medium was changed to a differentiation medium 
DMEM/F12/2%HS for a further 4 days. Post differentiation, scaffolds were fixed 
using 4% paraformaldehyde and stained with anti-myosin, mouse mAb 
(NOQ.5.4.D), followed by a goat anti-mouse alexafluor 488 conjugated 
secondary antibody. Images were captured using a Nikon A1 confocal 
microscope. Represented are merged images of several z-stack images (5 µm 
each stack, 150-200 µm deep into scaffold). Nuclei are stained with DAPI (blue) 
Scale bars -100 µm. Am: A. mylitta; Bm: B.mori; Aa: A.assamensis; Sr: S.ricini 
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Figure 5.19 Immuonostained 3D images revealed HSMMs differentiation on 
3D silk scaffolds. HSMMs (5x105) were cultured for 4 days in SkGM-2 
proliferation medium on ethanol fixed and sterilized Bm, Am, Aa and Sr silk 
scaffolds, and then the medium was changed to a differentiation medium 
DMEM/F12/2%HS for a further 4 days. Post differentiation, scaffolds were fixed 
using 4% paraformaldehyde and stained with anti-myosin, mouse mAb 
(NOQ.5.4.D), followed by a goat anti-mouse alexafluor 488 conjugated 
secondary antibody. Images were captured using a Nikon A1 confocal 
microscope. Represented are 3D merged images of several z-stack images (5 
µm each stack, spanning 100-250 µm deep into scaffold). Nuclei are stained 
with DAPI (blue) Scale bars -100 µm. Note the formation of myotubes in 
different planes and moving into the scaffolds. Am: A. mylitta; Bm: B.mori; Aa: 
A.assamensis; Sr: S.ricini 
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Figure 5.20. HSMMs differentiation on unfixed B. mori silk scaffolds. 
HSMMs (7.5x104) were cultured on unfixed B. mori silk scaffolds (3D) for 11 
days in SkGM-2 proliferation medium and then the medium was changed to a 
differentiation medium and cells were cultured for another 7 days. After cell 
differentiation, scaffolds were fixed with 4% paraformaldehyde and stained with 
Rhodamine phalloidin and imaged using a Nikon A1 confocal microscope (a); 
the colour coded images show the distribution and migration of cells into the 
scaffold (b and c); SEM images show myotube like structures on partially 
solubilised silk scaffolds (d, e). Nuclei are stained with DAPI (blue). Scale bar -
100 µm for a-c; 30 µm for d and 10 µm for e. 
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of the cells by rhodamine phalloidin and DAPI staining revealed multinucleated cells 
with elongated nuclei and F-actin fibres aligned in parallel orientation, which suggested 
that cells were differentiating (Fig 5.20. a). The 3D colour coded image indicated that 
cells were distributed up to a depth of 67 µm into the scaffold (Fig 5.20. b, c). SEM 
images of these scaffolds clearly showed that cells covered the entire scaffold surface 
and myoblasts had fused to form myotube like structures by day 15 of culture (Fig 5.20. 
d-e).   
5.2.13 qPCR Experimental workup:   
(a) RNA concentration and quality (section 2.8.2) 
HSMMs were cultured under 2D conditions on the silk substrates. RNA was isolated 
from HSMMs cultured for 4 days in SKGM-2 proliferation medium or for 4 days in 
SKGM-2 proliferation medium plus 1, 7 or 14 days in differentiation medium on wells 
coated with B. mori, A. mylitta, A. assamensis, S. ricini, collagen I or tissue culture 
plastic. The ISOLATE RNA KIT was used for this purpose. Since the RNA was to be 
used for qPCR experiments, RNA concentration and purity was assessed by measuring 
the absorbance spectrophotometrically and obtaining the ratio of A260/A280 nm. For all 
the RNA samples, A260/A280 values were between 1.8 and 2.1.  
The genes expressed by HSMMs cultured under 3D conditions were also examined by 
qPCR. RNA was isolated from HSMMs cultured for 4 days in proliferation medium or 
for 4 days in differentiation medium on either B. mori or A. mylitta 3D scaffolds using 
the TRIZOL method. For all the RNA samples, A260/A280 values were between 1.7 and 
2.1.  
(b) Melt Curve Analysis (section 2.8.5) 
Melt curve analysis was performed as described previously (chapter 4, section 4.3.3). As 
can be seen in Figure 5.20, melt curve histograms for three reference genes and four 
genes of interest respectively from cDNA samples from HSMMs cultured on silk fibroin 
coated 2D substrates at days 1 and 7 of differentiation, a prominent single peak was 
detected for each primer pair indicating gene specific annealing.  
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Figure 5.21 Melt curve analysis of reference genes for HSMMs cultured on 
solubilised silk fibroin. To assess the specificity of the primers, melt curve 
analysis was performed after every qRT-PCR run. Fluorescence (y-axis) is 
plotted versus temperature (x-axis). Melt curves show the temperature where 
two strands of DNA separate.  
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(c) Primer efficiency calculations (section 2.8.6) 
Briefly, five-fold dilutions (1/5, 1/25, 1/125 and 1/625) of neat cDNA (from cultures day 
3 of proliferation and 7 of differentiation) were prepared and were amplified for each 
primer pair (three reference genes and five genes of interest, Table 2.5) in a qPCR 
reaction. The reaction efficiencies derived from these experiments are shown in Table 
5.3.  
       Table 5.3 Primer efficiencies of reference genes and genes of interest 
Gene symbol Amplification 
efficiency (%) 
SDHA 88 
ACTAB 93 
TBP 108 
MYOD1 101 
MYF5 110 
MYH 1 67 
MYH 3 - 
ACTA 1 94 
 
(d) Validation of reference genes using Bestkeeper analysis (section 2.8.7) 
qRT PCR was performed on cDNA samples obtained from HSMMs cultured on B. mori 
and A. mylitta silk fibroin 3D scaffolds in DMEM/F12/2% HS medium at day 2 and day 
10 of differentiation. CT values obtained after performing the qRT-PCR were placed in 
the Bestkeeper software and analysed. Three reference genes (SDHA, TBP and ACTAB) 
were evaluated before performing the baseline correction for gene expression. 
On A. mylitta scaffold, TBP was found to be the most stable reference gene with CV±SD 
values of 1.79±0.50. The expression levels of SDHA and ACTAB were also within 
acceptable limits with values of 3.35±0.89 and 3.61±0.71 respectively. Similarly, on B.  
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Figure 5.22. Quantitative real-time PCR was used to determine the 
expression of four differentiation markers in differentiating HSMMs grown 
on Aa and Bm solubilised silk scaffolds. HSMMs (6x103 cells/cm2) were 
seeded on Aa and Bm coated wells in a 12-well plate and cultured for 4 days in 
SKGM-2 proliferation medium. Then the medium was changed to a 
differentiation medium DMEM/F12/2%HS and cells were cultured for 14 days in 
differentiation medium. RNA was isolated from cells at days 1, 7 and 14 of 
differentiation. Relative expression levels for MYF5, MYOD1, MYH1 and ACTA1 
were normalized to the Ct value of the reference gene (TBP) and fold change 
was determined using 2-delta delta Ct method. Day 7 and 14 differentiation 
expression levels were normalized to Day 1 of differentiation. Mean  SE of 4 
biological replicates are shown. Bm: B.mori; Aa: A.assamensis. 
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mori scaffold, TBP was the most stable reference gene with a value of 1.94±0.55, 
followed by ACTAB and SDHA with values of 2.30±0.65 and 2.94±0.60.  
5.2.14 Relative mRNA levels of myogenic markers in HSMMs on 2D silk 
substrates (section 2.12) 
Further, mRNA levels of muscle transcription factors, myogenic factor 5 (MYF5) and 
myogenic determinant protein-1 (MYOD1) and heavy chain myosin (MYH1) and skeletal 
muscle actin-α (ACTA1) was assessed using qRT PCR. TBP was used as a reference 
gene after validation using Bestkeeper analysis. Gene expression on days 7 (in 
differentiation medium) and 14 (in differentiation medium) was assessed when HSMMs 
(6x10
3
/cm
2
) were cultured on B. mori and A. assamensis silk fibroin substrates. The 
baseline expression of the differentiation genes was set at 1. 
On both B. mori and A. assamensis silk fibroin substrates, MYF5, MYOD1, and ACTA1 
showed a similar trend with an increase in the expression levels at day 7 of 
differentiation but by day 14 the expression levels of MYF5, MYOD1 were below the 
baseline expression at day 1 while ACTA1 levels remained close to the baseline level at 
day 14 (Fig 5.22). In contrast, the expression pattern of MYH1 differed on the two silk 
substrates. On A. assamensis silk fibroin, the expression of MYH1 was three fold higher 
on day 7 of differentiation than that at day 1 and then it dropped by day 14 of 
differentiation to below the baseline. However, on B. mori silk fibroin the expression of 
MYH1 was also three-fold baseline at day 7, but increased to five-fold baseline at day 14 
(Fig 5.22). 
5.2.15 Gene expression of myogenic markers in HSMMs on B. mori and A. 
mylitta 3D silk scaffolds (section 2.13.4) 
Since, cell behaviour may be altered when cells are cultured in a 3D microenvironment; 
the mRNA levels of MYF5, MYOD1, MYH1 and ACTA1 were measured using qRT PCR 
when HSMMs (5x10
5
/scaffold) were cultured on B. mori and A. mylitta silk fibroin 3D 
scaffolds. TBP was used as a reference gene and gene expression on day 10 (in  
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Figure 5.23. Quantitative real-time PCR was used to determine the 
expression of four differentiation markers in differentiating HSMMs grown 
on Bm and Am 3D silk scaffolds. HSMMs (5x105 cells/scaffold) were seeded 
on Bm and Am 3D silk scaffolds and cultured for 6 days in SKGM-2 proliferation 
medium. Then the medium was changed to a differentiation medium 
DMEM/F12/2%HS and cells were cultured for another 10 days in differentiation 
medium. RNA was isolated from cells at days 2 and 10 of differentiation. 
Relative expression levels for MYF5, MYOD1, MYH1 and ACTA1 were 
normalized to the Ct value of the reference gene (TBP) and fold change was 
determined using 2-delta delta Ct method. Day 10 differentiation expression levels 
were normalized to Day 2 of differentiation. Mean  SE of 4 biological replicates 
are shown. Am: A. mylitta; Bm: B.mori. 
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Figure 5.24. Quantitative real-time PCR was used to determine the 
expression of five differentiation markers in differentiating HSMMs grown 
on Bm and Am 3D silk scaffolds. HSMMs (5x105 cells/scaffold) were seeded 
on Bm and Am 3D silk scaffolds and cultured for 4 days in SKGM-2 proliferation 
medium. Then the medium was changed to a differentiation medium 
DMEM/F12/2%HS and cells were cultured for 4 days in differentiation medium. 
RNA was isolated from cells at day 4 of proliferation and day 4 of differentiation. 
Relative expression levels for MYF5, MYOD1, MYH1, MYH3, and ACTA1 were 
normalized to the Ct value of the reference gene (TBP) and fold change was 
determined using 2-delta delta Ct method. Day 4 differentiation expression levels 
were normalized to Day 4 proliferation. Mean  SE of 4 biological replicates are 
shown. Am: A. mylitta; Bm: B.mori.  
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differentiation medium) was assessed by normalizing expression relative to that at day 2 
of differentiation (Fig 5.23). 
 On A. mylitta 3D silk scaffold, MYF5, MYOD1 and MYH1 levels at day 10 of 
differentiation were similar to the levels at day 2 of differentiation. However, there was 
a marked decrease in the expression levels of ACTA1 at day 10 of differentiation. On B. 
mori 3D silk scaffold, MYF5 and MYOD1 expression levels went down at day 10 of 
differentiation whereas, the muscle myosin and actin isoforms, MYH 1 and ACTA 1 
increased. Since there was no significant change in the expression levels of myosin 
isoforms and actin isoforms decreased drastically on A. mylitta scaffolds, it was 
hypothesized that at many cells may have already crossed the threshold and were 
oriented towards a more mature differentiated phenotype than cells on B. mori scaffolds 
where the MYH 1and ACTA1 showed an increase at day 10 of differentiation. Therefore, 
to capture the early stages of differentiations, qRT-PCR was performed on day 4 (in 
differentiation medium) with normalizing to the baseline expression at day 4 of 
proliferation that is immediately before cells were stimulated to differentiation. 
The results are shown in Fig 5.24. On B. mori and A. mylitta scaffolds, MYF5 mRNA 
levels went down on both the scaffolds as the cells preceded towards differentiation and 
MyoD1 expression increased. On both scaffolds, a time dependent increase was 
observed in ACTA1, MYH1 and MYH7 levels indicative of mature myotubes. Although 
the increase in levels of ACTA1 mRNA was much higher on A. mylitta scaffolds than on 
B. mori scaffolds possibly suggesting early differentiation of HSMMs on A. mylitta 
scaffolds (Fig 5.24).  
5.2.16 3D muscle like tissue growth  
To visualize the formation of a 3D muscle-like tissue, HSMMs were seeded at (5x10
5
 
cells per 14 mm diameter scaffold) on B. mori silk scaffolds and maintained in SkGM-2 
proliferation medium for 4 days, and for a further 4 days in differentiation medium 
comprising of DMEM/F12/2%HS (Fig 5.25). The confocal images of a large area of the 
scaffold and myosin immunostaining (secton 2.13.2) suggested that myotubes were 
formed and covered a very large area of the scaffold i.e. 1.58 mm x 1.218 mm. The  
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Figure 5.25. Two-dimensional view of a confocal z-stack of multichannel images of 3D 
muscle-like tissue on B.mori scaffolds. HSMMs (5x10
5
) were cultured for 4 days in 
SkGM-2 proliferation medium on ethanol fixed and sterilized B. mori silk scaffolds, and then 
the medium was changed to a differentiation medium DMEM/F12/2%HS for a further 4 
days. Post differentiation, scaffolds were fixed using 4% paraformaldehyde and stained with 
anti-myosin, mouse mAb (NOQ.5.4.D), followed by a goat anti-mouse alexafluor 488 
conjugated secondary antibody. Images were captured using an Ultraview spinning disc 
confocal microscope. To capture a large area and to get an estimate of the coverage of the 
myotubes on scaffold surface, 50 z-stack images of 2.5 μm each stack were stitched 
together using the Volocity software. Note the extensive coverage of myotubes on the 
scaffold surface with x-axis (1.58 mm), y-axis (1.213 mm) and z-stack (125 μm). Scale bar-
150 μm.  
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length of the myotubes was also measured using the Volocity software and the analysis 
revealed that myotubes formed were very long with an average length of 347 μm ±7.2 
(Fig 5.25).   
5.3 Discussion 
This chapter describes the in vitro examination of four silk fibroins extracted from 
different silkworms, for their potential as biomaterials. The results showed that all four 
silk proteins, when solubilised and used as a substrate, promoted cell growth, 
proliferation and differentiation of C2C12 myoblasts in 2D serum free cultures. Silk 
fibroin substrates also supported the differentiation of primary human skeletal muscle 
myoblasts (HSMMs). These cells were shown to express myosin heavy chain and 
Glucose transporter 4, both muscle differentiation markers and the fusion of myoblasts 
to form myotubes was evident on all four silk fibroin materials. Interestingly, myoblasts 
cultured on 3D silk fibroin scaffolds deposited matrix proteins within a few days of 
culture to coat the scaffold framework. Although the rate of myoblast differentiation 
may be expected to be primarily regulated by the deposited matrix proteins, the evidence 
suggested that A. mylitta fibroin scaffolds promoted more rapid differentiation than B. 
mori scaffolds.  
Previous studies with silk as a potential biomaterial for skeletal muscle tissue 
engineering have used the murine myoblast cell line, C2C12 as the model cell type. In 
this study, in addition to C2C12 cells, HSMMs were also used to test the 
biocompatibility of silk fibroin biomaterials in 2D and 3D cultures. Additionally, a 
serum-free culture system was used with the C2C12 cells to better assess the role of 
these different silk proteins in regulating cell growth and differentiation.   
Initially, solubilised silk fibroin was used to coat tissue culture plastic and its ability to 
support myoblast adhesion and proliferation was assessed microscopically. Phase 
contrast micrographs showed that C2C12 myoblasts adhered and maintained their 
characteristic stellate shape on all solubilised silk matrices (Fig 5.2). The viability and 
proliferation of C2C12 cells was evaluated over a 3 day period; C2C12 cells were sub-
confluent at 3 days in a 96-well plate but after this time point contact inhibition altered 
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the rate of growth. These proliferation assays indicated an equivalent growth pattern on 
all fibroin films, collagen type I and fibronectin, and this was comparable to uncoated 
plastic on day 1 and 2 after seeding but at day 3 there was significantly higher growth on 
all silk matrices compared to tissue culture plastic (Fig 5.3). Although on A. assamensis 
silk C2C12 cells did grow more slowly than on the other protein substrates. We further 
tested the proliferation of HSMMs on silk and ECM protein substrates (Fig 5.10). Time 
points for assessing HSMM proliferation were day 2, 5, 8 and 11 as the doubling time of 
HSMMs was more than 42 hours (data not shown). The growth rate of HSMMs was 
similar on all silk fibroin substrates and was comparable to that on the ECM protein 
substrates and uncoated plastic until day 8. However, by day 11 of proliferation the 
number of cells on A. mylitta silk fibroin was higher than that on all other substrates.   
Immunostaining showed that both, C2C12 myotubes and the HSMM derived myotubes 
stained positively for myosin (slow skeletal heavy chain, MyHCB) (Fig 5.5 and Fig 
5.11). However, there was a difference in the orientation of myotubes derived from two 
muscle cell types. HSMM derived myotubes appeared more numerous and aligned in a 
parallel orientation on all silk substrates, which could potentially promote better 
differentiation and enhance myotube striations [281]. In contrast, C2C12 myotubes were 
thicker, having more nuclei per myofibre and were not as well aligned on the fibroin 
coated glass surfaces (compare Fig 5.5 and Fig 5.11). A similar finding was observed by 
Cheng et al (2014); they found that as primary human skeletal muscle cells (HSkM) 
differentiated, the diameter of these myotubes decreased, while C2C12 myotubes 
diameter increased [301]. In our study, HSMM derived myotubes expressed GLUT4, 
which has been used as a marker for mature, functional myotubes. Guillet-Deniau et al 
(1994) found that GLUT4 appeared only in spontaneously contracting myotubes 
cultured on an extracellular matrix and was located in small intracellular vesicles [302]. 
After a short exposure to insulin, GLUT4 was translocated to the plasma membrane of 
the myotubes [302]. An intracellular and cell surface location for GLUT4 matches our 
data for HSMMs on silk fibroin substrates. Although this suggests these myotubes were 
mature, contractile performance of the myotubes was not assessed. The extent of HSMM 
differentiation was further investigated by means of fusion index and counting the 
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number of myotubes formed on silk substrates. The results showed that myoblasts fused 
with similar capacities on three silk substrates: B. mori, A. mylitta and S. ricini and the 
two ECM protein substrates: collagen I and fibronectin with between 77%-80% of the 
nuclei within the myotubes and the number of myotubes per field of view being between 
13 to 17 for all substrates. However, on the A. assamensis silk substrate, both the fusion 
index and number of myotubes formed were significantly lower than on other substrates. 
These findings were curious given that A. mylitta silk fibroin is known to have an 
integrin binding peptide, RGD, in its amino acid sequence whereas B. mori does not. 
Whether the other non-mulberry species also have the RGD peptide in their silk fibroins 
is unclear [138, 140].  
Given that C2C12 cells were shown to secrete ECM proteins onto etched glass, it was 
also possible that they also secreted these proteins onto the silk substrates thereby 
providing their own microenvironment. Immunofluorescence analyses revealed that 
C2C12 cells secreted major ECM proteins like collagens type I, IV and VI, fibronectin 
and perlecan although not all these silk fibroin substrates triggered the same level of 
ECM protein deposition (Fig 5.6-5.9). The reason for the differential 
production/deposition of ECM proteins on different silk substrates may be due to 
differences in the structure of these silk fibroins. Immunostaining results similarly 
showed that all four silk scaffolds in their 3D form supported matrix protein deposition 
by HSMMs (Fig 5.15). Scanning electron microscopy images of HSMMs on an A. 
mylitta scaffold further supported the immunofluorescence observations, as clear protein 
deposition can be seen (Fig 5.17 c). Secreted ECM proteins play an important role in 
muscle differentiation. Chan et al (2007) [295] performed a proteomic analysis of 
C2C12 cells cultured in serum free medium and identified 80 non-redundant proteins, of 
which 27 were secretory proteins. Some of these secretory proteins were molecules 
involved in ECM remodelling, cell proliferation, migration, and signalling [295]. For a 
biomaterial to be successful as an implanted graft, it should support the resident 
progenitor cells to synthesize and deposit their own matrix and to form a natural ECM 
which would better support tissue repair.  
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Other researchers have used a hybrid scaffold of cell derived ECM and a silk fibroin for 
nerve tissue engineering in vivo. In particular, Gu et al (2014) used silk fibroin scaffolds 
coated with Schwann cell derived ECM proteins to successfully repair a 10 mm gap in 
the sciatic nerve of rats [303]. These researchers cultured Schwann cells in the presence 
of ascorbic acid on silk fibroin/chitosan conduits for a period of 14 days and then 
decellularized the scaffolds leaving cell deposited fibronectin and laminin on the 
scaffolds. These ECM coated scaffolds were then implanted in a rat model of sciatic 
nerve injury and the repair outcomes compared to those of Silk fibroin/Chitosan 
scaffolds or an acellular nerve graft. After 12 weeks functionality was significantly 
better in either the Schwann cell-derived ECM modified scaffold or the acellular nerve 
graft than the scaffold only group [303]. Since all four silk fibroins in our study, both in 
a solubilised form as 2D substrates and as 3D scaffolds supported the deposition of 
ECM proteins by myoblasts, these scaffolds with their deposited skeletal muscle cell 
derived ECM may similarly perform better in vivo to repair volumetric muscle loss than 
silk scaffolds that lack ECM proteins.   
It is necessary to evaluate the cell responses in a 3D microenvironment as the 
information obtained from 2D cell culture is potentially not complete due to a difference 
in the cell niche encountered by cells in a 3D environment. Moreover, the arrangement 
of membrane proteins responsible for cell-ECM and cell-cell interactions can be very 
different between 3D and 2D substrates [304]. The geometry of the 3D scaffolds can 
have an impact on the “stemness” and behaviour of stem cells as compared to a flat 2D 
substrate. A recent study by Wei et al (2014) showed that mouse embryonic stem cells 
cultured on collagen, chitosan and PLGA based 3D scaffolds revealed better 
maintenance of stem cell like phenotype which was marked by an increase in the 
number of G0/G1 phase cells, up-regulation of Oct4 and down-regulation of Sox2 genes 
and higher clonal formation ability as compared to the cells cultured on a 2D substrate 
[304]. In addition, 3D scaffolds mimic in vivo situations as they offer better nutrient and 
gaseous exchange, and removal of waste products is much more effective in a 3D 
scenario. 
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To investigate in in vitro assays, whether coating silk scaffolds with solubilised muscle 
matrix (chapter 3) would alter cell adhesion and spreading, HSMMs were cultured on 
muscle matrix coated B. mori 3D silk scaffolds. Cytoskeletal staining for actin fibres 
revealed that after 5 days in culture, HSMMs appeared well distributed and elongated on 
both, the matrix coated B. mori scaffolds and uncoated B. mori scaffolds (Fig 5.14). 
However, a higher cell density and better cell alignment was achieved on matrix coated 
scaffolds. Other workers have found that coating biomaterials with ECM proteins 
enhances cell proliferation and differentiation. In one such study, silk scaffolds obtained 
from B. mori were combined with the ECM proteins: collagen type I, type IV and 
fibronectin and evaluated for their potential in bladder tissue regeneration [305]. Two 
structurally distinct silk scaffolds were prepared: smooth, compact multi-laminates and 
rough, porous lamellar-like sheets and then coated with the ECM proteins. Interestingly, 
the rough, porous sheets coated with fibronectin promoted the highest attachment of 
human bladder smooth muscle cells, urothelial cells, murine embryonic stem cells and 
induced pluripotent stem cells when compared to the other scaffolds [305]. 
Immunohistochemistry and real time RT-PCR analysis revealed that the fibronectin 
coated silk scaffolds also supported the contractile differentiation of smooth muscle cells 
which was marked by a significant up-regulation of α-actin and SM22α mRNA and 
protein expression levels following TGFβ1 stimulation [305]. This indicating the 
fibronectin-coated rough porous scaffolds best assisted embryonic stem cells and iPS 
cell differentiation toward both urothelial and smooth muscle lineages [305]. The 
decellularized muscle matrix, prepared in our study (chapter 3) is a mixture of structural 
collagens, glycoproteins, including fibronectin and proteoglycans, and although the 
HSMMs were not stimulated to differentiate on the muscle matrix coated B. mori 
scaffolds, the alignment and density of these cells suggested that they were proceeding 
to differentiation more rapidly than HSMMs on the uncoated B. mori scaffolds. Given 
the findings of Franck et al (2013) [305], this should have been investigated further.  
F-actin staining and SEM images illustrated that HSMMs adhered to and spread evenly 
on 3D silk scaffolds and formed a cell sheet by day 5 in culture (Fig 5.13. and Fig 5.16-
5.17). Immunostaining against slow skeletal muscle myosin (MyHCB) showed 
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differentiation of HSMMs on the 3D scaffolds was triggered more readily on some 
scaffolds than on others (Fig 5.18 and 5.19). On B. mori scaffolds HSMMs formed 
extremely long, well aligned myotubes, whereas the myotubes formed on A. mylitta 
scaffolds appeared thicker and much shorter. Myosin expressing myotubes on scaffolds 
from A. assamensis were perpendicularly oriented in 2 layers on the 3D scaffolds and S. 
ricini silk fibroin poorly supported differentiation of HSMMs (Fig 5.18 and 5.19). This 
result was surprising given that on S. ricini 2D silk fibroin substrates the fusion index 
and myotube number were not different from those observed on A. mylitta or B. mori 
substrates. This suggests that the porosity of the scaffolds may have been a contributing 
factor. Interestingly, the cell sheet covering S. ricini scaffolds were quite different in 
appearance to that on the other silk scaffolds. The SEM images revealed what appeared 
to be a many cell thick layer (Fig 5.16), whereas the underlying structure of the A. 
mylitta, B. mori and A. assamensis scaffolds was visible under a much thinner cell layer. 
Others have shown that optimum pore size architecture is a crucial component of silk 
fibroin scaffolds. In particular, Zhang et al (2010) reported that human bone marrow 
mesenchymal stromal cells seeded on silk fibroin scaffolds of different pore sizes were 
found to prefer scaffolds of a pore size between 100 μm – 300 μm and showed better 
cell proliferation and ECM production on these scaffolds [306]. Furthermore, in vivo 
transplantation of these silk scaffolds together with the bone marrow mesenchymal 
stromal cells promoted de novo bone formation [306].  
When the B. mori scaffold was used without fixation, it started to partially dissolve (Fig 
5.19). Remarkably, when HSMMs were cultured on these “partially solubilised” B. mori 
silk scaffolds, they lined up and displayed well aligned F-actin fibres and elongated 
nuclei along the length of the actin fibres, which suggested differentiation of myoblasts 
into aligned myotubes (Fig 5.20). A useful property of silk scaffolds that promotes their 
use as a bio-implant for tissue regeneration purposes is their biodegradability without 
releasing any toxic products. Testing the biodegradation of the four silk scaffolds used 
here was beyond the scope of this study, but others have demonstrated their 
biodegradability under in vitro [307, 308] or in vivo conditions [151, 152]. Given 
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scaffolds are bio-degradable in vivo the result shown in Fig 5.20 was encouraging as it 
suggests that partially degraded B. mori silk scaffolds can still support myogenesis.  
To quantify the extent of differentiation of the HSMMs on the different silk scaffolds, 
the expression pattern of a number of genes that trigger the differentiation of myoblasts 
to myotubes were investigated. MYF5 is the first muscle regulatory factor to be 
expressed during mouse embryogenesis while MYOD1 promotes cell cycle withdrawal 
and induction of differentiation [197]. MYH 1 and MYH 7 are adult heavy chain myosin 
isoforms and ACTA 1 is muscle actin isoform [284]. In this study, TBP was found to be 
the most stable reference gene which is in accordance with the study conducted by 
Stern-Straeter et al (2009), where these authors examined the expression of six reference 
genes: Beta-actin; Beta-2-microglobulin; glyceraldehyde-3-phosphate dehydrogenase; 
peptidylprolyl isomerase A; TATA box binding protein (TBP) and ribosomal protein, 
and large P0 (RPLPO) in human skeletal muscle myoblast cultures [309]. They found 
that RPLPO was the most stable reference gene and TBP was the second best. We did 
not included RPLPO in our study; but among ACTAB, SDHA and TBP, the latter was 
found to be the best reference gene.  
 
There were some differences observed in the gene expression profile of HSMMs in 2D 
and 3D cultures (Fig 5.22-5.24). The lower number of cells seeded in 2D cultures 
(6x10
3
) as compared to the cell numbers seeded on 3D scaffolds (5x10
5
) may have been 
a contributing factor as well as the nature of the supporting protein. In 2D cultures of 
HSMMs on A. assamensis and B. mori silk fibroin, MYF5, MYOD1 and ACTA1 showed 
a similar pattern of expression where the levels increased by day 7 of differentiation and 
then decreased at day 14 of differentiation, with ACTA 1 levels remaining close to the 
baseline.  
 
The anti-myosin immunostaining data indicated that HSMMs differentiated very well on 
A. mylitta and B. mori scaffolds (Fig 5.18), hence we examined the gene expression 
prolife of differentiation markers on these two silk scaffolds. Since it is not easy to 
visualize the formation of myotubes on 3D scaffolds, the differentiation was assessed 
after culturing HSMMs for 17 days (7 days in proliferation and then 10 days in 
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differentiation medium), giving them maximum time to differentiate. Firstly, the 
differentiation was assessed at day 10 of differentiation (Fig 5.23). The results suggested 
that on A. mylitta 3D silk scaffolds, the cells are differentiating early as there was 
virtually no change in the expression of MYF5, MYOD1 and MYH1 while ACTA1 shows 
a significant decrease at this time point. The data also suggested that cells on B. mori 
scaffold were still differentiating as there was a concomitant increase in MYH1 and 
ACTA1 levels (Fig 5.23). This is a possible scenario as the cells were in proliferation 
medium for 7 days and then for a further 10 days in differentiation medium and we 
chose day 2 differentiation levels as our normalization levels. With the higher cell 
number (5x10
5 
cells/scaffold) it is very likely that myoblasts may have fused earlier than 
expected. Hence to capture the early stages of differentiation, another experiment was 
conducted where cells were cultured for 8 days: 4 days in proliferation medium and 4 
days in differentiation medium. On both scaffolds, a decrease in MYF5 levels and an 
increase in MYOD1 levels suggested that cells had ceased proliferation. MYH7 showed a 
10 fold and 8 fold increase on B. mori and A. mylitta respectively which correlated with 
the protein expression levels of this gene product (MyHCB) (Fig 5.18). The other 
myosin isoform, MYH1 showed only a slight increase on both silk scaffolds but ACTA1 
levels were much higher on A. mylitta than on B. mori (Fig 5.24). The cells may be 
differentiating early on A. mylitta as the silk fibroin from this silkworm species 
possesses an integrin binding RGD peptide and others have shown that neonatal 
cardiomyocytes cultured on B. mori and A. mylitta silk scaffolds attach and spread much 
faster on A. mylitta silk than B. mori silk. Furthermore, the cardiomyocytes cultured on 
A. mylitta scaffolds differentiated towards a more mature phenotype exhibited by well 
aligned sarcomeres and sustained contractions in culture [141]. Mudera et al (2010) 
investigated the effect of increasing cell density on the maturation and contractile ability 
of muscle derived cells in a 3D collagen based model of skeletal muscle [310]. Their 
results showed that maximal peak force was obtained at an optimum seeding density of 
30x10
6
 cells/collagen construct while a distinctive force contraction profile was obtained 
when cells were seeded at 40x10
6
 cells/collagen construct. A concomitant increase in the 
myogenic expression profiles of MYH7 was seen: from 8-fold to 40-fold when cells were 
seeded at a density of 30x10
6
 and 40x10
6 
cells/collagen construct respectively [310]. 
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Their study showed that cell density in a 3D microenvironment can govern the 
phenotype of human skeletal muscle cells.  
 
Natural ECM in a functional muscle is highly orientated and muscle fibres extend 
longitudinally, sometimes up to the length of 35 cm within this natural ECM to form the 
contractile machinery. In order to form a functional muscle graft, the regenerated fibres 
should join end to end or else muscle atrophy will occur. Our data suggested that 3D silk 
fibroin scaffold from B. mori was highly supportive of myoblast differentiation and the 
confocal imaging showed that the myotubes formed were very long, 347 μm in length 
and cells covered a very large area of the scaffold (1.58 mm x 1.218 mm) (Fig 5.25); 
myotube formation was a result of the fusion of myoblasts in different planes. Creation 
of 3D skeletal muscle tissue constructs which mimic the characteristics of the muscle 
tissue in vivo will provide a better system to the research community for skeletal muscle 
tissue engineering purposes and might fill the gap between 2D and 3D 
microenvironment. A recent study by Tang-Schomer et al (2014) further supports our 
observation although their study was focussed on construction of a functional brain-like 
cortical tissue in 3D in vitro cultures [311]. The researchers cultured primary rat cortical 
neurons on silk fibroin-ECM (collagen) composites and found that compartmentalized 
and interconnected neural network formation occurred in these silk fibroin based 3D 
biomaterials. Furthermore, this “brain like” tissue displayed electrophysiological and 
mechanical properties simulating in vivo brain functions and responded to induced injury 
in vitro rendering the applicability of this “brain like” tissue for the assessment of brain 
disorders like traumatic brain injury [311]. 
 
5.4 Conclusion 
In summary, our results demonstrated that silk fibroin extracted from four different 
silkworms was effective in supporting both, mouse and human myoblast proliferation 
and differentiation under in vitro 2D and 3D culture conditions. In a 2D scenario, A. 
assamensis silk fibroin was least able to support proliferation of C2C12 cells and 
differentiation of HSMMs. All four silk scaffolds supported ECM production by 
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HSMMs with a similar degree of arrangement of ECM. In 3D cultures, B. mori and A. 
mylitta were found to best support HSMMs differentiation. As a result, it is proposed 
that B. mori and A. mylitta silk scaffolds are most likely to be useful as three 
dimensional frameworks for skeletal muscle repair in in vivo muscle injury models.  
5.5 Future Directions 
Since these scaffolds showed promising results in vitro it will be intriguing to test these 
silk scaffolds in animal models for the treatment of volumetric muscle loss. Another 
useful experiment to perform is to evaluate the immune-modulatory properties of these 
silks scaffolds either in vitro using macrophage cultures or in an in vivo implantation 
situation with subsequent analyses of several inflammatory cytokines.   
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Chapter 6: 
Atomic force microscopy: applications in muscle matrix 
biology 
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6.1 Introduction  
The supramolecular structure of ECM assemblies is responsible for the function of many 
connective tissues including skeletal muscle. For a better understanding of the role of 
ECM in muscle repair and regeneration, it is imperative to know more about the 
ultrastructure of the complex mesh of molecules that make up the ECM. Existing 
imaging techniques like electron microscopy requires samples to be fixed with strong 
fixatives like paraformaldehyde or gluatraldehyde which might alter the structure of the 
samples. Atomic force microscopy provides a better alternative for imaging structural 
features of ECM, as samples can be imaged without fixing.  
A basic atomic force microscope consists of a silicon nitride cantilever to which a sharp 
silicon tip (radii of 20-60 nm) is attached. It works on the basic principle of tip-sample 
interactions. The AFM tip scans over the sample surface and the AFM records 
interactions between the tip and the surface. The cantilever deflects in a z-direction as 
the tip scans over the surface and this deflection is detected by a photodiode. A 
computer processes the electrical signal of the photodiode and generates a feedback 
signal for the piezoscanner to maintain a constant force on the tip. This information is 
transferred into a topographic image of the surface (Figure 6.1). Atomic Force 
Microscopes can be operated in different imaging modes – for example contact and 
tapping modes (also called as intermittent contact mode), depending on the sample: hard 
materials are imaged with contact mode whereas soft biological samples are imaged 
using tapping mode.  
Contact mode: In this mode, the tip is in permanent physical contact with the sample 
surface and the force between the tip and the sample surface is kept constant via an 
electronic feedback loop. Contact mode can be used to image hard and stable samples 
which are not affected by the frictional force components the tip applies to the sample. A 
significant disadvantage of Contact Mode are the lateral forces occurring between probe 
and sample during scanning. 
Tapping mode (Intermittent contact mode): In this mode an oscillating tip (near its 
resonance frequency) is used and the tip is not in contact with the surface for most of the  
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Figure 6.1. Schematic representation of an atomic force microscope. A 
basic atomic force microscope consists of a silicon nitride cantilever to which a 
sharp silicon tip (radii of 20-60 nm) is attached. It works on the basic principle of 
tip-sample interactions. The AFM tip scans over the sample surface and the 
AFM records interactions between the tip and the surface. The cantilever 
deflects in z-direction as the tip scans over the surface and this deflection is 
detected by a photodiode. A computer processes the electrical signal of the 
photodiode and generates a feedback signal for the piezoscanner to maintain a 
constant force on the tip. This information is transferred into a topographic 
image of the surface. Image adapted from University of Neuchatel, Switzerland 
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oscillation cycle. When the tip (driven by piezo) moves towards the surface, it begins to 
tap the surface. This leads to an energy loss by the oscillating tip which reduces the 
amplitude significantly. In Tapping Mode, the amplitude of the oscillation is used as a 
feedback parameter for imaging the topography of the sample. Tapping Mode can be 
done in air and also in fluids and thus is suitable for imaging biological specimens. 
Lateral forces, which occur during scanning in contact mode, are nearly non-existent in 
tapping mode. 
It is also possible to combine the high-resolution topographical imaging capabilities of 
an atomic force microscope with the optical imaging abilities of a confocal microscope. 
Using this technique it is possible to determine the biochemical composition of the 
matrix along with the topographic image. Another useful AFM technique in matrix 
biology is ‘force volume’ imaging. In this mode, the tip measures individual forces at 
different points on the matrix and these individual force curves are combined to produce 
a volume image. This can be very useful to determine the elasticity of different cells or 
extracellular matrices in tissues. 
Here in this chapter, AFM imaging of undifferentiated C2C12 myoblasts and 
differentiated myotubes on collagen I matrix was performed to investigate the cell-
matrix and cell-cell interactions at molecular level and to get a quantitative estimate of 
the height of the cells when spread on collagen I. The ultrastructure of the skeletal 
muscle matrix of mice was also visualized; both the control muscle and muscle 
decellularized using the PLA2 method were imaged. A thin layer of fibronectin coated 
on glass and gelatin gels crosslinked with heparin (2% w/v) were imaged to get an 
insight into any change in the gel structure after modification with GAGs. We also 
attempted to biochemically analyse the decellularised matrix obtained in chapter 3 using 
the picoTREC imaging technique. Finally, “force volume” imaging was also performed 
on the decellularised matrix to determine the elasticity of the acellular muscle matrix.  
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6.2 Supplementary Materials and Methods 
6.2.1 Cell culture or muscle tissue sectioning  
C2C12 (Passage 15) cells (5x10
4
) were seeded on collagen I (10.0 µg/cm
2
) coated cover-
slips in growth medium (DMEM/10% FBS) and maintained at 37ºC and 5% CO2. After 
24 h (80% confluence), cells were transferred to differentiation medium (DMEM/2% 
horse serum) and were cultured for 5 days. Cells at day 1 after seeding and day 5 after 
differentiation were fixed in 4% paraformaldehyde for 10 min and stored in PBS at 4ºC 
until imaging. Muscle sections (triceps or gastrocnemius) were cut (10 µm) using a 
cryostat.  
6.2.2 Preparation of gelatine gel  
Gelatine (500 mg) was dissolved in 10 ml of hot water to yield a solution of 50 mg/ml. 
This gelatine solution (6 ml) was pipetted in to a mould and incubated at 4ºC O/N to 
allow gel formation.   
6.2.2.1 Cross linking the gelatine gel with GAGs  
The gelatine gels each containing 50 mg of gelatine were incubated in 20 ml of 40% v/v 
ethanol containing 50 mM 2-morphilinoethane sulfonic acid (MES) pH 5.5 for 10 min at 
RT. Gels were subsequently immersed in 20 ml 40% v/v ethanol containing 50 mM 
MES pH 5.5 and 2% Heparin (w/v) for 4h at RT with 24mM of 1-Ethyl-3-[3-
dimethylaminopropyl] carbodiimide hydrochloride (EDC, Sigma-Aldrich). N-hydroxy 
succinimide (NHS, Sigma-Alrdich) was added in an EDC: NHS ratio of 5:1 and 
incubated overnight at RT. Next day, the gels were washed twice in 0.1M Na2HPO4 (pH 
9.1) for 1h. Finally to remove uncoupled heparin from the gels were washed twice in 1M 
NaCl for 2h, 2M NaCl for 1 day (6 changes of washing solution) followed by washing 
with distilled water. Gels incubated without heparin in the presence of EDC/NHS were 
used as controls. 
6.2.3 AFM Probes used for imaging 
NCH probes (NanoWorld, Neuchatel, Switzerland) for tapping mode in liquid and DNP 
probes (Bruker, Billerica, MA) for contact mode in air 
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 NCH probes:specifications (www.nanoworld.com) 
Cantilever Data Value Range* 
Thickness 4.0 µm 3.5 - 4.5 
Mean Width 30 µm 25 - 35 
Length 125 µm 120 - 130 
Force Constant 42 N/m 21 - 78 
Resonance Frequency 320 kHz 250 - 390 
 
    Schematic of a tip 
DNP probes:specifications (http://www.brukerafmprobes.com) 
Material: Silicon Nitride 
Geometry: Triangular 
Cantilevers Number: 4 
Cantilever Thickness (Nom): 0.6 µm 
Cantilever Thickness (RNG): 0.55 - 0.65 µm 
Back Side Coating: Reflective Gold 
Top Layer Back: 45 ± 5 nm of Ti/Au 
 
Shape 
Resonant Freq. kHz Spring Const. N/m Length µm Width µm 
Nom. Min. Max. Nom. Min. Max. Nom. Min. Max. Nom. Min. Max. 
A Triangular 65 50 80 0.35 0.175 0.7 120 115 125 25 20 30 
B Triangular 23 16 28 0.12 0.06 0.24 205 200 210 40 35 45 
C Triangular 56 40 75 0.24 0.12 0.48 120 115 120 20 15 25 
D Triangular 18 12 24 0.06 0.03 0.12 205 200 210 25 20 30 
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 Schematic of cantilevers 
6.2.4 Mounting the cantilever on scanner  
A cantilever was mounted on the scanner with tip positioned at the edge of the scanner 
centre point. The Scanner was then placed in an inverted position on the microscope 
stage and the laser spot was aligned on the cantilever.   
6.2.5 Sample mounting 
Firstly, a silicon wafer was placed on the fluid cell assembly and then the cover-slip 
(24mm
2
) either containing C2C12 cells (undifferentiated or differentiated) or muscle 
sections was placed on the silicon wafer and then sealed with an O-ring. The silicon 
wafer reflects the light from the bright field microscope and makes it easier to view the 
sample otherwise it is difficult to trace the sample on a cover-glass. PBS was then added 
drop wise to the fluid cell. The O-ring prevents any leakage of PBS from the fluid cell 
assembly. The assembly was then carefully slid onto the microscope so that the nose of 
the scanner is right at the centre of the stage, allowing access to the sample. The laser 
spot was readjusted on the cantilever to compensate for the shift due to liquid in the flow 
cell.  
6.2.6 AFM imaging 
6.2.6.1 Contact mode in air  
Images of gelatin gels were acquired using a Nanoscope IIIa (Digital Instruments Inc., 
Santa Barbara, CA) atomic force microscope with V-shaped silicon nitride cantilever in 
contact mode and a long range scanner. 
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6.2.6.2 Tapping mode in liquid 
All the samples (except the gelatin gel) were imaged using a PicoPlus AFM (Agilent 
Technologies, Santa Clara, CA) with tapping mode in liquid using a silicon nitride 
cantilever with a spring constant of 0.32 N/m. The cantilever was tuned with a frequency 
range of 1-60 kHz. Cantilever oscillation frequencies and drive amplitudes were 
determined by the Pico Scan 5 software before every scan. Once the desired frequency 
was reached with a sharp peak obtained, the tune frequency was narrowed down and the 
tip was retracted by 10 µm and approached with a slower speed. The amplitude voltage 
to start the scan was between 3V and 5V and when the tip approached the sample, the 
voltage falls. Once the cantilever reached the surface of the sample, the set-point was 
lowered and the scan rate was decreased which enabled the collection of high resolution 
images. All the images were obtained only after optimising the gain settings (integral 
and proportional gains were close to 1). Height, amplitude and phase images at different 
scan areas of 80 µm
2
, 50 µm
2
, 10 µm
2
 and 2 µm
2
 were captured between scan rates of 1 
to 5 Hz using the software Pico Scan 5. All reported images were acquired with 512 × 
512 pixels definition. Depending on the area of the scan, either a long range scanner or a 
short range scanner was used. 
6.2.7 picoTREC Measurements 
6.2.7.1 AFM tip functionalization 
Amine groups were introduced onto inert AFM tips using the vapour phase deposition 
method [312]. Briefly, AFM tips (Type VI Mac Levers, Agilent Technologies) were 
washed in methanol (3 times), dried and then washed again with chloroform (100 %) for 
5 min and dried. Tips were then placed in a desiccator to remove all air and moisture 
from the tips. After complete drying, tips were placed on para-film in a petri-dish 
(35mm
2
) with 30 µl of fresh 3-(Aminopropyl) triethylsiloxane (APTES (99%), Sigma 
Aldrich) and 10 µl of tetraethyl-ammonium chloride (TEA (0.5%), Sigma Aldrich) and 
incubated for 2 h at RT.  
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6.2.7.2 Antibody linking to the tips 
Antibody coupling to the AFM tips is a three step protocol where firstly, an amine group 
is attached to the AFM tip (see above), followed by linking a flexible cross-linker 
molecule (NHS-PEG800-aldehyde in this case) and finally the covalent binding of the 
desired antibody (an anti-collagen I antibody in this case) to the cross-linker [312, 313]. 
Briefly, 10 µl of an anti-collagen I rabbit polyclonal antibody (Abcam) was diluted in 
100 µl of sterile PBS and then centrifuged in a Ultra 15 centrifugal filter unit (Amicon, 
Millipore) at 10,000 g for 10 min at 4ºC to remove the sodium azide from the antibody 
mixture. The heterobifunctional cross-linker NHS-PEG800-aldehyde (Sigma-Aldrich) 
was covalently bound to the amine groups on the tips at a concentration of 6.6 mg/mL in 
chloroform with 1% (vol/vol) triethylamine for 2h at RT. Tips were then placed in a 1 
mg/ml antibody solution (25µl) and 2 µl of sodium cyanoborohydride (NaCNBH3) 
solution (32 mg NaCNBH3, 50 µl of 100 mM NaOH in 450 µl MilliQ water) for 2 h. 
Subsequently, 5 µl of 1 M ethanolamine-hydrochloride (Sigma-Aldrich) was added to 
the solution for 10 min to quench any remaining aldehyde groups. Finally, the probes 
were washed and stored in PBS buffer at 4°C. 
6.2.7.3 Simultaneous topography and recognition imaging (TREC) measurements 
This procedure uses a receptor functionalised tip on a magnetic-coated cantilever (MAC 
probe) driven by a magnetic field (MAC mode). For AFM topography and recognition 
measurements, MAC probes (nominal spring constant 0.2 – 0.9 N/m) modified with the 
collagen I antibody as described were used for imaging. Gastrocnemius muscle sections 
(thickness, 20 µm) on glass coverslips were placed in a fluid cell filled with PBS at RT. 
MAC mode non-contact images were acquired using a PicoPlus AFM and a 
picoTREC
TM 
box (Agilent Technologies), spanning regions of interest less than 5 × 
5 μm2. Cantilevers were tuned to a very low drive frequency (3.5 kHz) at scanning 
speeds of 1 line/s (or slower) using full amplitude feedback. For the MAC mode probes, 
the thermal noise method was used for calibration and spring constants were found to be 
between 0.2 and 0.9 N/m. 
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6.2.8 Force spectroscopy and force volume imaging 
To measure the elastic forces of the gastrocnemius muscle samples, PicoPlus AFM was 
used according to the protocol described earlier to capture topographic images (tapping 
mode in liquid). In AFM “force spectroscopy” experiments, the cantilever and tip were 
moved towards the sample until they were in contact, and then retracted again while the 
force of the interaction between the tip and sample was measured (Figure 6.2). This step 
was then repeated at different locations of the sample to build up a map of tip-surface 
interactions. The Topograph and spectroscopy sweep (SPS) option was selected in the 
buffer assignment window and an SPS sweep was performed at every 32
nd
 and 16
th
 point 
using contact mode and tapping mode in liquid. Closest SPS curve was extracted to load 
a spectroscopy sweep of the closest data point. Seven to eight data points were examined 
and the raw data collected for cantilever deflection and z-piezo movement for every 
force curve was then subsequently analysed using a custom MATLAB script. The elastic 
modulus of the muscle samples was then determined by fitting the modified Hertz model 
to force indentation curves.  
6.2.9 Image Analysis 
All the images acquired using AFM were analysed using the Gwyddion data analysis 
software version 2.31 (http://gwyddion.net/). Standard gwyddion tools were used for 
plane levelling and line correction of images. Some images were also modified using the 
‘scar’ correction tool to remove the background noise.  
6.3 Results  
6.3.1 Fine structure of cells and cell-matrix interactions were visualized using 
AFM 
Undifferentiated C2C12 cells (day 1 in proliferation media) and differentiated myotubes 
(day 5 in differentiation media) (section 6.2.1) were visualized using AFM by tapping 
mode in liquid (section 6.2.6.2).  
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Figure 6.2. Force distance curve to map tip-sample interactions. An AFM 
force-distance curve is a plot of tip-sample interaction forces vs. tip-sample 
distance. The schematic diagram shows the movement of the cantilever and tip 
during the force spectroscopy experiment-towards the sample (the approach 
part, shown in red) and the withdraw part (the retract part, shown in blue). A 
force curve is obtained by the graphing of force (cantilever deflection, calculated 
in volts) plotted on y-axis versus the piezoelectric position (as a distance) plotted 
on x-axis. The tip-sample force is given by Hooke's law: F=Kx where k is the 
spring constant of the cantilever, and x is the deflection of the cantilever. (Image 
adapted from Bruker.com) 
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Figure 6.3. AFM imaging of C2C12 myoblasts on collagen I coated 
coverslips. C2C12 cells (5x104) were plated on collagen I coated cover-slips in 
growth medium (DMEM/10% FBS). After 24 h (80% confluence), cells were 
fixed using 4% paraformaldehyde and imaged by AFM with tapping mode in 
liquid (PBS) using a silicon nitride cantilever with a spring constant of 0.32 N/m 
and a long range scanner. Topography (a), amplitude (b) and phase images (c) 
at scan sizes of 80 µm were captured at an initial scan rate of 1.97Hz. (d) 3D 
representation of cells providing an estimate of their height as they sit on the 
glass surface. 
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Atomic force micrographs show single cell high resolution images where 
undifferentiated C2C12 cells were well spread and attached to the collagen I coated 
plastic surface (Figure 6.3). The AFM topography image provides estimates of both 
lateral (xy) and height (z) measurements of cells (Fig 6.3. a). AFM deflection or 
amplitude images show how the tip is deflected as it encounters sample topography (Fig 
6.3 b). AFM phase images highlight sharp features of the cells (like the edges). It also 
provides qualitative information about hardness and elasticity of the surface as the phase 
signal depends on the surface properties of the object and can be affected by relative 
softness or hardness or chemical nature of the surface (Fig 6.3. c). The AFM 3D image 
provided information about the height of the individual cells spread on the collagen 
coated surface. The height was 3.3 μm (Fig 6.3. d).  
Differentiated myotubes (section 6.2.1) were captured at different stages of their 
development. Fully fused myotubes appeared elongated and spindle shaped in 
appearance with tube like structures at the ends (short arrow, Fig 6.4. b). It was also 
possible to visualize the fusion process of two myoblasts where microprocesses (thin 
fibrous extensions) of varying lengths at the ends of the two fusing myoblasts were seen 
(long arrow, Fig 6.4 b). The AFM 3D images also provided information about the height 
of these myotubes and in this case the height was 3.4 μm (Figure 6.4 d) which is very 
similar to that of the undifferentiated cells (Fig 6.3. d).  
6.3.2 Muscle matrix ultrastructure visualized using AFM  
As the goal was to characterize the structure of the matrix in skeletal muscle tissue, 
AFM was used to examine the 3D ultrastructure of the skeletal muscle tissue sections. 
Triceps muscles from 12 week old mice were decellularized using the PLA2 method 
(section 2.2.2.3) and a comparison of the tissue structure was done before and after the 
decellularization using AFM.  
The amplitude image shows the sections containing cells attached to the matrix with flat 
and even images of individual myofibres (Figure 6.5 a). The Topography image shows 
clear intercellular spaces between the two myofibres (arrow) (Figure 6.5 b) possibly 
showing the endomysium around a single muscle fibre. It is represented as a map of  
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Figure 6.4. AFM imaging of differentiated C2C12 myotubes on collagen I 
coated coverslips. C2C12 cells (5x104) were plated on collagen I coated cover-
slips in growth medium (DMEM/10% FBS). After 24 h (80% confluence), cells 
were transferred to differentiation medium (DMEM/2% horse serum), cultured for 
5 days, fixed using 4% paraformaldehyde and imaged by AFM with tapping 
mode in liquid (PBS) using a silicon nitride cantilever with a spring constant of 
0.32 N/m and a long range scanner. (a) Topography, (b) amplitude and (c) 
phase images at scan sizes of 80 µm were captured at an initial scan rate of 
1.97Hz. (d) 3D representation of cells providing an estimate of their height as 
they sit on the glass surface. Long arrow represents the point of fusion between 
two myoblasts.  
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Figure 6.5. AFM imaging of the triceps muscles of mice (control and PLA2 
decellularised) revealed the ultrastructural details of the extracellular 
matrix. Muscle sections were imaged using a PicoPlus AFM with tapping mode 
in liquid using a Silicon Nitride cantilever with a spring constant of 0.32 N/m and 
a long range scanner for control sections (a, b) and PLA2 decellularised sections 
(d, e and f). (c) 3D representation of muscle fibres providing an estimate of their 
height as they sit on the glass surface. Arrow represents the endomysium 
around single muscle fibre. Amplitude (a, d) and topography (b, e, f) images at 
scan sizes of 60 µm (a, b and d) and 2 µm (e-f) were captured at an initial scan 
rate of 1.97Hz. Arrow in (f) points to collagen fibres.   
Chapter 6 
223 
 
differently coloured pixels with a colour bar relating colour to height, with black being 
low and white high on the scan. The 3D image provides information about the height of 
the individual myofibres and in the image shown this is 2.4 μm (Figure 6.5 c).  
After decellularisation of muscle sections with PLA2, the surface appeared rough with 
several ridges seen along the whole section (Fig 6.5 d-e). A root mean square (rms) 
value which is a measure of the roughness of the surface was 0.717 µm for 
decellularized sections as compared to 0.415 µm for the control sections. A longitudianl 
scan of the tissue section at a higher resolution with a scan area of 2µm
2
 reveals an 
intricate network of collagen fibres in the matrix (Fig 6.5 e). The topography image 
reveals the characteristic banding pattern of collagen I bundles with a 67 nm gap/overlap 
region (white arrows Fig 6.5 f).   
6.3.3 AFM imaging of natural ECM proteins and scaffolds 
Fibronectin (2 µg/cm
2
) was coated onto the glass surface for 2 hr at RT and then the 
glass coverslip was imaged using a PicoPlus AFM. Gelatin gel (50 mg/ml) (section 
6.2.2) was imaged either alone or when modified using 2 % heparin (section 6.2.2.1) 
using a Nanoscope IIIa AFM. A topographic image of fibronectin coating the glass 
surface showed that the fibronectin layer was not evenly spread across the glass surface 
and there were areas left uncoated (arrow, Fig 6.6 a). A height map of the same scan 
area reveals a 60 nm thick fibronectin coating on the glass surface (Fig 6.6 d). The 
surface scanning of gelatin gel revealed the smooth surface of the gel (Fig 6.6 b) and the 
respective height map of the gel showed the indentations on this surface to be 4 nm deep 
(Fig 6.6 e). After modifying the gelatin gel with heparan sulphate, the surface appeared 
rougher with gaps appearing in the gel (Fig 6.6 c) and the height map showed bigger 
indentations of 8 nm deep (Fig 6.6 f).  
6.3.4 picoTREC imaging of muscle sections (section 6.2.7.3) 
TREC imaging was applied to the control gastrocnemius muscle sections in PBS buffer 
using collagen I antibody functionalized tips. PBS has a pH of 7.4 which closely mimics 
the physiological pH and thus serves as an ideal fluid for imaging conditions. 
Measurements were made in small areas on the muscle sections varying from 5 µm
2
 to  
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Figure 6.6.AFM imaging of different scaffolds with their height maps. 
Topographic images of Fibronectin (2 µg/cm
2
) coated on glass (a), gelatin gel (b) 
and gelatin gel modified with heparan sulfate (c); imaged using a Nanoscope IIIa 
atomic force microscope with V-shaped silicon nitride cantilevers in contact 
mode and a long range scanner. Respective height maps of the above three 
surfaces (d-f).  
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Figure 6.7. AFM imaging of the gastrocnemius muscles of mice using MAC 
mode in PBS. Muscle sections were imaged using a PicoPlus AFM with tapping 
mode in liquid using MAC mode probes with a spring constant of 0.2 -0.9 N/m 
and a short range scanner. Images on the left (a, c) are topographic images 
while images on the right (b, d) are their respective recognition images. (a and 
b) are acquired with a tip oscillation amplitude of 22 nm, c and d with 33 nm.  
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1.5 µm
2 
and with amplitudes from 20nm-50nm. Fig 6.7 (a, c) shows the topographic 
image of the muscle section, with respective TREC images of the same area of muscle 
section in Fig 6.7 (b, d). Recognition spots were very difficult to interpret in these 
images.  
6.3.5 Force spectroscopy imaging of muscle sections (section 6.2.8) 
 
Gastrocnemius muscle sections (10 µm) were imaged using the topograph and SPS 
option in the PicoScan software. The result shows (Figure 6.8 a and b), a topographic 
image of the muscle section (20 µm
2
) and the corresponding points where the 
spectroscopy sweeps were performed with contact mode (section 6.2.6.1) imaging and 
tapping mode (section 6.2.2.2) imaging in PBS. Calculation of the elastic modulus of the 
muscle samples was not possible due to the excessive number of force curves taken per 
image and there was no MATLAB script available to convert those force curves to yield 
a Young’s modulus (Y) value. Agilent Technologies, the manufacturer of the 
microscope were contacted regarding a programme for the direct conversion of the force 
curves, but they did not have a programme for this application. If the experiments were 
performed now, it would have been easier to map the elasticity of the samples using new 
AFM imaging systems, which have more advanced features. For example, WITec alpha 
300s scanning near field optical microscope (SNOM) is now available and it can provide 
force spectroscopy data in real time.  
6.4 Discussion 
The application of AFM imaging in cell biology is still in its infancy but in recent years 
it has gained huge attention. The aim of this chapter was to obtain images of myoblasts 
undergoing the process of fusion to provide insights into the muscle differentiation 
processes. Also performed was high-resolution imaging of the control muscle and PLA2 
decellularised matrix to investigate the ultrastructure and surface roughness of the 
remaining matrix.  
Frequently, the interaction between the hard surface of a tip and soft cell surface makes 
it difficult to obtain good resolution images using AFM [314]. Therefore, the C2C12  
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Figure 6.8. AFM force volume imaging of the gastrocnemius muscles of 
mice using contact and tapping mode in PBS. Muscle sections (10 µm) were 
imaged using a PicoPlus AFM with contact mode and tapping mode in liquid 
using silicon nitride cantilevers with a spring constant of 0.36 N/m and a long 
range scanner. Only the respective topographic images were shown in the 
above figure. (a) Contact mode imaging in PBS. (b) Tapping mode imaging in 
PBS. The letters A, B ….. G denote the points where respective force curves 
were taken on the muscle section.  
 
Chapter 6 
228 
 
cells were fixed with paraformaldehyde as fixing made cell surfaces more rigid and 
easier to image. The images obtained revealed the cell shape and micro-structure at the 
point of cell fixation (Fig 6.3 and 6.4). 3D images of the myoblasts and myotubes shows 
that there was not a significant difference in the height of individual cells. Intercellular 
interactions between myoblasts during the fusion process have also been captured by 
others using an AFM [314]. However, the images obtained were generated using contact 
mode in liquid. Contact mode imaging is not the preferred mode of AFM imaging when 
softer surfaces like cells are imaged, as frictional forces generated by lateral tip-sample 
interactions can damage the cells [315]. The images of myoblasts and myotubes in this 
chapter were obtained using tapping mode in liquid and as a consequence better 
resolution images were captured compared to those published by Kim et al (2008) [314]. 
Time lapse imaging of C2C12 myoblasts at various stages of the cell cycle was 
performed to capture myoblast cell fusion and cell division in real time by Stadler and 
colleagues [316]. Although, these researchers succeeded in capturing images of 
myoblasts undergoing fusion, only a few images of cell division were taken because of 
difficulties associated with myoblasts being loosely adhered to the substratum. It is clear 
from the above studies that AFM imaging is a difficult technique and requires a lot of 
user time to obtain good images and useful information from those images.  
Cryo-sectioned control muscle tissues and PLA2 decellularized muscle were imaged in 
PBS as cryo-sectioning preserves the native protein structure of the samples during 
sample preparation and imaging in PBS keeps the pH at a physiological level [224]. 
High resolution images were obtained and they revealed minute changes in the 
nanotopography (surface structure) of the muscle samples as the AFM tip encountered 
the collagen and elastic fibres in the muscle (Fig 6.5). Root mean square (rms) value of 
the control and PLA2 decellularized muscle tissue revealed that after decellularisation 
the remaining ECM was much rougher than the control muscle. Tissue section AFM has 
been used to visualize the macromolecular structures of fibrillar collagens in skin, 
cartilage and intervertebral disc; elastic fibres in the aorta and lung, as well as the 
intracellular organelles like desmosomes and mitochondria [224] but it had not been 
used for imaging muscle matrix.  
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The AFM images provided useful information about the topography of different 
scaffolds. The ECM molecule fibronectin coated on glass and heparan sulfate cross-
linked gelatin gels were imaged with AFM. A marked increase was observed in the 
surface roughness of heparan sulfate modified gelatin gels (Fig 6.6). The 
nanotopography of a synthetic surface plays a key role in determining cell adhesion, 
proliferation and differentiation and recent studies suggested that cells respond to these 
nano-topographical features [317-319]. It is likely that the observed differences in the 
nanotopography of the gelatin gels with or without immobilized heparin sulfate will alter 
cell behavior when cells are seeded on these gels in vitro. Designing synthetic scaffolds 
which mimic the natural ECM in their structure can markedly increase the regenerative 
response of cells when seeded on these scaffolds. From our data, it is clear that AFM 
images will assist in understanding the nanotopography of both natural ECMs and their 
synthetic scaffold mimics.   
picoTREC measurements were made using an anti-collagen I antibody tethered to the 
AFM tip. It was not possible to interpret the data obtained by picoTREC measurements 
(Fig 6.7), as it is not clear that the respective recognition images in Fig 6.7 are true 
recognition events and not an artefact because the control experiments to verify the 
specificity of the antibody-protein interaction were not performed. If experiments with 
an excess of antibody in the imaging medium were performed and this resulted in a 
significant decrease in the molecular recognition events, then it is possible to be more 
certain of the specificity of the interactions recorded. Due to lack of this experiment, the 
data presented here gave an idea about the picoTREC technique and its applicability in 
muscle matrix biology. Creasey et al (2011) performed antibody recognition imaging on 
human lens capsules to examine protein aggregates in pseudoexfoliation syndrome 
[320]. An example of a true molecular recognition signal can be seen in “Fig 3” of their 
article. In their experiments, when a tip oscillation amplitude of 30 nm was applied, a 
recognition area in relation to the topography features was observed and with a tip 
oscillation amplitude of 54 nm, a reduction in recognition was observed. In our 
experiments the amplitudes of 22 nm and 33 nm were examined and visual differences 
were observed in the recognition images.      
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With the aim of measuring the elastic properties of the muscle, force spectroscopy was 
performed on the gastrocnemius muscle sections. Topographic images and the force 
curves at marked points were obtained but a mathematical value for the elastic modulus 
could not be calculated due to unavailability of the MATLAB script (Fig 6.8). 
Decellularized muscle scaffolds have been prepared for transplantation into animal 
models [292, 321]; but, the elastic properties of the obtained ECM scaffolds were not 
evaluated. Darling et al (2010) measured the biomechanical properties (elastic moduli) 
of the pericellular matrix and ECM of articular cartilage obtained from human, porcine 
and murine knee joints in situ using AFM [322]. Elastic properties of the pericellular 
matrix were evaluated for regions surrounding cell voids in the middle zone of articular 
cartilage while ECM elastic moduli were evaluated in regions visually devoid of 
pericellular matrix. Of the three species examined, the elastic moduli of the ECM and 
the pericellular matrix of human articular cartilage was the highest while porcine 
cartilage exhibited the softest mechanical properties and murine samples showed a value 
in between [322]. This study suggests that the elastic modulus of ECM can vary between 
different species. Ghosh et al (2007) investigated the mechanical properties of adult 
human dermal fibroblasts (AHDF) cultured on hydrogels that were composed of 
hyaluronan and fibronectin in different proportions to impart different viscoelastic 
properties to the hydrogels [323]. Measurements of the elastic modulus, cellular traction 
forces and cytoskeleton structure revealed that cells on stiffer substrates had a higher 
modulus and a better organized actin cytoskeleton, which exerted larger traction forces 
on the substrate. Furthermore, as an implication of this modulation of cellular 
mechanics, cells migrated faster on softer substrates and proliferated better on stiffer 
ones [323]. These two studies and those conducted by Engler et al (2004, 2006) [164, 
228], underline the fact that it is important to evaluate the decellularized muscle 
scaffolds for their elastic properties, before they are used for xenogeneic transplantation 
purpose or in the clinic for muscle injury repair. Only limited work with AFM has been 
done on ECM scaffolds and AFM has only occasionally been applied to measure the 
elastic forces of muscle samples. Designing scaffolds of matching stiffness to muscle 
tissue and implanting these scaffolds at the muscle injury site may improve cell-scaffold 
interactions and enhance the outcome of muscle repair processes.  
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6.5 Conclusion  
Our data indicate that AFM imaging method can be useful for analyses of: 
 Cell-matrix interactions at nanometer levels, including the height and width of 
cells and capturing information of the different stages of skeletal muscle 
differentiation in vitro; 
 Three dimensional in-situ imaging of skeletal muscle sections and visualization 
of fine ultrastructure, e.g. collagen fibrils in natural muscle ECM and PLA2 
decellularised ECM, and  
 AFM provides an additional tool to visualise synthetic scaffolds that have been 
modified, with ECM proteins for example, to enhance their functional attributes. 
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7.0 Conclusion and Future perspectives 
The results presented in this thesis corroborate the importance of cell-matrix interactions 
and their role in supporting the proliferation and differentiation of both mouse and 
human myoblasts. This conclusion is based on evidence from experiments where ECM 
derived from skeletal muscle or natural silk fibroins were used as substrates in 2D and 
3D serum/serum free in vitro cultures.  
Several skeletal muscle decellularisation methods have previously been published by 
others. These methods report varying degrees of success in the removal of DNA and the 
preservation of ECM molecules in the decellularised matrix [174-176]. This current 
study is the first report of a decellularised skeletal muscle matrix with intact well-
preserved proteoglycans (perlecan and decorin) and a heparan sulphate epitope 
recognised by the antibody, EV3C3. When solubilized, this ECM supported mouse and 
human myoblast proliferation and differentiation in a serum free culture system. In 
contrast to the previous studies conducted using C2C12 cells and solubilised skeletal 
muscle matrix [174, 175], our data showed that C2C12 cells proliferated at a  slower rate 
on the solubilised skeletal muscle matrix than on pure collagen I or fibronectin. This 
may be attributed to the presence of some growth factors in the solubilized skeletal 
muscle matrix, for example, myostatin (a TGF-β family member) negatively regulates 
the growth of C2C12 myoblasts and Thomas et al (2000) showed that when 
C2C12 myoblasts were incubated with myostatin, proliferation of myoblasts decreased 
[324]. Although the cells proliferated at a slower rate on the solubilised ECM substrate, 
the alignment of myotubes was much better on the muscle matrix coated surfaces 
compared to collagen I substrates and comparable to fibronectin coated surfaces. 
Although the differentiated cells expressed slow muscle myosin (MyHCB) on all three 
substrates qPCR data indicated that the expression of myosin heavy chains, MYH1 and 
MYH7, and skeletal muscle actin (ACTA1), increased in a time dependent manner on all 
three substrates suggesting the maturation of myotubes. However, the increase in MYH1 
expression at day 4 was higher on muscle matrix than on collagen I or fibronectin which 
suggested that myotubes on muscle matrix were transiting faster towards a more 
differentiated phenotype.  
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This difference in cell growth on solubilized muscle matrix from other reports may be 
attributable to the fact that in the previous two studies DMEM/10 % FBS medium was 
used for cell culture experiments while we used a completely serum-free medium 
containing known concentrations of growth factors for all cultures of C2C12 mouse 
myoblasts. The presence of sera in tissue culture medium introduces variables and 
makes it difficult to assess the response of cells to the muscle matrix substrates. Soluble 
ECM molecules in the serum, like fibronectin and vitronectin, will bind to the matrix 
substrate thereby masking the characteristic signals of the muscle matrix. Moreover, any 
growth regulatory functions of molecules like myostatin that are contained in the muscle 
matrix may be suppressed by the growth stimulating components of serum. In our hands 
major basement membrane components that contribute to the “satellite cell niche”, like 
collagens type IV and type VI were retained in the decellularised muscle matrix.  Thus 
in our study components that control satellite cell quiescence were present in the muscle 
matrix substrates and these would have contributed to the signalling milieu regulating 
cell growth. We also found that the myoblasts secreted their own matrix proteins onto 
the substrate. Although only fibronectin and collagen IV were examined, it was clear 
that different amounts of these matrix molecules were secreted depending on the 
substrate. These subtle differences attributable to signals from the different substrates 
would be lost in the presence of serum.   
Perhaps the most interesting data generated from the investigation of cell-matrix 
interactions, was the patterning of C2C12 cells and HSMMs on the acellular 3D muscle 
matrix. Cells were aligned in concentric patterns around the transversely cut muscle 
fibres, whereas when the acellular muscle matrix was cut along the length of the tissue 
the seeded cells aligned in longitudinal patterns. This clearly indicated that cells can 
follow the matrix “cues” left after decellularisation. It also suggests that it is the 
arrangement of muscle matrix molecules in intact muscle that directs/maintains the 
aligned myotubes. Hence, when this 3D pattern is disrupted by solubilizing the matrix, 
this information is lost. These findings may have practical implications as aligned ECM 
grafts, compared to grafts placed in random orientations, at the injury site should lead to 
better regenerative outcomes for muscle injuries [291].  The data also suggested that on 
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the 3D whole muscle scaffolds, the cells were not only present on the surface of the 
scaffold but they also migrated into the scaffold by as much as138 μm. Cell migration is 
an important prerequisite for myoblasts to make cell-cell contacts, fuse and form 
multinucleated myotubes. However, a functioning muscle requires directional cell 
migration and myotube alignment, cell behaviours that from our data seem to be 
determined at least in part by the matrix substrate.  
This study found that when solubilised silk fibroin, prepared from four different 
silkworms: A. mylitta, B. mori, S. ricini and A. assamensis was used as substrates, 
C2C12 cell and HSMM proliferation was comparable to that seen when purified ECM 
proteins like collage type I and fibronectin were used as substrates. This data suggests 
that silk fibroin can be used as an alternative protein substrate for cell culture studies. 
Secretion of ECM proteins was also seen on silk fibroin substrates but different silks 
triggered the deposition of different amounts of these proteins. The signalling pathways 
causing this effect are unclear, but it is likely to involve differences in the structures of 
fibroin proteins.    
Another interesting finding was when an artificial scaffold (B. mori silk fibroin in this 
case) was coated with a tissue derived decellularised ECM (skeletal muscle ECM in this 
case), this “hybrid scaffold” better supported spreading and adhesion of HSMMs. The 
artificial scaffold provided a platform for cell adhesion and spreading while the ECM 
coating provided a complex mixture of fibrous proteins, glycoproteins, proteoglycans 
and possibly some growth factors like bFGF (associated with these proteoglycans) 
which the cells would encounter if they were present inside the body. Like the muscle 
matrix these silks scaffolds also supported the deposition of ECM proteins by HSMMs 
at very early stages of their cell cycle (day 2 after seeding). The arrangement of the 
deposited proteins was three-dimensional and appeared as “lattice” which presumably 
assisted the cells to align and fuse.   
In this study, unfixed 3D silk scaffolds when used for cell culture experiments partially 
dissolved and failed to maintain their original structure. Remarkably, HSMMs lined up 
with well aligned F-actin fibres and differentiated to form well aligned myotubes on this 
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partially dissolved scaffold. This experiment is pertinent to the in-vivo situation because, 
as silk scaffolds are biodegradable, if they are to be used in muscle repair in vivo, it is 
important to understand the extent to which a biodegrading scaffold can still support 
HSMM differentiation. That is if a silk scaffold implant is placed at the muscle injury 
site the muscle construct should not collapse as the silk slowly biodegrades.  
The final areas of the investigation involved the testing of silk scaffolds in 3D in vitro 
cultures with a view to use them in future as biomaterials in in vivo animal models of 
muscle repair. Natural ECM in a functional muscle is highly orientated and muscle 
fibres extend longitudinally within this natural ECM to form the contractile machinery. 
In order to form a functional muscle graft, the regenerated fibres should join end to end 
to avoid muscle atrophy. Our data suggested that 3D silk fibroin scaffolds prepared from 
B. mori was highly supportive of myoblast differentiation. Confocal imaging showed 
that very long myotubes were formed, in the order of 347 μm in length, and cells 
covered a large area of the scaffold. It was also apparent that myotube formation was a 
result of the fusion of myoblasts in different planes. All of which points to the potential 
of this biomaterial for muscle repair. 
Given that it appears  silk fibroin scaffolds are potential biomaterials for use in skeletal 
muscle regeneration, we envisage that multilayered silk fibroin porous sheets of 5 cm 
length and 5 mm in thickness, prepared  from silk fibroin from B. mori or A. mylitta 
silkworms, could be packed together to give a silk fibroin bio-composite material. This 
material could be implanted in a large animal model of muscle injury either alone, or in 
combination with a coating of soluble ECM derived from skeletal muscle. These 
scaffolds would be tested either pre-seeded with cells or without cells. The first 
approach would require seeding of myogenic progenitor cells/fibroblasts, or progenitor 
cells and fibroblasts in a co-culture onto the scaffold in vitro using our serum-free 
culture system and then transplanting the scaffold into the animal. These thin sheets of 
silk fibroin would allow cell migration into the scaffold (as our data suggests that 
HSMMs migrate into the scaffolds) and the thin and porous nature of the scaffolds will 
also allow in-growth of blood vessels into the functional graft. Serum free culture of 
cells to be used for transplantation provides an additional advantage that it does not 
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contain any animal derived proteins, so it minimizes the chances of evoking an 
immunologic response. It does not have to face the stringent regulatory approvals, for 
example from the FDA, to be used for clinical purposes because there is no risk of 
transferring viruses or disease from animals to man, with a serum free culture system.   
In future, after further testing on human myoblasts this serum-free culture system could 
also be useful for manufacturing cells for muscle transplantation purposes. The second 
approach requires the scaffold to be placed at the injury site and be populated by the 
resident myogenic progenitor cells residing inside the body. To cover all the necessary 
requirements of a functional implant, a thorough examination of the regeneration 
process at the site of implant is warranted. The graft site should be assessed for cell 
growth, re-innervation, and vascularization, infiltration of pro/anti-inflammatory 
cytokines and the contraction ability of the graft. A large animal model is ideal to assess 
the efficacy and safety of the biomaterial pre-clinically, before being used as a clinical 
bio-implant. Moreover, another important factor to be assessed in future studies as far as 
regenerative outcomes are concerned is the age of the animal as it is known that middle 
aged people between 40-80 years lose 20%-30% of the regenerative capacity of the 
muscles [3].   
Previously, thin sheets of porcine SIS-ECM were successfully implanted to repair 
volumetric muscle loss in a patient and the regenerated muscle tissue had greater 
functionality than was obtained without the implant [129]. Although porcine SIS-ECM 
has been approved by the FDA for clinical use, there is one study which suggests this 
SIS-ECM is not a complete acellular matrix and this may have possible implications in 
human transplantation [217]. Providing the animal studies produce favourable results, 
using silk fibroin based scaffolds as described should avoid the issues associated with 
the use of a porcine ECM.  
It is also very important to determine the elasticity of the decellularised scaffolds as it 
has been shown that substrates of different elasticity can determine the  stem cell 
phenotype seeded on those substrates [228]. Elasticity of the muscle derived scaffold can 
play a major role in myogenic differentiation. Our study showed that AFM could be 
used to measure the elastic profile of solubilised muscle matrix coated silk fibroin 
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scaffold. Silk scaffolds are generally considered to be very rigid, but we predict that the 
muscle matrix would form an elastic layer onto the scaffold. These experiments are 
easier to perform now with advanced AFM instruments and imaging applications like 
PeakForce QNM (Bruker Scientific).  It is now possible to quantify the mechanical 
properties of cells and ECM in real time at a very high resolution 
(http://www.bruker.jp/axx). AFM can be a very useful technique in the field of muscle 
matrix biology as it is possible to investigate the cell-matrix interactions at nanometer 
levels under physiological conditions. Our data suggested that it is pertinent to study the 
ultrastructure of a decellularized matrix and artificial scaffolds as cells in their 
natural/artificial environments can sense ECM structures in the nanometre scale and 
respond to these nanostructures [318, 319, 325].  
In the last decade or so, decellularized muscle ECM scaffolds have been prepared from a 
selection of muscles and transplanted into animal injury models. The numbers of 
published reports in this area have been gradually increasing [25, 130, 214, 215, 291, 
292, 321, 326-328]. Although the field of skeletal muscle tissue engineering has 
progressed, there are still a number of significant challenges before we can think of 
translating the idea of a skeletal muscle scaffold, prepared off-the-shelf, into a treatment 
for patients in the clinic. However, the field of tissue engineering as a whole, has made a 
significant progress and successful clinical transplantation of bio-artificial tissues 
including pulmonary valves, bladders, urethra and tracheas is underway [329-333].   
We are optimistic that the data obtained from this thesis will contribute to the long term 
goal of developing therapeutic options to improve muscle function in people suffering 
from muscle mass loss due to a traumatic injury.  
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